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SUMMARY
It has been reported that the phenomenon of biased hypermutation, associated with 
measles virus recovered from brain tissue, can be reproduced experimentally by 
propagation of measles virus in cultured neuroblastoma cells. The purpose of the 
research described in this thesis was to evaluate this claim and establish whether biased 
hypermutation could be induced in measles virus from an acute infection (ADD-MV), or 
in an RNA virus not implicated in neural disease such as human respiratory syncytial 
virus (huRS virus). Accordingly, an isolate of ADD-MV and huRS virus were passaged 
10 times in two neuroblastoma cell lines (SK-N-SH and IMR-32), in human lung 
fibroblasts (MRC-5) and in monkey kidney epithelial (Vero) cells.
The M gene sequence of huRS virus passaged 10 times in each cell line was compared 
with the M gene sequence of virus passaged once in the same cells. No base change was 
observed in the M gene of huRS virus as a result of passage in these cell lines.
A 750 base pair fragment of the M gene of ADD-MV was sequenced. Comparison of the 
sequence obtained from virus passaged 10 times in Vero cells with that from virus 
passaged once did not reveal any base changes. The M gene sequence of virus passaged 
10 times in SK-N-SH cells contained one base change, at position 222, a uracil to 
cytosine transition. Two base changes were observed in the M gene of virus passaged 10 
times in MRC-5 cells, one at position 222, as described above, and one at position 217, a 
cytosine to guanine base change. No changes were observed in virus passaged 10 times 
in IMR-32 cells when compared to that passaged once.
These data indicate that neither ADD-MV, nor huRS virus, underwent enhanced 
mutational events during propagation in cells of neural origin, contrary to observations 
reported previously by Wong, et al. (1989), which suggested that propagation in 
neuroblastoma cells induced biased hypermutation.
To determine if biased hypermutation occurred at a frequency too low to be detected by 
cycle sequencing, the M gene of ADD-MV passaged 9 times in IMR-32 cells, generated 
by PCR, was cloned into the bacteriophage vector M13. Twenty-four clones were 
sequenced in full. In total 21 base changes were observed, however, no more than 5 
changes were seen in any one clone, and there was no directional bias in the mutations 
observed. However, each clone contained a large deletion at the 3' region of the gene, 
ranging from 1008 to 622 bases. Thirteen of the clones also contained a 56 base 
insertion. This insertion was shown to have high identity with human mitochondrial 
transfer RNA (tRNA).
The M gene of Yamagata-1 (SSPE) virus resembles that of acute measles, but contains a 
number of additional mutations, mainly uracil to cytosine transitions. Propagation of this 
virus in neuroblastoma cells resulted in additional mutations not observed in virus 
propagated in Vero cells (Wong et al., 1989). Yamagata-1 virus was passaged in the two 
neuroblastoma cell lines (SK-N-SH and IMR-32), both with and without propagation in 
human lung fibroblast cells prior to passage in the neuroblastoma cells. Three M gene 
clones from passage numbers one and five in both cell lines used for this experiment, 
were sequenced.
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Analysis o f  the M gene sequence of Yamagata-1 virus passaged in each cell line revealed 
that the virus stock contained a heterogeneous population of M gene mRNA's. Both 
mutated sequences and sequences identical to the M gene of ADD-MV were obtained.
Comparisons of the M gene sequence from virus passaged 5 times in neuroblastoma cells 
with that passaged once revealed no biased hypermutational events. However, the 
sequence data determined from two clones appeared to be a chimera consisting of both 
ADD-MV M gene sequence and Yamagata-1 virus M gene sequence. The 
recombination point is at position 457, a G-A mutation which is the only base change 
common to both ADD-MV M gene and Yamagata-1 M gene sequence.
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L U _The Paramyxoviridae Family
Introduction
The Paramyxoviridae family of viruses contain a single-stranded, negative sense, non- 
segmented RNA genome. Mutation appears to be the only means of generation of 
variation among these viruses as intramolecular recombination has not been detected in 
viruses with linear negative-strand genomes, and variation by the reassortment of genome 
subunits is not applicable as the genome is not segmented (Pringle, 1991).
This family has been classified into 4 genera: the genus Paramyxovirus, the genus 
Morbillivirus, the genus Rubulavirus and the genus Pneumovirus (Fig. 1). Classification 
was initially based on the distinctive dimensions of the nucleocapsid, the length of the 
envelope surface projections and the route of transmission. Paramyxoviruses and 
rubulaviruses are closely related biochemically because of the haemagglutinating and 
neuraminidase activities of their attachment glycoproteins (Kingsbury et al., 1978; 
Matthews, 1982), whereas the morbilliviruses exhibit haemagglutinating activity only. 
Pneumovirus of mice (PVM) is the only member of the Pneumovirus genus exhibiting 
haemagglutinating activity which is restricted to mouse red blood cells (Ling and Pringle, 
1989).
The classification derived on this basis has been supported by recent biochemical and 
molecular studies. Figure 2 illustrates the molecular organisation o f the viral genome. 
Genes of homologous function are transcribed in the same order from a single 3' promoter 
site. The core protein genes are followed by the envelope protein genes with the 
polymerase encoding gene located furthest from the promoter. Morbilliviruses and
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paramyxoviruses have 6 or 7 similarly sized open reading frames (ORF) and intergenic 
regions (Collins, 1991).
Figure 1. The Family Paramyxoviridae
Sub-family Paramyxovirinae
Genus Paramyxovirus
Human parainfluenza virus type I (type species)
Human parainfluenza virus type 3 
Bovine parainfluenza virus type 3 
Murine parainfluenza virus type I (Sendai virus)
Simian parainfluenza virus type 10
Genus Morbillivirus
Measles virus (type species)
Dolphin morbillivirus 
Canine distemper virus 
Peste-des-petites-ruminants virus 
Phocine distemper virus 
Rinderpest virus
Genus Rubulavirus
Mumps virus (type species)
Avian paramyxovirus 1 (Newcastle disease virus)
Avian paramyxovirus 2 (Yucaipia virus)
Avian paramyxovirus 3 
Avian paramyxovirus 4 
Avian paramyxovirus 5 (Kunitachi virus)
Avian paramyxovirus 7
Avian paramyxovirus 8
Avian paramyxovirus 9
Human parainfluenza virus type 2
Human parainfluenza virus type 4a
Human parainfluenza virus type 4b
Porcine rubulavirus (La-Piedad-Michoacan-Mexico vims)
Simian parainfluenza vims 4 
Simian parainfluenza vims 41 
Mapuera vims
Sub-family Pneumovirinae
Genus Pneumovirus
Human respiratory syncytial vims 
Bovine respiratory syncytial vims 
Pneumonia vims of mice (murine pneumonia vims)
Turkey rhinotracheitis vims
Unassigned viruses in the family
Fer-de-Lance vims 
Penguin paramyxoviruses 
Equine morbillivirus
(Murphy, et a!., 1995; * Henderson et a!., 1995)
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Figure 2. Genomic organisation of viruses included in the family 
Paramyxoviridae
Sub-Family Paramyxovirinae
Genus Morbillivirus Measles virus
3' NP P/CA/' M F H L 5'
Genus Paramyxovirus 
3’ NP P/CA/ M F
Parainfluenza virus III 
HN L 5'
Genus Rubulavirus Mumps virus
NP PA/ M F SH HN L 5'
S ub-F am i 1 y Pneumo virinae
Genus Pneumovirus Respiratory syncytial virus
3' 1C 1B N P M SH G F 22K L 5'
Genus Pneumovirus Pneumonia virus of mice
3' 1C 1B N P M SH G F 22K L 5'
Genus Pneumovirus Turkey rhinotracheitis virus
3' 1C 1B N P M  F 22K SH G |_ 5'
Notes: I . P/C/V: multiple open reading frames of the P gene, coding for two additional proteins
2. It has not been determined whether TRTV does contain the two non-structural genes 1C and 
1B. Recent results suggest that these genes are not present (personal communication Dr. 
Randhawa, University of Warwick, U.K.)
3. Adapted from Pringle (1995)
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The pneumoviruses are unique, possessing 4 extra proteins; two non-structural proteins, 
IC (NS1) and IB (NS2), a second non-glycosylated envelope protein, 22K (M2) and a 
small hydrophobic protein, SH, which is also present in some of the rubulaviruses. 
Turkey rhinotracheitis virus (TRTV) is significantly different from the other 
pneumoviruses in that the gene order is different and it may lack the 1C and IB genes 
(Randhawa, J., University of Warwick, Coventry. Personal communication). The 
pneumovirus proteins are smaller than those o f the corresponding proteins in viruses of 
the other genera and have distinct amino acid sequences (Spriggs and Collins, 1986; Barr 
et al., 1991; Yu et al., 1992a and 1992b; Chambers et al., 1992). The F and L proteins do 
share a small amount of sequence homology with the F and L proteins of 
paramyxoviruses and morbilliviruses (Spriggs et al., 1986; Stec et al., 1991).
1,1.2 Genus Morbillivirus
1.1.2.1 Members of the Genus
Measles virus is a member of the genus Morbillivirus of the family Paramyxoviridae. 
Other members of this genus include canine distemper virus (CDV) which causes a 
debilitating disease in dogs; rinderpest virus (RPV) which causes disease in cattle and 
other large ruminants; peste-des-petits-ruminants (PPRV) which is specific to sheep, 
goats and other small ruminants; phocine distemper virus (PDV) which causes disease in 
seals, and cetacean distemper virus which causes disease in porpoises and dolphins. All 
vimses within this genus are closely related antigenically. They can be distinguished
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easily by differential neutralisation using homologous and heterologous viruses and sera. 
Each virus is antigenically stable, but different strains can be isolated which show widely 
differing pathogenicity in the host species. Measles virus and canine distemper virus are 
known to persist and cause chronic neurological disease in a small proportion of cases 
(Barrett el al., 1991).
Morbilliviruses are distinct from other members of the sub-family Paramyxovirinae in 
that they do not have any detectable neuraminidase activity, and infection with these 
viruses causes the formation of intranuclear inclusion bodies as part of their 
cytopathology.
1.1.3 Measles Virus - the Type Species
Measles is a highly contagious, self-limiting disease of childhood. The acute disease 
virus enters through the upper respiratory tract. The respiratory epithelium is thought to 
be the primary site of infection (Riley et al., 1978). The primary site of replication is not 
the respiratory epithelium, however, but the local lymph nodes (Cherry, 1992) 
Replication leads to a primary viraemia and infection of the reticuloendothelial system at 
multiple sites. A secondary viraemia develops 5 to 7 days after the primary viraemia. 
This leads to infection of endothelial cells causing enanthema, and epithelial cells causing 
exanthema (Ruckle and Roger, 1956). The virus is associated with leukocytes (mainly 
monocytes) in blood. It binds to the human membrane cofactor protein, CD46 (Naniche 
el al., 1993a), or the membrane protein moesin if CD46 is not present on the cell surface
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(Dunster et al., 1995) . The primary antibody response to measles virus infection is IgM 
closely followed by IgG (Mathiesen et al., 1990). Cell mediated immunity is expressed 
via CD4 and CD8 T cells. This response helps to eliminate virus that is tissue-associated 
(van Binnedijk et al., 1989, 1990). During measles virus infection, and for several weeks 
after, there is some degree of immunosuppression. Infection with measles virus results in 
a lifelong immunity. Measles virus only infects humans and primates, but effectively, 
there is no animal reservoir.
The epidemiology of measles virus is determined by the contact of a susceptible 
individual with an infectious individual. One study estimated that 76% o f household 
exposures of susceptibles lead to measles virus transmission, compared to 61% for 
varicella and 31% for mumps (Hope-Simpson, 1952). It has been suggested that, in an 
isolated population, a minimum of 400,000 to 500,000 susceptible individuals is required 
to sustain measles virus transmission (Bartlet, 1957; Black, 1966). In large populations, 
the rate of entry of new susceptible persons is high enough to maintain continuous 
measles virus transmission, so that measles is endemic. In small, isolated populations, 
measles may die out as the number of susceptible individuals declines before a new 
epidemic can occur following exposure to an incoming infectious individual.
A modified measles virus infection can develop in individuals where the virus is 
attenuated by antibodies (Edmonston, 1990). This is common in children who have 
received an immunoglobulin injection in too small amount to abort the infection. Infants 
with placental immunoglobulin can develop a modified measles virus infection when 
passive immunity is in decline and not fully protective. It may also be due to partial
8
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failure of the measles virus vaccine. There is no IgM response in modified measles 
infection. The incubation period is longer, but the clinical symptoms are milder. (Katz, 
1995)
Organs where complications occur due to measles virus infection include the heart 
(myocarditis); the respiratory tract (laryingotracheobronchitis); the gastrointestinal tract 
(diarrhoeal disease associated with vomiting); the haematopoietic system 
(thrombocytopenic purpura); and the central nervous system (sub-acute sclerosing 
panencephalitis).
Measles virus was first isolated in 1954 (Enders and Peebles, 1954). Characteristic 
cytopathic effects of measles virus infection include the formation o f multi-nucleated 
giant cells and eosinophilic intranuclear and intracytoplasmic inclusion bodies in-vitro. 
In the 1960's the presence o f structures resembling paramyxovirus nucleocapsids in 
neurones and glial cells of a patient with subacute sclerosing panencephalitis (SSPE) was 
reported (Bouteille el ah, 1965). SSPE is a fatal neurological disease o f children and 
adolescents and the presence o f intranuclear inclusion bodies in neurones and glial cells 
suggested a viral aetiology. Later, measles virus antigens and high levels o f anti-measles 
virus antibody in the cerebrospinal fluid and serum of patients with SSPE were 
demonstrated (Connolly et ah, 1967). These observations provided strong support for the 
hypothesis that measles virus was the causative agent of SSPE.
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1.1.3.1 The Measles Virus Genome
Measles virions are quasi-spherical, enveloped particles with an internal helical 
nucleocapsid. Figure 3 is a diagrammatic representation of the structure of measles virus. 
The diameter of these pleomorphic particles ranges from 100 to 250 nm. The virus 
genome is a linear, single-stranded RNA of negative polarity. There is a 52-53 nucleotide 
leader sequence (Billeter et a i, 1984; Crowley et a i, 1988), followed by six non­
overlapping genes (Fig. 2): nucleocapsid (N), phosphoprotein (P), which also encodes 
three non-structural proteins (C, V and R), matrix (M), fusion (F), haemagglutinin (H) 
and the polymerase or large protein (L). At the 5' end there are 36 untranscribed 
nucleotides constituting the trailer
1.1 .3 .1 .1  T h e  H a e m a g g lu t in in  P r o te in  (H )
The H protein is a type II transmembrane glycoprotein, the function of which is the 
attachment of virus to the cell receptor (CD46) molecule on the host cell. The H protein 
contains 617 amino acids with 5 potential glycosylation sites, 4 of which are used (Hu et 
a l, 1994b). These glycosylation sites are clustered in a small region in the extracellular 
domain of the H protein. The H protein is synthesised as monomers, most of which are 
converted to dimers by the formation of disulphide bonds. The enzyme responsible for 
this is the host-cell encoded protein disulphide isomerase which is located in the 
endoplasmic reticulum (ER) (Freeman, 1984). Dimerization takes place in the ER before 
transportation to the Golgi apparatus. Maturation of the antigenic epitopes also occurs in 
the ER (Hu et al., 1994c).
10
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The H protein is antigenically stable (Giraudon et al., 1988), and monoclonal antibodies 
raised to the H protein of measles virus do not cross react with the H protein of other 
members of the genus (Sheshberadaran et al., 1983). Sequence homology of the H 
protein within the morbilliviruses is poor (Gerald et al., 1986; Tsukiyama et al., 1987; 
Kovammees et al., 1991a), and could reflect the host specificity of the morbilliviruses. 
Studies have shown that the measles virus H protein has 60% homology with RPV and 
37% with CDV (Gerald et al., 1986; Tsukiyama et al., 1987; Kovamees et al., 1991a and 
1991b).
There are few conserved regions within the H proteins of the morbilliviruses, therefore it 
is difficult to assign functional domains. There are 12 cysteine residues that are located in 
the ectodomain of the protein, and 7 of which are conserved within the group. These 
residues (287, 300, 381, 394, 494, 579 and 583) play a critical role in the antigenic 
structure and processing of the H protein (Fig. 4). They possibly participate in the inter- 
or intramolecular disulphide bonding (Hu et al., 1994a).
Phenotypic differences between laboratory-adapted measles virus strains i.e., Edmonston, 
and recently isolated wild-type strains have been mapped to amino acids 451 and 481 of 
the H protein. These amino acids are thought to play a crucial role in CD46 down- 
regulation, hemadsorption and HeLa cell viral fusion (Lecouturier, et al., 1996). Recently 
isolated wild-type strains of measles virus appear to lack these functions (Naniche et al., 
1993a & b), which may result in a stronger immune response against measles virus.
12
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The H protein does not contain a signal peptide at the amino terminus. It has been 
suggested that the transmembrane region fulfils this role (Zerial et al., 1987).
Figure 4: Glycosylation sites of the H protein
Transmembrane anchor
Key::
C: cysteine residues critical in antigenic 
structure and processing of the H protein
: potential glycosylation sites
1.1 .3 .1 .2  T h e  F u sio n  P r o te in  (F )
The F glycoprotein is a type I membrane protein responsible for fusion of the virion and 
host cell membranes. This process takes place at neutral pH and the viral nucleocapsid is 
released into the cytoplasm of the host cell.
After synthesis, the precursor, F„, protein is transported to the ER where it is
glycosylated. There are 4 potential N-linked glycosylation sites, one is in the signal
peptide, at Asn 6, the other three are in the F2 region of the protein at Asn 29, 61 and 67
(Richardson et al., 1986). Mutations at the Asn sites 29 and 61 produce mutant proteins
that are defective in F0 protein cleavage, cell surface expression and in causing cell
fusion. It seems likely, therefore, that these two sites have significant influence in the F
protein conformation (Hu et al., 1995; Alkhatib et al., 1994b). The glycosylated F protein
is transported to the Golgi apparatus, where a subtilisin-related protease cleaves the F0
13
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protein into two disulphide linked subunits F] and F2 . Identification of the cleavage site 
was made by sequencing the F \ polypeptide (Varsangi et al., 1985). Cleavage is initiated 
at a pentapeptide region comprising 5 basic amino acids (Arg-Arg-His-Lys-Arg; residues 
108 to 112), and the Arg 112 residue is critical for proteolytic cleavage (Alkhatib et al., 
1994a). Proteolytic cleavage and transport to the cell surface occur in parallel but 
independently. A portion of uncleaved F protein does reach the cell surface, but released 
virions do not contain uncleaved F protein (Graves, 1978). This suggests that there is a 
positive selection of cleaved F proteins for incorporation into the virion, or that cleavage 
is initiated intracellularly, but continues extracellularly (Sato et al., 1988). Fully 
processed F protein arrives at the cell membrane as an oligomer or possibly a tetramer 
(Sechoy et al., 1987; Buckland et al., 1992). F proteins are anchored in the plasma 
membrane by their C terminus (Blumberg et al., 1985; Richardson et al., 1986).
The F protein contains three hydrophobic regions (Fig. 5). The first is a signal peptide 
region located at the amino terminus of the F2 subunit. This region directs the insertion 
of the F protein into the plasma membrane. The second hydrophobic region is the 'fusion' 
peptide at the amino terminus of the F 1 subunit. This region is implicated in the fusion 
process. The third hydrophobic region is the transmembrane anchor at the carboxy 
terminal of the F[ subunit, which is responsible for anchoring the protein in the 
membrane. A cysteine-rich region, which is conserved in the F genes of all 
paramyxoviruses (Richardson et al., 1986), interacts with the H protein during the fusion 
process (Wild et al., 1994; Malvoisin and Wild, 1993). Cysteine residues 1 and 2, and 3 
and 4 respectively, form disulphide loops on the F | subunit. It has been suggested that 
the H protein domain that interacts with the F protein consists of a pocket to house these
14
Introduction
disulphide loops. There are potentially two a-helices in this protein, one is carboxy 
terminal to the fusion peptide (AAH), the other is amino terminal to the transmembrane 
region and is known as the leucine zipper (Buckland and Wild, 1989). The leucine zipper 
is essential for fusion (Buckland el al., 1992). The function of the last 14 amino acids in 
the cytoplasmic tail is not fully understood. They are conserved in all morbillivirus F 
proteins and could be involved in the interaction of the F protein with the envelope 
associated matrix (M) protein.
Figure 5. Structural elements of the Fo protein which may be functionally 
important
F2 < - ->  FI
V
Key: |  signal peptide
□  cleavage motif (RRHKR) 
|  'fusion peptide'
§  alpha helix (AAH) 
Adapted from Wild & Buckland (1994)
^  cysteine-rich region
§  leucine zipper 
$  transmembrane region 
(0 cytoplasmic tail
There is at least 70% conservation of the amino acids in the F protein within the 
Morbillivirus genus (Barrett et al., 1987; Buckland el al., 1987; Tsukiyama el al., 1988; 
Kovamees el al., 1991a). Comparison of F protein primary sequences from different 
paramyxoviruses reveals a number of conserved structurally important elements which 
aid in the assignment of domains (Morrison and Portner, 1991).
15
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1.1 .3 .1 .3  T h e  M a tr ix  P ro te in  (M )
The M protein is the smallest of the structural proteins of measles virus, consisting of 335 
amino acids. The mRNA encoding the M protein, however, contains a long untranslated 
region of 425 nucleotides at the 3' end. There are two small open reading frames (ORF) 
following the M protein translation termination codon. The first translation initiation 
codon (AUG) is at position 1057 - 1059 and the second is at position 1082 - 1084. These 
ORFs are designated MX1 and MX2, however, attempts to determine if these ORFs are 
translated into proteins have been unsuccessful, thus the M gene is considered to be 
monocistronic. (Bellini el al., 1986; Wong el al., 1987).
The function of the M protein is to mediate an interaction between the envelope 
glycoproteins and the nucleocapsids in the cytoplasm to form new virus particles. This 
could be achieved by the attachment o f the M protein to the nucleocapsids causing a 
conformational change in the M protein, so revealing regions that could interact with the 
cytoplasmic tails of the envelope proteins; or, the M protein could interact with the 
envelope glycoproteins first, so revealing regions for interaction with the nucleocapsids.
Measles virus M protein has been shown to bind nucleocapsids (Hirano et al., 1993). 
Analysis of chimeric M proteins suggest that the conformation of the M protein is 
important for such an interaction, thus conformational changes in the M protein could 
contribute to a non-productive infection. There is no direct evidence to show interaction 
between the M protein and viral glycoproteins; although, in Sendai virus it has been 
shown that the M protein is associated with the viral glycoproteins prior to expression at
16
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the cell surface. It was suggested that the M protein becomes associated with the viral 
glycoprotein during transport to the cell membrane (Sanderson et al., 1993). Measles 
virus M protein can not be chemically cross-linked to either of the two envelope 
glycoproteins (Markwell and Fox, 1980), therefore, it is unknown whether it interacts 
with either or both of the viral envelope glycoproteins. The cytoplasmic domain of the F 
protein is highly conserved within the morbilliviruses, suggesting an essential function 
(Buckland et al., 1987; Tsukiyama et al., 1988). The following hypothesis has been put 
forward for the interaction of M protein with the F and H proteins (Wild et al., 1991). 
First the M protein interacts with the cytoplasmic domain of the F protein. Then the F 
and H proteins interact, consequently it may not be necessary for the M protein to interact 
specifically with the H protein. Since the cytoplasmic domains of the H proteins of 
morbilliviruses are not conserved, it seems unlikely that this region has a specific 
function in assembly (Kovamees et al., 1991b).
There is 67% identity at the nucleotide level and 76% identity at the amino acid level 
between the M genes of measles virus and canine distemper virus (Bellini et al., 1986; 
Greer et al., 1986). The C terminal one-third of the M protein is the most conserved 
across the paramyxovirus group and is hydrophobic in character. The predicted 
secondary structure for this region contains a combination of non-polar hydrophobic and 
(1-sheet domains which suggest that the M protein may interact with a lipid environment, 
but may not actually span the membrane since the hydrophobic regions are considered to 
be too short (Bellini et al., 1986; Li et al., 1980). From cell fractionation studies it is 
clear that the M protein is associated with the plasma membrane (Bowen & Lyles, 1982; 
Lamb & Choppin, 1977). On the whole the M protein is hydrophobic and highly basic.
17
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The basic nature of the protein suggests that interactions with the nucleocapsid could be 
via ionic attraction as the nucleocapsid is more acidic at its carboxy terminus; the highly 
basic amino terminus is associated with genomic RNA (Morgan et al., 1984; Heggeness 
et al., 1981) (Fig. 6). The M protein of measles virus is also associated with the cell 
cytoskeleton, particularly actin filaments (Bohn et al., 1986). Ribonucleoprotein (RNP) 
cores complexed with M protein have been shown to exhibit reduced transcriptional 
activity, whereas RNP cores free of M protein exhibited substantially higher 
transcriptional activity. These results suggest that M protein may be an endogenous 
inhibitor of measles virus ribonucleoprotein transcription (Suryanarayana et al., 1994).
RNA extracted from brain tissue o f deceased SSPE patients has revealed that the M gene 
o f measles virus persistently infecting the CNS is highly mutated. Fifty percent of the 
mutations seen in the M gene of measles virus isolated from an measles inclusion body 
encephalitis (MIBE) patient were U to C changes, a phenomenon termed biased 
hypermutation (Cattaneo et al., 1986). Such mutations will, theoretically, effect the 
assembly and budding of intact viral progeny. If the recognition sites for the F protein 
cytoplasmic tail, and/or the nucleocapsid are mutated, then viral assembly will be 
diminished, thus the viral progeny cannot be released from the host cell. Thus, biased 
hypermutation of the M gene may play a role in the development o f  measles virus 
persistence in the CNS. It is currently suggested that biased hypermutation may occur as 
a consequence of propagation in neural cells (Wong et al., 1989), and testing this 
hypothesis is one of the aims of this project. Increased activity of a double-stranded RNA 
adenosine deaminase enzyme has been suggested as the mechanism responsible for the U
18
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to C transitions seen in the M gene of CNS-associated measles virus (Rataul el a i, 1992; 
Bass et a i, 1989).
Figure 6. Functional domains of the M protein
¡¡¡C
335
region that interacts with 
lipid bilayer
region associated 
with genomic RNA
1 .1 .3 .1 .4  T h e  N u c le o c a p s id  P ro te in  (N P )
Mature NP protein is quickly and selectively incorporated into viral nucleocapsids, and is 
a target for interaction with the phosphoprotein, P (Gombart et a i, 1993). The 
conformational change, producing mature NP protein, does not require the participation 
of other viral proteins or genomic RNA; assembly of the NP protein into nucleocapsid 
structures can occur independently of the presence of other viral proteins or virion RNA 
(Fooks et a i, 1993).
The function of the NP protein is to encapsidate the viral RNA. Only genomic and 
subgenomic length RNAs which possess a 56 nucleotide leader sequence are encapsidated 
by the NP protein (Castaneda & Wong, 1990), suggesting an interaction between the 
leader sequence and the NP protein.
Nucleotide sequence comparisons of the NP protein gene of the different members o f the 
genus Morbillivirus reveal regions of high and low homology. Residues 501-1215 are19
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strongly conserved; residues 1-500 are moderately conserved and the region 1216-1625 is 
weakly conserved (Rozenblatt et al., 1985; Barrett and Diallo unpublished results cited in 
Barrett et al., 1991: Morgan, 1991). Three antibody binding sites have been mapped to 
the NP protein; site I is a constant epitope, and is located nearer the amino terminus 
(residues 122-150). The variable sites (II and III) are located toward the carboxy 
terminus (residues 457-476 and 519-525) of the protein (Buckland et al., 1989). The 
amino terminus and the middle region of the protein are thought to be critical for 
interaction with the P protein (Gombart et al., 1993) (Fig. 7).
Figure 7. Structural features of the NP protein
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Adapted from Buckland et al., 1989; Gombart et al., 1993
Measles virus nucleocapsids can be found in the cytoplasm (rough nucleocapsids) and in 
the nucleus (smooth nucleocapsids). Nuclear-located nucleocapsids are observed more 
frequently during persistent infections (Robbins et al., 1983) and in neural cells from 
patients with SSPE (Dubois-Dalaq et al., 1974b). Dingwall and Laskey (1991) have 
identified a bipartite nuclear location motif which consists of 2 basic amino acids, a 
spacer region of 10-15 amino acids, followed by a second region where 3 out of 5 amino 
acids are basic is nature. A similar motif has been found in the NP protein of measles
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virus. The motif is located between residues 220-239 and consists of 2 arginine residues, 
a spacer of 9 amino acids and a region where 4 out of 9 amino acids are basic. The region 
is conserved in all NP proteins sequenced thus far.
The NP protein elicits a strong humoral immune response, second only to that against the 
H protein (Stephenson and ter Meulen, 1979), and is able to stimulate the production of 
specific CD4+ T lymphocytes that can protect against encephalitic disease in an animal 
model (Bankamp et al., 1991).
1 .1 .3 .1 .5  T h e  P h o sp h o p r o te in  (P )
The P gene is 1657 nucleotides long, coding for a protein of 507 amino acids, with a 
molecular weight o f 54-55 kDa. This gene contains two overlapping reading frames, 
allowing the synthesis of a shorter (186 amino acid), non-structural C protein (Bellini et 
al., 1985; Thomas et al., 1988). The C protein co-localises in infected cells with the NP 
protein, suggesting it may play a role in either transcription or replication. The V protein 
is accessed from the P reading frame by introduction o f one additional G residue at 
position 751 during transcription, a phenomenon known as RNA editing, causing the 
replacement of the last 227 amino acids of the P protein, with 68 other amino acids from 
the V reading frame. This cysteine-rich region has been shown to specifically bind zinc 
(Cattaneo et al., 1989a; Liston and Briedis, 1994) (Fig. 8).
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Figure 8. Organisation of the P/C/V/R cistron
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Adapted from Liston and Briedis, 1995
The P protein is antigenically the least conserved (Sheshberadaran et al., 1986) and its 
nucleotide sequence is one of the most variable. It is the only cDNA, however, which 
cross-hybridises between all the members of the Morbillivirus genus (Barrett el al., 1985; 
Barrett and Underwood, 1985).
The P protein is thought to act as a co-factor in viral transcription. It retains the 
nucleocapsid protein (NP) in the cytoplasm by specifically interacting with it. There are 
two domains on the P protein that are important in its interaction with the NP protein, the 
carboxy terminal 100 amino acids and the extreme amino terminal residues (Huber et al., 
1991; Harty and Palese, 1995).
In Sendai virus and Vesicular Stomatitis virus the amino terminus of P is highly 
phosphorylated and possibly interacts electrostatically with the polymerase (L) protein 
(Chattopadhyay and Banerjee, 1987; Vidal et al., 1988). Phosphorylation is thought to be 
mediated by the host cell casein kinase II. Three phosphorylation sites at the amino 
terminal region of the P protein in measles virus have been found; Ser 86, Ser 151 and Ser 
180. These phosphorylation sites will also be present in the V protein, though what effect 
this may have on its function has not been determined (Das el al., 1995).
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Recently, ribosomal frame-shifting of the measles virus P protein mRNA has been shown 
to generate a novel P cistron-encoded protein (R). Analysis of immunoprecipitated 
proteins from measles virus infected cells has detected a protein species consistent with 
the predicted molecular weight of R. Frame-shift frequency was estimated at 1.8% 
(Liston and Briedis, 1995).
1.1 .3 .1 .6  T h e  P o ly m e r a se  P r o te in  (L )
The measles virus L gene is 6639 nucleotides in length and contains only 90 untranslated 
nucleotides. The L protein contains 2183 amino acids and is highly basic in nature. 
Comparison of the L gene of measles virus and CDV has revealed approximately 67% 
conservation at the amino acid level (Sidhu el al., 1993). Comparisons of the L gene 
sequence o f other paramyxoviruses have been published (Blumberg et al., 1988; Sidhu et 
al., 1993). Strong sequence homology was identified in 6 blocks previously defined by 
Poch et al. (1990), which are thought to represent functional domains of the protein. 
These regions of homology are linked by hinge regions of low conservation. Blocks II to 
V have the highest amino acid conservation and are located in the centre of the protein, 
with divergence occurring mostly at the carboxy-terminal region of the protein (Fig. 9). 
1 he functions associated with these domains have not yet been identified. More recently 
the L genes of 7 strains of measles virus were sequenced, along with the L genes of 
phocine morbillivirus and dolphin morbillivirus. These were then compared with CDV L 
gene sequence, and 3 domains of homology, linked by 2 hinge regions of low 
conservation, were observed. It was suggested that the function of domain I was RNA
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binding, domain II contained the replicase machinery and domain III contained an ATP- 
binding motif and protein kinase functions (personal communication, Dr. B. Rima, The 
Queens University of Belfast). The L protein contains 11 clusters of basic amino acids 
suggesting some of these might represent domains involved in electrostatic interactions 
with the RNA genome. It also contains two Gly-Asp-Asp (GDD) motifs (positions 3770- 
3779 and 4412-4420) which are thought to be characteristic of RNA-dependent RNA 
polymerases (Blumberg el al., 1988: Komase et al., 1995).
Figure 9. Conserved regions in the L protein
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I to VI: putative functional domains of the L protein 
Adapted from Poch et al., 1990
11A__Measles Virus Replication
1.1.4.1 Attachment and Entry
1 .1 .4 .1 .1  M e a s le s  V ir u s  R e c e p to r  (C D 4 6 )
Vaccinia virus recombinants expressing measles virus H and F proteins were used to 
infect HeLa cells in order to screen for monoclonal antibodies which inhibited the fusion 
activity of the vaccinia virus recombinants. An antibody which specifically inhibited
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measles virus binding and infection of human cells was shown to immunoprecipitate one 
or two glycoproteins with apparent molecular weights of 57 and/or 67 kDa, depending on 
the cell line used (Naniche el al., 1992). These glycoproteins were shown to be the 
human membrane cofactor protein, CD46 (Naniche et al., 1993a; Dorig el al., 1993). 
CD46 is a member of the regulators of complement activation gene cluster; its biological 
role is to inhibit the deposition of complement proteins C3b and C4b on host cells, by 
acting as a cofactor for plasma serine protease factor I (Liszewski el al., 1991). Multiple 
isoforms of CD46 (Cl, C2, BC1 and BC2) are expressed on human cells and have been 
shown to act as a receptor for measles virus (Manchester el al., 1994)
The release of N-linked oligosaccharides from CD46 by treatment with N-glycosidase F 
abolished the recognition of measles virus, thus N-glycan has a direct effect on the 
binding of measles virus to the receptor. Measles virus was unable to recognised the 
receptor after cleavage of the disulphide bonds, indicating that the receptor determinant 
on CD46 is conformation dependent (Maisner el al., 1994). It has been recently 
confirmed that the N-linked oligosaccharides maintain the conformational protein domain 
that is recognised by the measles virus H protein (Maisner and Herrler, 1995).
CD46 is a type I membrane glycoprotein in which the amino-terminal two thirds are 
composed of 4 short consensus repeats (SCR). Each SCR is a cysteine-rich repeating 
domain of approximately 60 amino acids. The 4 SCRs precede a ser/thr/pro rich domain, 
a domain of potential heavy O-glycosylation. The extracytoplasmic region of CD46 
encompassing the 4 SCRs is sufficient to act as a receptor for measles virus. The 
cytoplasmic and transmembrane regions o f CD46 may not play a major role in the signal
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for the haemagglutinin down-regulation of CD46 and / or endocytosis of measles virus 
(Varior-Krishnan et al., 1994; Manchester el al., 1995). SCR1 and SCR2 have been 
shown to make up the measles virus receptor determinant in CD46 (Manchester et al., 
1995; Buchholz et al., 1996); SCR3 and 4 appear to enhance measles virus binding 
which suggests that one of these domains may bind the virus secondarily or that they 
both, in some way, influence the disposition of SCR 1 and 2 (Buchholz et al., 1996).
The membrane-organising extension spike protein, moesin, has also been shown to be 
linked with susceptibility of cells to measles virus infection (Dunster et al., 1994). This 
protein is localised at the cytoplasmic side of the plasma membrane, but is also accessible 
to antibodies on the cell surface. Moesin provides an alternative route of entry for 
measles virus on cells that do not contain CD46 on the surface i.e. murine cells, although 
the uptake of vims is reduced considerably (Dunster et al., 1995). Evidence has been put 
forward which suggests that moesin and CD46 are located in close proximity to each 
other and could, therefore, form a complex supporting the infection of cells with measles 
vims (Schneider-Schaulies et al., 1995).
1.1 .4 .1 .2  V ir a l A tta c h m e n t a n d  F u s io n
Measles vims attaches to the cell via the H proteins affinity with the cell surface receptor, 
CD46 (Naniche et al., 1993a). The CD46 receptor is preferentially expressed on the 
apical membrane, while the moesin (the alternative receptor) appears to be present in 
similar amount on both the apical and basolateral cell surfaces. As such, measles vims 
attaches to and enters epithelial cells in a polarised fashion through the apical plasma
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membrane (Blau and Compans, 1995). Infection of HeLa or Jurkat cells with measles 
virus leads to a down regulation of the cell receptor at the cell surface (Naniche et a l, 
1993b). Removal of the receptor results in the infected cells being more susceptible to 
complement mediated lysis, however, such cells will have reduced fusability, which could 
lead to viral persistence.
Fusion has been shown to required both the F protein and the H protein (Wild et a l,  
1991; Cattaneo and Rose, 1993; Malvoisin and Wild, 1994). H and F proteins are 
processed in the cell at different rates; F arrives at the cell surface faster than H (Sato et 
al., 1988), which suggests that the interaction of the two glycoproteins may occur at a 
later stage, and not during transport. The details of virus binding and cell fusion are 
poorly understood in measles virus. The majority of the information available for 
morbillivirus replication has been extrapolated from that of the other paramyxoviruses 
and Sendai virus.
A ternary complex consisting of H, F and the cell surface receptor is thought to be a 
prerequisite for fusion. The H protein may have a positioning role to optimise the 
conditions for fusion, however, if the F protein is present at a high enough concentration 
or is orientated correctly in the membrane, the H protein is no longer required (Alkhatib 
et al., 1990). The overall function of the H protein may be to anchor the infected cell to 
the receptor of the target cell and then to associate with the F protein, so that it can 
interact with the cell membrane of the target cell.
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The hydrophobic domain at the amino terminal region of the F protein is exposed after 
cleavage and is highly conserved among the paramyxovirus F proteins. It has been 
suggested that this region, the fusion peptide, could promote fusion with the target 
membrane (Gething et al., 1978). However, it has been shown that regions of the F 
protein other than the fusion peptide can influence fusion activity (Richardson et al., 
1980; Novich and Hoekstra, 1988; Hull et al., 1987). It is likely that the fusion peptide 
makes the initial contact with the target membrane, however, its ability to form a water­
tight fusion pore has not been confirmed. The leucine zipper region on the F protein 
(Buckland et al., 1992) is essential for fusion. It is thought to pack the a-helices together, 
so forming the fusion pore which can expand as more tetrameric F proteins are 
constructed.
1.1.4.2 Transcription and Replication
1.1.4.2.1 T ranscrip tion
Transcription is initiated on the nucleocapsid bound RNA at the 3' terminus, synthesising 
a 56 nucleotide positive strand leader RNA (Horikami and Moyer, 1991). RNAs destined 
for encapsidation are distinguished from those destined for translation by presence or 
absence of a transcribed leader sequence (Castaneda and Wong et al., 1990). Leaderless 
mono- and bicistronic RNAs are associated with ribosomes and function as mRNAs 
which are translated. RNA species containing leader sequence are encapsidated.
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Transcription occurs sequentially. It is thought that the polymerase detaches from the 
nucleocapsid template at the intergenic regions with increasing frequency as the distance 
of the gene from the promoter increases, leading to the polar accumulation of mRNAs. 
Messenger RNA abundance is thought to be the main determinant of protein abundance. 
Transcription frequencies of mRNA in infected cells relative to the NP mRNA (100%) 
are P (81%), M (67%), F (49%) and H (39%) (Cattaneo et al., 1987; Schneider-Schaulies 
et a l ,  1989). At the end of each gene the polymerase terminates synthesis following 
polyadenlyation and then reinitiates at the consensus sequence of the next gene without 
transcribing the intergenic trinucleotide (Banerjee, 1987; Banerjee and Barik, 1992). 
Viral mRNAs are capped and polyadenylated (Yoshikawa et al., 1986). The stop region 
of each gene is an A/U rich sequence, followed by 4 - 7 uracil residues. This is thought to 
be the signal for polyadenylation of the mRNA (Udem and Cook, 1984; Yoshikawa et al., 
1986). The poly A tail is thought to be synthesised by a slippage mechanism in which the 
polymerase slips or backs up and copies the multiple uracil residues repetitively 
(Kolakofsky et al., 1991).
Cattaneo et al. (1989a) showed that in measles virus-infected cells half of the P mRNA 
was complementary to genomic RNA and half was altered by the insertion of a single 
non-templated G nucleotide at position 757, giving a third open reading encoding the V 
protein. These data suggest that RNA editing is an additional function of the RNA 
polymerase. P mRNA editing is thought to occur by a stuttering or slippage mechanism 
similar to that propose for polyadenylation (Vidal et al., 1990a, b).
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Cellular proteins are also required for viral RNA synthesis (Moyer et al., 1990; Horikami 
and Moyer, 1991; Blumberg et al., 1991). Tubulin may act as either a subunit of the viral 
RNA polymerase (Moyer et al., 1986), as an acidic activator o f the RNA polymerase 
(Chattopahyay and Banerjee, 1988), or as an anchoring site for the transcription / 
replication apparatus (Hamaguchi et al., 1985).
1.1 .4 .2 .2  G e n o m e  R e p lic a t io n
Replication in the Morbillivirus genus has not been extensively studied. The following 
model for replication is based on that determined for VSV and Sendai virus. The 
synthesis of both genome and antigenome length RNA is coupled to their concomitant 
encapsidation by the NP. The first product of replication, the antigenomic RNA is 
encapsidated with the NP protein during its synthesis. This is then assembled into a 
replication competent complex and serves as a template in the synthesis of progeny viral 
RNA. Amplification of the progeny viral RNA and assembly into nucleocapsids serves 
two functions: the genomic nucleocapsids can be incorporated into mature virions, and it 
provides additional transcriptionally active complexes for further production of mRNA 
and subsequent amplification of proteins that are required for virion assembly (Choppin 
and Compans, 1975; Choppin and Scheid, 1980). De novo protein synthesis has been 
shown to be a requirement for replication (Carlsen et al., 1985).
The P-L transcription complex and the availability of the NP protein is thought to 
regulate the transition from transcription to replication (Banerjee, 1987; Blumberg et al., 
1981b). As only leader-containing RNA is replicated, it follows that there must be some
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recognition site for the interaction of the NP protein to the RNA. The first 14 bases at the 
5' end of the leader sequence maps to the site for the initiation of nucleocapsid assembly 
(Blumberg et al., 1983). A minimal model for the switch from transcription to replication 
has been put forward for VSV (Blumberg et al., 1981a & b; Kolakofsky and Blumberg, 
1982; Amheiter et al., 1985; Banerjee. 1987). Insoluble NP protein complexes with the P 
protein producing a soluble substrate for encapsidation. The RNA polymerase catalyses 
the binding of NP to the leader RNA, releasing P. Encapsidation with NP coupled with 
further RNA synthesis masks the termination signals at each gene boundary, preventing 
termination and mRNA processing, thus, yielding full length assembled nucleocapsids.
1.1.4.3 Assembly and Release of Viral Progeny
The sequence of events in the assembly of measles virus proteins at the plasma membrane 
are; (i) transport vesicles carrying H and F proteins from the Golgi apparatus fuse with 
the plasma membrane. It is likely that these proteins arrive at the plasma membrane in 
separate vesicles as the maturation and transport of the F protein is faster than that o f the 
H; (ii) newly delivered proteins are probably distributed randomly in the cell surface and 
are mobile, so they can diffuse laterally in the plane of the membrane; (iii) the M protein 
becomes associated with the plasma membrane, probably by interaction with the 
cytoplasmic domain of the F protein; (iv) viral glycoproteins are localised in specific 
patches of the plasma membrane containing M protein, from which host-cell surface 
proteins are excluded; (v) nucleocapsids associates with the modified areas of the plasma 
membrane, probably by interaction with the M protein, presumably triggering the
31
Introduction
budding process (Misek et al., 1984; Matlin & Simons, 1984; Pfeiffer et al., 1985; 
Rindler et al., 1984).
Virions are formed by a process of outfolding, or budding, at the cell surface (Compans et 
al., 1966). The budding process of measles virus starts with a gradual elevation of strand­
like structures from the plasma membrane, leading to larger protrusions which eventually 
progress into spherical virus particles (Bohn et al., 1983). Although most cellular 
membrane proteins are effectively excluded from the envelopes of budding virus 
particles, it has been shown that the cellular cytoskeleton, particularly actin filaments, is 
involved in virus budding, and that budding itself is possibly the result of a vectorial 
growth in actin filaments (Bohn et al., 1986). Measles virus release has been shown to be 
polarised i.e., it only occurs at the apical surface of epithelial cells (Blau and Compans, 
1995).
LT5_Measles Virus Immunobiology
1.1.5.1 Humoral Response
Antibodies to the measles vims are first detectable with the onset of the rash (Bech. 
1959). The initial immunoglobulin isotypes produced are IgM and IgA. followed by the 
IgG. The IgG response is mediated by two isoforms o f this class of immunoglobulin, 
namely IgGl and IgG4 (Mathiesen et al., 1990; Ehmst, 1978). IgGl is efficiently 
transported across the placenta. Plasma levels of IgE also rise, but there is no evidence 
that these immunoglobulins are measles virus-specific (Black, 1989; Griffin et al., 1985).
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Infection with the measles virus leads to life-long immunity but the mechanism of the 
longevity of the antibody response is not known.
Maternal antibodies are important for protection of new-boms. Such passive immunity 
wanes gradually as the infant catabolises maternal antibodies. The majority of infants are 
susceptible to measles virus infection by the age of approximately 12 months in 
developed countries, and 9 months in developing countries (Black, 1989; Halsey el al., 
1985). The average age at measles virus infection depends on the age at which maternal 
antibody is lost and on age-related changes in frequency of contact with other persons. In 
developing countries measles virus infection occurs in younger children due to the higher 
birth rates, more crowded living conditions and the earlier loss of maternal antibodies 
(Black el al., 1986).
Antibodies are capable of preventing virus-induced membrane fusion and lysis of 
infected cells. They are also capable of modulating viral antigen expression at the cell 
surface and suppressing intracellular synthesis of virus protein and RNA in-vitro. 
Therefore, antibodies may play a role in controlling viral replication and also in 
establishing persistent infections (Ehrst, 1975; Barrett el al., 1985; Fujinami and 
Oldstone. 1979; Schneider-Schaulies el al., 1992; Rammohan el al., 1983).
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Non-specific and specific cellular immune responses may be activated during systemic 
measles virus infections. Interferon (IFN) a  and p levels in plasma are not elevated 
(Shiozawa et al., 1988) and natural killer cell activity is lower in infected individuals 
when compared to non-infected controls (Griffin et al., 1990a).
Proliferation of peripheral blood mononuclear cells (PBMC) and elevation of plasma 
levels of CD8 and IFN-y are highest during the rash (Griffin et al., 1989; 1990b). This is 
consistent with the likely role of MHC class I-restricted (CD8) cytotoxic T cells in 
clearance of the virus from its sites of replication (van Binnendijk et al., 1990). More 
prolonged increase occurs in levels of soluble interleukin 2 (IL-2) receptor, a product of 
IL-2 stimulated T cells (CD4). and neopterin, a product of IFN-y stimulated macrophages, 
and P2 -microglobulin (Griffin et al., 1989; 1990b; 1992). Long after recovery from 
measles virus infection, memory CD8 cytotoxic T cells can be demonstrated in PBMC 
(Lucas et al., 1982; van Binnendijk et al., 1989).
CD4 T cells are also activated in response to measles virus infection. These cells also 
proliferate during the rash (Ward et al., 1989) and soluble CD4 becomes elevated and 
remains so for several weeks (Griffin and Ward, 1993). Measles virus specific MHC 
class II-restricted cytolytic CD4 cells are generated (van Binnendijk et al., 1989; 
Jacobson et al., 1984. 1989) and may contribute to virus clearance from tissue, however, 
C D4 T cells probably exert most influence by secreting cytokines. Measles virus proteins
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that stimulate the proliferation of MHC class II-restricted CD4 cells include H, N, P and F 
(Rose et a l, 1984; van Binnendijk et a l, 1992; Bellini et al.. 1981; Ilonen et a l, 1990; 
Jacobson et a l , 1989).
The immune suppression that accompanies measles virus infection is thought to 
contribute to the susceptibility to secondary infections that account for most of the 
morbidity’ and mortality associated with measles virus infection (Beckford et al., 1985). 
Possible mechanisms to explain how immunosuppression may occur include: (i) virus 
killing of infected lymphocytes, thus no secretion of cytokines and no activation of the 
immune system occurs; (ii) virus effects on monocytes; (iii) a direct viral effect on 
lymphocyte functioning. It is possible that all three mechanisms play a role in immune 
suppression.
11-6_Measles Virus Vaccines
The measles vaccine (Edmonston strain) in use currently is an attenuated live vaccine, 
administered subcutaneously, between the ages of 9 to 20 months. The antibody response 
is good, primarily IgGl (Mathiesen et al., 1990), provided it is administered after 
maternal antibody levels have declined (Albrecht et al., 1977). Antibody levels induced 
by vaccination are lower than those seen in natural infections, but a response can still be 
measured 10-15 years after vaccination, in the absence of boosting infections (Black, 
1989; King et a l,  1993; Markowitz et al., 1990).
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Cell-mediated immune responses have not been extensively studied, but are thought to be 
comparable to that o f a natural infection. Antigen-presenting cells are found to be 
infected and able to process measles virus proteins in both MHC class I and II restricted 
cells, thus CD8 and CD4 T cells should be stimulated.
A high titre version o f the Edmonston-Zargreb vaccine containing >10^-^ pfu/dose was 
shown to elicit an immune response in individuals containing maternal antibodies. 
Therefore, in 1992, clinical trials using this vaccine were conducted in developing 
countries. This type of vaccine was thought to be useful in such countries as children 
come into contact with measles virus at a much earlier age, when maternal antibodies are 
still circulating and the standard vaccine is ineffective. A few children who received the 
high-titre vaccine were observed to die of unrelated diseases, such as pneumonia, 
diarrhoea and parasitic infections, at later times, perhaps as a consequence of immune 
suppression induced by the vaccine, allowing the secondary' infections to become 
established (Weiss, 1992). Due to the slight excess o f cumulative deaths in vaccinated 
children the trials were terminated (Garenne el al., 1991).
Inactivated measles vaccine, developed prior to the use of the attenuated live virus
vaccine, was found to elicit measles virus neutralising and HI antibody, but little antibody
to N and none to F (Carter el al., 1962; Norrby el al., 1975;). Antibody response and
protection by this vaccine was short-lived. Individuals receiving the inactivated vaccine
"ere likely to develop an atypical form of measles virus, which can be life-threatening
after exposure to wild-type virus (Cherry' el al., 1972; Brodsky, 1972).
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Live attenuated vaccine works well, but periodic outbreaks of measles infection do still 
occur in developed countries even where there is a high vaccination rate. Improper 
storage of the vaccine may be responsible in part, however, data also suggests that 
measles virus may spread among vaccinated as well as unvaccinated individuals without 
causing major symptoms (Chen et al., 1990; Pedersen et al., 1989). New generation 
vaccines may help to overcome this problem. Such vaccines may include live vectors e.g. 
vaccinia virus and adenovirus presenting different structural proteins of measles virus 
(Taylor et al., 1991b; Wild el al., 1992; Alkhatib et al., 1990), or genetically engineered 
newly attenuated measles virus. Novel non-infectious vaccines, comprising viral 
glycoproteins incorporated into subunit structures, known as immune-stimulating 
complexes (ISCOMS), have shown promise (de Vries et al., 1988). Chimeric peptides of 
measles virus F protein and promiscuous T-cell epitopes, which bind several forms of 
MHC class II molecules, have been evaluated for their ability to elicit an immune 
response in mice. The results indicated that the promiscuous T-cell epitopes can be used 
with immunogenic peptides to produce highly immunogenic preparations capable of 
overcoming haplotype-restricted responses (Lairmore et al., 1995). Vaccinia virus 
recombinants have been shown to greatly improve the immune responses in mice if two 
protein genes are inserted. Vaccinia virus recombinants containing only the F protein 
gene only elicit a poor immune response. However, if the NP gene is also inserted, the 
response is increased by more than 75% (Wild et al., 1992).
Adenovirus recombinants containing only the NP gene have been assayed for their ability 
to elicit an immune response in mice. Such recombinants have been shown to induce a
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humoral response to NP protein; an MHC class I restricted antigen-specific cytotoxic T 
cell response: and protection against challenge with the homologous measles virus strain 
in mice (Fooks et al., 1995). This type of vaccine overcomes the maternal antibody 
barrier and can be used in immunocompromised patients (de Vries el al., 1988). 
However, there is likely to be an immune response elicited against the adenovirus 
proteins present.
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Measles vims associated with the central nervous system (CNS) can lead to acute or 
chronic disease progression. Acute measles encephalitis is a rare complication of acute 
measles virus infection (Aarli, 1974) which can occur during the infection or shortly after 
recovery. It is thought to be the result of virus-induced autoimmune reactions (Schneider- 
Schaulies et al., 1995). Sub-acute sclerosing panencephalitis (SSPE) and measles 
inclusion body encephalitis (MIBE) are very rare complications associated with measles 
vims persistence in the CNS. SSPE can present many years after the acute disease. It is 
characterised by progressive cerebral dysfunction. MIBE affects immunocompromised 
patients, such as those with leukaemia or AIDS (Hughes et al., 1993; Aicardi et al., 
1977). It has a variable incubation time and presents as a non-specific encephalitis.
As early as 1965 a paramyxovirus was the suspected causative agent of SSPE. Electron 
micrographs of brain tissue of an SSPE patient showed paramyxovirus-like nucleocapsids 
within the cells (Boutille et al., 1965), subsequently confirmed by others (Dayan et al., 
1967; Katz et al., 1969).
The mechanisms which define how measles vims changes from a lytic, self-limiting 
infection, to that of a non-productive, persistent infection are not clear. There is a latent 
period of 6 to 7 years between the initial acute measles vims infection and the onset of the 
first neurological changes seen in SSPE patients. There is a 2- to 3-fold excess of SSPE 
in males, with children from mral areas at greater risk. SSPE tends to develop in children 
who contract acute measles at an early age; i.e. an average age of 2 years (Modlin et al.,
Introduction
1.2.1 Subacute Sclerosing Panencephalitis and Other Progressive
Neurological diseases
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1979). The earliest signs of SSPE consist of intellectual deterioration and behavioural 
changes, followed by progressive neurological impairment leading to cortical blindness, 
dementia and finally death. The majority of patients die within 1 to 3 years o f the onset
of the disease.
The incubation period from acute measles virus infection to the first signs of MIBE can 
vary from 1 to 6 months, and is confined to patients with immune deficiency. This 
disease is less well defined than SSPE. It is a haemorrhagic leukoencephalitis with 
intranuclear inclusion bodies which contain paramyxovirus nucleocapsids.
Elevated measles antibody titres in the serum and cerebrospinal fluid of SSPE patients is 
observed, especially to the NP protein and the P protein and, to a lesser extent, the two 
surface glycoproteins, H and F. Measles virus antigens can also be detected in the brain 
of SSPE patients by immunofluorescence (Freeman et al., 1967; Connolly et al., 1967). 
Inflammatory lesions in both the white and grey matter of the brain, and occasionally the 
cerebellum and spinal cord, can be seen, and demyelination is also seen to varying 
degrees. Reduced levels of viral envelope protein mRNA, probably due to enhanced 
attenuation o f transcription at each gene junction, is also observed. Expression of 
envelope proteins seems to be diminished by specific translational inhibition (Schneider- 
Schaulies et a/., 1993; Yoshikawa and Yamanouchi. 1984; Miller and Carrigan. 1982).
Infectious virus can be recovered from the brain tissue of SSPE patients, by co-cultivation 
with cells permissive for growth of measles virus (Homma et al., 1982; ter Meulen et al., 
1972). Measles virus found in the brains of SSPE patients is non-productive and non-
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lytic; no detectable extracellular virus particles are produced. However, virus recovered 
by co-cultivation (usually called SSPE virus) is generally productive and lytic in tissue 
culture. Attempts to recover virus from brain tissue by co-cultivation have a failure rate of 
approximately 80%, thus the rescued virus may represent either a minor population of the 
virus present, or a new mutant that occurs during the co-cultivation procedure. 
Nucleotide sequence comparisons indicate, however, that some so-called SSPE viruses 
i.e.. Halle. Mantooth and Horta-Barbosa (1.3.2. Table 1) are in fact derived from standard 
strains probably as a result of cross-contamination occurring in the laboratory.
Occasionally, a non-lytic SSPE virus may be rescued. Non-lytic virus remains cell- 
associated and little or no infectious virus is produced (Bumstein cl al., 1974; Ueda el al., 
1975; Homma el al., 1982). Some non-lytic SSPE viruses recovered by co-cultivation 
can cause neurological disease when used to infect mice (Homma el al., 1982), and this 
type of virus may reflect more accurately the characteristics of the virus in the brain. An 
example of such a virus is the Yamagata-1 strain, which is the subject of extensive 
characterisation in this thesis.
Ill__Molecular Biology of SSPE Viruses
I.2.2.1 Experimental Material and Viral Strains
Due to the difficulty in isolating live virus the majority of the work carried out on SSPE
viruses has been done by extracting RNA from the brain tissue of deceased patients.
Several genes of a variety of different SSPE virus strains have been sequenced, in
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particular the M. F and H. and to some extent NP. Comparing the sequences obtained 
with that of a consensus sequence for acute measles virus, nucleotide changes were 
observed, particularly in the M gene (Cattaneo el al., 1986, 1988a, b; Wong et al., 1989; 
Ballart et al., 1991). Interpretation of the significance of nucleotide differences between 
brain derived (SSPE and MIBE) and other non-defective, tissue culture adapted measles 
virus has been hampered by the fact that the non-defective viruses can be grouped into 
several different genotypes (Cattaneo el al., 1989b; Taylor el al., 1991a; Rima et al., 
1995b). In order to determine beyond doubt that nucleotide differences between SSPE 
viruses and acute disease virus are significant, the lineage of the acute virus which 
initially infected the patient would be required for sequence comparisons. Unfortunately, 
the circulating lineage at the time of the acute infection is rarely known and can only be 
surmised, therefore, most studies have used a consensus sequence for the acute virus, as 
such, some of the conclusions may be misleading.
Analysis o f different areas of the brain of SSPE patients has revealed both wild-type-like 
and variant sequences. The distribution of the virus variants, determined by sequence 
analysis and in-situ hybridisation, suggested that the mutated viruses expanded clonally 
throughout the brain (Baczko el al., 1993). Five different measles virus variants were 
observed on the basis of the major sequence changes. These 5 variants appeared to have 
evolved from a progenitor by at least 5 independent hypermutation events. Variants with 
M gene sequence corresponding to group B3 were found in all brain regions tested. 
Variants belonging to group B4, which appear to have been derived from the B3 variants, 
were only detected in the right frontal lobe of the brain. Variant virus B2 has apparently 
undergone at least one hypermutation event in which 13 uracil residues of the B1 virus
43
Introduction
variant were replaced by cytosine residues. The relationship between B 1, B2 and B3 was 
not linear. An hypothetical intermediate, termed Bx, was required to develop a clonal 
link between groups B2 and B3. Although wild-type-like intact genes were found, 
functional M protein could not be detected (Baczko el a l, 1993).
The nucleotide sequence of the M gene of two wild-type strains of measles virus (,TM, 
isolated from Bethesda. USA in 1977, and CM. isolated from USA in the late 1970's), 
both of which are distinct from vaccine strains of measles virus, has been determined 
(Bazcko el al., 1991). These two wild-type viruses have been placed in separate 
genotypic groups (1.3.2). The sequences obtained were compared with the sequence of 
the M gene o f an SSPE virus (Case B) and that from an MIBE patient. It was found that 
the acute virus strain. JM. was very similar to the SSPE virus (case B), whereas the acute 
strain. CM. was similar to the MIBE virus. The number of differences between the M 
gene sequence o f the SSPE virus and JM resulted in only 6 amino acid changes between 
the two strains. The number of differences betw een JM and the SSPE virus was so small 
that it probably represents a divergence no greater than that observed between virus 
strains within one group. These results suggest that there is little or no difference 
between wild-type and SSPE viruses of the same genotype. However, the differences 
observed between the MIBE M gene and that of CM revealed many nucleotide 
exchanges, with a bias for uracil (U) to cytosine (C) transitions (biased hypermutation). 
After correcting for the U-C transitions the mutation rate was only 0.9%. This suggests 
that an acute disease virus from the CM lineage may have caused the initial measles virus 
infection in the MIBE patient, implying that the biased hypermutation events may be
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important in altering the phenotype of the virus from a h tic  infection to a cell associated, 
persistent infection (Baczko et a l,  1991).
Eighty percent of the nucleotide differences found in the M gene of the Biken strain of 
SSPE and the Nagahata strain of acute measles virus were U-C transitions. It was 
presumed, therefore, that the Nagahata strain of measles virus was the acute progenitor of 
the Biken strain of SSPE (Wong et a l,  1991). Such biased hypermutation accounted for 
all but one of the predicted amino acid substitutions. As a result of these mutations the 
Biken M protein loses conformation-specific epitopes that are conserved in the acute 
virus. Such conformational epitopes are also missing in the Niigata and Yamagata SSPE 
viruses (Wong et a l,  1991).
1.2.2.2 Theoretical Mechanism of Biased Hypermutation
Sequence data from the matrix gene of an MIBE case revealed that 50% of the U residues 
were changed to C and the phenomenon was termed biased hypermutation. It was 
hypothesised that the mutations may confer a selective advantage to the virus, so 
guaranteeing their survival (Cattaneo et a l, 1988a). Wong et al. (1989) attempted to 
reproduce this phenomenon in-vitro. One aliquot of an SSPE virus (Yamagata-1) was 
propagated in a non-neural cell line (Vero) and another aliquot was propagated in a 
neuroblastoma cell line (1MR-32). The neuroblastoma cell-passaged virus contained a 
cluster o f additional U-C transitions that were not observed in the non-neural cell 
passaged virus. Ninety percent of these additional changes were identical to the 
hypermutated nucleotides seen in the M gene of the MIBE patient discussed above. The
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random nature, apparent host dependency and specific location o f these mutations 
suggested that they might be caused by an extrinsic biased hypermutational activity rather 
than intrinsic polymerase errors (Wong et al., 1989).
A possible explanation for the observed clustering of the U-C transitions in the MIBE 
case is that transcription of the genome is carried out by a measles virus RNA polymerase 
complex which is prone to non-selectively incorporate U or C residues when copying 
adenosine (A) (Cattaneo et al., 1986). Another hypothesis is that biased hypermutation is 
due to the activity of a cellular enzyme which causes the deamination of adenosine 
residues in dsRNA (Bass et al., 1989). This enzyme, double-stranded RNA adenosine 
deaminase (DRADA) was originally found in Xenopus eggs and several mammalian cell 
lines (Bass and Weintraub, 1987; Wagner and Nishikuro, 1988). DRADA activity has 
been found to be present in a wide range of tissues and cell types, regardless of cell 
differentiation, and is located in the nucleus. It is thought to be a housekeeping enzyme, 
modifying dsRNA prior to degradation (Wagner et al., 1990). The enzyme unwinds ds 
RNA, deaminating A residues to generate inosine (I). Inosine can then direct the 
incorporation of C into the positive strand mRNA, thus expressing a U-C transition (Bass 
el al., 1989). Two hypotheses have been suggested to account for the presence o f dsRNA 
during transcription of the viral genome. The first is that nascent transcripts could 
occasionally remain base paired with the template RNA ("collapsed" transcription), which 
would lead to the eventual arrest of transcription. Alternatively, localised double- 
stranded regions could occur due to the hybridisation of measles virus mRNAs to 
genomic RNA. Except for the similarly biased nature of the mutations seen in measles 
virus and the observation DRADA activity exists, there has been no evidence that links
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these two phenomena. How ever, the level of activity of this enzyme has been found to be 
higher in IMR-32 cells (a neuroblastoma cell line) than in Vero cells (monkey kidney 
epithelial cells) (Rataul el al., 1992).
Measles virus replicates in the cytoplasm, so how might genomic RNA of measles virus 
be exposed to this nuclear enzyme? The nuclear membrane has been shown to 
breakdown during meiosis and mitosis, which may lead to the leakage of the enzyme into 
the cytoplasm, however, neurones do not divide after maturation and. as this is the site of 
infection during SSPE and MIBE, it is unlikely that this explanation is tenable. 
Alternatively the integrity o f the nuclear membrane may be disrupted at a late stage of 
infection. Cells infected with acute measles virus do show nucleocapsid structures in the 
cytoplasm (fuzzy in appearance) and the nucleus (smooth in appearance) (Dubois-Dalaq 
el al., 1974b). Although post-mortem brain sections from SSPE patients do show a 
greater number of nuclear located nucleocapsids, there is no evidence that these smooth 
nucleocapsids are active in RNA replication and are able to pass on genetic changes to 
progeny virus. Measles virus RNA can be recovered from the nuclear fractions of 
measles virus infected cells, and as DRADA is a nuclear associated enzyme it is possible 
that the viral RNA could be exposed to the enzyme (Carter el al., 1973; Schluederberg 
and Chavanich, 1974).
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1.2.2.3 Matrix Protein of SSPE Viruses
The conformation of the M protein is important if it is to successfully interact with the 
nucleocapsid prior to viral budding (Hirano el al., 1993). Mutations in the amino 
terminal, carboxy-proximal or carboxy-terminal regions of the M protein seem to abolish 
nucleocapsid binding. M protein from the Biken strain of SSPE cannot interact with 
nucleocapsids, although its progenitor's M protein (Nagahata) can bind nucleocapsids 
from the acute Nagahata infection, and that from the defective virus (Biken). The 
interaction of acute viral M protein with SSPE derived nucleocapsid, however, is 
unstable. As such the SSPE virus M protein appears to be functionally different 
compared to its progenitor acute measles virus strain (Hirano el al., 1992a, b; 
Suryanarayana el al., 1994). The M protein in acute measles virus is thought to interact 
with the nucleocapsid and the two surface glycoproteins in order to aid the release of the 
viral progeny. The failure of the M protein to interact with the nucleocapsids, in SSPE 
viruses may prevent the viral progeny from being released from the host cell, thus 
explaining the lack of viral progeny seen in persistent infections of measles vims in the 
CNS.
There is a reduced antibody response to the M protein of measles virus in patients with 
SSPE (Hall el al., 1979; Wechsler el al., 1979). This is possibly due to a reduction in the 
amount of protein produced in infected cells. In SSPE cell lines, which have been shown 
to produce only cell-associated vims, mRNA specific for M protein was observed but it 
was not translated into functional protein (Carter el al., 1983). The lack of functional M
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protein could be due to premature termination o f translation due to nonsense mutations in 
the mRNA, loss of a translation initiation codon or possibly rapid degradation of any 
protein that is produced (Enami et al., 1989; Ayata et al., 1991). An alternative 
explanation is that translation of the M gene is aberrant due to synthesis of M mRNA 
exclusively in a P-M bicistronic form (Cattaneo et al., 1986). Bicistronic mRNA is 
unable to direct protein synthesis form the downstream cistron (Wong and Hirano, 1987). 
As such, this transcriptional defect effectively blocks protein synthesis from the M 
cistron. Support for this explanation comes from the observation that Vero cells 
persistently infected with the hamster neurotropic strain of measles virus show no virus 
production, and display a predominance of bicistronic M-F transcripts. No F protein 
could be detected, probably due to the block of translation of the downstream cistron 
(Hummel et al., 1994). Matrix protein itself has been shown to down-regulate 
transcription of measles virus ribonuclear protein (Suryanarayana et al., 1994).
1.2.2.4 Fusion Protein of SSPE Viruses
Mutations were found in the F gene of SSPE viruses. Such mutations are predicted to 
cause truncations, elongations or non-conservative amino acid replacements (Schmid et 
al., 1992). It was suggested that alterations in the cytoplasmic domain of the F protein 
could hinder the interaction between the M protein and F, thus preventing viral release. 
Truncation of the F protein intracellular domain (33 amino acids) in SSPE viruses does 
not impair the fusion activity of the protein, however, it may reduce functional interaction
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with the M protein, thus, hindering viral assembly and budding (Cattaneo and Rose,
1993).
1.2.2.5 Haemagglutinin Protein of SSPE Viruses
Analysis of the sequence of the H protein gene of SSPE viruses has suggested that the 
proteins may be defective in intracellular transport, oligosaccharide modification, 
dimerization and fusion (Cattaneo and Rose, 1993). Fusion activity is maintained in 
SSPE viruses, although it occurs at a greatly reduced rate. This is primarily due to the 
reduced expression of functional H protein (Billeter et a l, 1993). The neurovirulence of 
various neutralising monoclonal antibody escape mutants of the rodent adapted CAM 
strain of measles virus has been correlated with specific protein changes between amino 
acid residues 368 and 396 in the H protein (Liebert et al., 1994). Measles virus 
replicating in the brain at the terminal stage of infection is typically defective in M 
protein and the two surface glycoproteins. M protein appears to be dispensable 
altogether, whereas partial preservation of F and H function is required. Limited cell 
fusion will enable the virus to transfer replicating ribonuclear proteins from cell to cell, 
while only minimal amounts of viral proteins are exposed at the cell surface, thus hiding 
the infection from immune surveillance.
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Introduction
Nucleotide sequence comparisons indicate that amino acid changes accumulate in the 
carboxyl terminus of the N protein and the amino terminus of the P protein. However, 
these changes are not thought to significantly alter the products (Cattaneo el al., 1989a). 
The hamster neurotropic (HNT) strain of measles virus was found to have 5% amino acid 
changes in the N protein, 8.1% in the P protein, 2.9% in the V protein and 7.0% in the C 
protein when compared to the progenitor strain. Editing of the P mRNA of the 
neurotropic strains was found to shift from transcripts with the single guanine (G) 
insertion, which produces the V protein, to transcripts with greater than two G's inserted. 
The altered editing phenotype of the persistent measles virus strain could be a 
consequence of mutations in P, L or both, or related to changes in the recognition motif. 
Curran el al. (1991) suggested that the V protein may play a role in paramyxovirus 
persistence. They found that increased V protein expression resulted in a decrease in the 
replication of a defective interfering Sendai virus genome. The altered editing 
distribution of HNT in the study by Vanchiere el al. (1995) would, therefore, be expected 
to favour viral replication since the expression of the V protein might be reduced by the 
decrease in P mRNAs with 1 G inserted. By relieving the inhibitory effects o f V under 
limiting levels of L, viruses with altered editing distributions may have a selective 
advantage in the persistent state (Vanchiere el al., 1995).
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In vivo experiments using Lewis rats with acute encephalitis and subacute encephalitis 
have shown strongly attenuated transcription of mRNA along the measles virus genome. 
A steep gradient of measles virus transcripts was found in the brain tissue. This was 
probably due to strongly attenuated transcription o f mRNAs along the viral genome, 
representing particularly low levels of transcription of the glycoprotein genes. The 
transcriptional restriction of the glycoprotein-specific mRNAs was seen as soon as 
measles virus-specific mRNA was detectable in infected brains. This phenomenon was 
independent of the incubation time after infection, suggesting that brain-specific host cell 
factors may primarily interfere with measles virus gene expression. Only N and P 
proteins were consistently translated (Schneider-Schaulies el a l, 1989). Fusion and H 
protein mRNA can be found only in low levels in the brain tissue of SSPE patients, 
compared to lytically infected cells (Baczko et al., 1986). Overall, measles virus specific 
transcription is substantially reduced in brain tissue from SSPE patients (Schneider- 
Schaulies et al., 1992, 1994b).
1.2.2.7 Summary
In general, the nucleotide sequences of the individual genes of the SSPE viruses resemble 
those of the acute measles virus strain that is thought to be its progenitor (Wong et al., 
1991). In many cases the differences between the acute measles virus strain and the 
SSPE virus are U-C transitions, a phenomenon termed biased hypermutation. Such 
mutations are thought to confer a selective advantage for the survival of the measles virus 
in the CNS (Wong el al., 1991; Cattaneo el al.. 1988a, b). It has been hypothesised that
the U-C transitions could be the result of the activity of a nuclear located DRADA
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enzyme (Bass et al., 1989). Measles virus specific transcription is reduced in brain tissue 
from SSPE patients (Schneider-Schaulies et al., 1992, 1994b). Cell lines derived from 
SSPE brain tissue produce only cell associated virus. This could be as a result of the 
mutations observed within the SSPE virus genomes, in particularly the M gene. Little or 
no M protein can be detected in SSPE virus infections. As this protein is required to 
orchestrate viral assembly and budding, reduction in its production is likely to result in a 
reduction of viral progeny release. Mutations in the F protein, particularly the 
cytoplasmic domain which is thought to interact with the M protein during viral 
assembly, will also have an effect on the release of viral progeny (Cattaneo et al.. 1986; 
Cattaneo and Rose, 1993; Schmid et al., 1992; Enami et al., 1989; Ayata et al., 1991; 
Carter et al., 1983).
1-2.3_Maintenance of Viral Persistence in the CNS
1.2.3.1 Mechanisms of Persistence
It is thought that measles virus entering the CNS is not defective, and that the initial stage
of infection in the CNS involves an acute infection producing cell free virus, since an M
gene sequence isolated from the brain tissue of an SSPE patient resembled an acute
disease measles virus strain (Baczko et al., 1993). Persistent infection of lymphocytes or
monocytes has been suggested for the pathogenesis of measles virus associated disease
processes including CNS complications (Cosby et al., 1989; Cosby, 1993). The
establishment of persistence may occur due to down-regulation of transcription. Thus,
the integrity of the viral protein functions associated with transcription and intracellular
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replication may be maintained, while the expression o f  the envelope glycoproteins is 
attenuated or abolished. The mechanism of measles virus persistence is thought to be 
host controlled as the transcription initiation sequence and viral polymerase encoding 
gene differ only slightly in persistent measles virus when compared to acute measles 
virus. At a later stage of infection only cell-associated virus can be detected. Carrigan 
(1985; 1986) has described two distinct variants of the same virus associated with the 
lytic and persistent stages of infection. A round cell (RC) variant of measles virus is 
found during the first stage of infection, producing cell free virus; the second variant is 
called the syncytiagenic (S) form. This variant does not release virus from the cell and 
little or no expression of viral M protein is observed. This form is associated with 
neurovirulence (Carrigan, 1985). The RC variant shows little or no neurovirulence, and 
there was a lack of histopathological changes in infected CNS tissues during the period 
when production of the RC variant was the greatest. No acute or histopathological 
disease occurred in newborn hamsters infected intra-cerebrally (i.c) with dilutions of the 
virus stock containing only the RC variant. The RC variant is capable of converting to 
the syncytiagenic form but the stimulus for the conversion is unknown, although the 
mechanism is thought to be by mutation. Conversion to the syncytiagenic form correlates 
with an increase in antiviral immune responses, therefore not only the state of infection, 
but also the selective decrease of the RC variant with respect to the syncytiagenic variant 
are due to immune responses to infection (Carrigan, 1986). Inter-conversion between 
these two variants may provide a mechanism for change from productive infection to 
defective infection of measles virus in the CNS.
In the later stages of infection measles virus is able to maintain a persistent infection by 
attenuating the expression of M, F and H proteins due to low mRNA frequencies and / or
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the incorporation o f mutations in the reading frame o f those genes leading to defective 
expression or the abolishment of expression. Reduced expression of the membrane 
glycoproteins results in low expression of the major viral antigenic determinants on the 
cell surface, thus there is reduced recognition of infected cells by the host immune 
system. Down-regulation of measles virus gene expression in human brain cells can 
occur by a cell type-dependent regulation of viral mRNA transcription and a 
differentiation-dependent regulation of translation, both of which may be important for 
establishment of persistent measles virus infection in the CNS (Schneider-Schaulies el al., 
1993).
The Biken strain o f SSPE dominantly interferes with the replication of wild-type measles 
virus in cultured cells. The mechanism of such interference is unknown, however the 
ability o f a mutant virus to interfere with the growth of wild type virus would confer a 
selective advantage to the mutant virus in a long-term mixed infection, as is seen in the 
CNS during SSPE. Such a mutant virus could eventually predominate and displace the 
parental virus (Hirano, 1992a).
1.2.3.2 Role of Host Regulatory Factors in the Maintenance of Persistence
Host regulatory factors must also play a role in the maintenance of a persistent measles
vims infection. Specific binding of various, uncharacterised, host proteins to the leader
sequence of measles vims has been shown in many cell lines, including brain cells
(Leopardi el al., 1993). Total cellular phosphorylation in persistent measles virus
infections of most neuroblastoma cell lines has been shown to increase by 50%, which
correlates with an increase in protein kinase C activity. The release of infectious measles
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virus was strongly inhibited by incubating the infected cells with a protein kinase C 
inhibitor, so suggesting that measles virus induces phosphorylation at a cellular level, 
which is essential for measles virus production. It was shown that the proteins 
phosphorylated were of cellular origin and that their phosphorylation was induced by the 
virus. These results suggest that the enhanced phosphorylation activity of persistently 
infected cells is induced by the virus and that protein kinase C-mediated phosphorylation 
plays an important role in the maturation of infectious measles virus (Segev et al., 1994).
Increased protein tyrosine kinase activity has been seen in cells persistently infected with 
measles virus. The NP protein of measles virus in such cells is phosphorylated on 
tyrosine in addition to the normally phosphorylated serine and threonine residues in acute 
infections. Phosphorylation of the tyrosine residue on NP protein may introduce 
conformational changes which interfere with the interaction of NP with the M protein so 
preventing the assembly and release of virus progeny (Segev et al, 1995).
As already described (1.2.2.2) DRADA may promote biased hypermutation which may 
contribute to the restriction of viral replication. This enzyme is thought to be a cellular 
house-keeping enzyme important in editing cellular RNA and destabilising duplex RNA 
to facilitated their degradation by RNAses.
The induction of cytokines may also help to maintain the persistent infections. Type I 
IFN (a and (5) is induced in brain cells during persistent measles virus infections. Recent 
studies suggested that interferon induces MxA protein which can interfere with measles
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virus replication in a tissue specific manner (Schneider-Schaulies et al., 1994a). 
Inhibition of measles virus replication at the level of primary RNA synthesis only occurs 
when MxA is expressed in brain cells.
Persistent infections of C6 rat astrocytoma cells with SSPE or canine distemper virus 
(also associated with neurological disease in dogs) caused the loss of endothelin-1 (ET-1) 
binding to its receptor and, subsequently, the loss of the ET-1 induced Ca^+ signalling 
pathway. Endothelins are vasoconstrictive peptide factors, whose receptors are found in 
the CNS, endothelial cell and fibroblasts among others. Down-regulation of the ET-1 
receptor might be advantageous for the establishment of persistent infections because 
cells are then less responsive to exogenous ET-1 stimuli, resulting in reduced 
phosphatidylinositol biphosphate (PIP2 ) cleavage and the loss of Ca2+ signalling. 
However, PIP2 cleavage has been shown to stimulate measles virus replication 
(Vainionpaa el al., 1991; Meissner and Koschei, 1995).
1.2.3.3 Role of Defective Interfering Particles in Persistent Infections
Brain cells of patients with SSPE have been shown to contain mutant measles virus 
genomes with 5' copy-back defective interfering (DI) RNA's (Sidhu el al., 1994). The 
role of measles virus Dis in persistent infection has been suspected for some time (Rima 
el al., 1977). How Dis contribute to the development and survival of persistent infection 
of brain cells and the restriction of measles virus gene expression is still unknown. The 
following theory has been suggested to account for the presence of the DI particles and 
their possible role. SSPE infected brains may lack the high degree of selective pressure
57
Introduction
encountered in tissue culture measles virus infections, thus, allowing the co-existence of 
numerous replication-competent defective particles. Such defective RNAs may act to 
limit full length measles virus genome replication by providing a pool of measles virus 
replicative promoter sequences which effectively competes for replicative polymerase 
complexes. As such, they are likely to reduce the measles virus transcriptional efficiency 
by limiting the abundance of polymerase complexes available to engage the promoter and 
initiate transcription, thus, explaining the low levels of mRNA detected in SSPE virus 
infected cells (Sidhu et a l, 1994).
1.2.3.4 Summary
The persistence of measles virus in the CNS is likely to be the result of both host 
regulatory factors and mutational mechanisms that significantly alter the genome of the 
virus. Such mutated virus could then be selected for propagation in the CNS. An 
effective way of maintaining a persistent infection would be to attenuate the expression of 
the membrane-associated proteins i.e., F, H and particularly M, as the M protein is 
responsible for facilitating viral assembly and budding. As previously explained, the M 
protein of SSPE viruses have been shown to contain many U-C transitions (Cattaneo et 
al, 1986; Wong et a l, 1989). Propagation of the Yamagata-1 SSPE virus in 
neuroblastoma cells has been shown to induce additional U-C transitions (Wong et a l, 
1989), leading to the hypothesis that a cellular factor may be responsible for the 
mutational activity. The theory that a nuclear located enzyme (DRADA) (Bass et a l, 
1989) is responsible for such biased hypermutations may be mis-leading as measles virus 
does not require the cell nucleus for replication. It, therefore, remains unclear as to
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whether the biased hypermutations seen in SSPE viruses, which may have extreme 
consequences for the virus, occur as the result of growth in neural cells or as a function of 
the viral genome itself. It is one of the aims of this project to analyse this process in 
greater detail.
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L3J_Antigenic Variation
Introduction
Measles virus has been considered as monotypic as only one serotype has been identified. 
Monoclonal antibody studies have demonstrated, however, that a number o f strains differ 
in their patterns of antibody binding (Sheshberadaran et al., 1983). M and H protein 
appeared to have the strongest degree of variation between strains while P, NP and F 
proteins were antigenically more stable. Giraudon et al. (1988) confirmed the presence of 
epitopic variation in measles virus when studying the antibody binding affinities of the 
NP protein of different strains o f measles virus.
1=3-2_Genetic Variation
Comparisons and alignments o f paramyxovirus and morbillivirus major structural protein 
sequences (Rima, 1989) have shown that the carboxy-terminal part of the NP and the 
amino-terminal 100 amino acids of P and C (Baczko et al., 1992) are variable. The H 
protein is slightly less variable than the NP and P.
The H and NP protein coding sequences have been extensively analysed because these 
proteins elicit strong immune responses in the host. The carboxy-terminal 151 amino 
acids of the NP protein were originally analysed in 46 strains of measles virus. These 
strains were found to have up to 7.2% divergence at the nucleotide sequence level and 
10.6% divergence at the amino acid sequence level (Taylor et al., 1991a). The measles 
virus strains were found to fall into 6 different genotypic groups, some of which have not
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been isoitted recently, and so are regarded as extinct. Analysis of the H protein 
nucleotide sequence confirmed the division of the measles virus strains into the various 
lineage groups (Rima et al., 1995a) previously described by Taylor et al. (1991a). 
Variation in the H gene may be an expression o f the immunological pressure on the 
protein as it is the main immunogen for neutralising antibodies. However, it is also 
expected that the necessity of the H protein to bind to the CD46 membrane receptor 
places a greater structural constraint on the protein. More recent data utilising the 
nucleotide sequence of the carboxy-terminal region of the N protein in 65 measles virus 
strains, including viral RNA isolated from SSPE patient tissue, has identified a possible 8 
different genotypes (Rima et al., 1995b) (Table 1). The different genotypes are not 
geographically restricted and there appear to be at least 4 co-circulating genotypes at 
present.
Group A contains all vaccine strains used to date, and is typified by the Edmonston strain 
of measles virus. This group also contains early American isolates (Rota et al., 1994a) 
and three SSPE derived strains, Halle, Mantooth and Horta-Barbosa (Horta-Barbosa et 
al., 1971). Group A is homologous with the group 1 genotypes described by Taylor et al. 
(1991a).
Group B contains two clusters of African isolates from two independent epidemics in 
Gabon (1984) and Cameroon (1983). The isolates are divergent among themselves, and 
so are grouped separately, B1 corresponds to the Cameroon isolates and B2 to those from 
Gabon (Taylor et al., 1991a; Rota et al., 1994b). This group is homologous with the 
group 6 genotype described by Taylor et al., 1991a). Measles virus isolates from the
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Gambia were found to form a distinct group when the H gene sequences were compared 
to other African isolates, confirming that African isolates are divergent among themselves 
(personal communication, Dr. M. Outlaw, University of Warwick).
Group C is divided into 3 sub-groups. C 1 group is typified by the SSPE isolate MF, and 
contains mostly SSPE isolates with the exception of two wild-type isolates from Madrid 
in 1978 and 1979. This sub-group may represent an extinct genotype as the last 
representatives were identified in the late 1980’s. Cl is homologous with group 2 
identified by Taylor et al. (1991a). The C2 group is typified by strain JM isolated from 
the USA in 1970. This genotype has been reported in the 1980s from Germany and 
Austria, and since 1990, every year in Germany, in Holland in 1991 and in 1992/93 in 
Spain. This group circulates currently in populations with high vaccination rates, and is 
homologous with group 4 genotype described by Taylor et al. (1991a). The C3 group 
contains only one virus isolate, SBI (Bonn, Germany). This virus probably represents a 
novel imported virus genotype rather than drastically mutated C group viruses.
Group D also contains 3 sub-groups: D1 contains 4 isolates related to the MVO strain 
(Bristol, 1974). The viruses in sub-group D1 are homologous with those in group 5 as 
described by Taylor et al (1991a). The first isolates in the sub-group D2 were from the 
UK in 1988 and this strain was still circulating in the UK in 1991. A related strain was 
isolated from Canada in 1989 and caused a major outbreak in the USA in 1989/90 (Rota 
etal, 1994b).
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The earliest isolate in group E is the Woodfolk strain. It does not appear to be circulating 
at present, and may, therefore, be extinct. This group is homologous with group 3 virus 
strains described by Taylor el al (1991a).
Group F contains only two SSPE isolates isolated in 1979 and 1994 from two patients 
who had an acute measles virus infection in 1967 and 1968, respectively. The wild-type 
virus circulating at the time of onset of the symptoms o f SSPE belongs to group C, which 
circulated from 1970. However, the virus isolated from the patients is not of group C 
lineage. This evidence supports the hypothesis that the wild-type virus circulating at the 
onset of SSPE symptoms is not the strain that gives rise to the persistent infection. It is 
more likely that the persistent virus isolated from these patients belongs to a virus lineage 
which was circulating in 1967/8 at the time of their primary infection.
Group G contains two wild-type isolates from the USA in 1983 (Rota et al, 1994b). They 
are distinct from any of the other groups and may represent imports from a group 
circulating in other countries or an extinct lineage group.
This information indicates that virus genotypes belonging to the sub-groups C2 and D2 
may be still circulating, and that genotypes belonging to the groups A, E and F have not 
been isolated recently and may be extinct.
All measles virus strains isolated before 1970, with the exception of two SSPE strains 
isolated in Madrid in 1968 and 1967, belong to group A, along with all the vaccination 
strains. Vaccination with Edmonston-derived vaccines was started, in many countries,
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Table 1. Group relationships between several measles virus strains
Introduction
Group Name Description Sequence Reference
A Edm V Edmonston-Enders vaccine/USA/1954 Rozenblatt et al. (1985)
Edm P9 SDA variant o f Edm strain" Taylor et al. (1991)
Edm B Edm B vaccine Rota et al. ( 1994a)
Edm wt Edm Wild-type/USA/1954 Rota et a l (1994a)
Edm wtpf Edm Wild-type/USA/1954 plaque pure Rima et al. (1995)
Edm Zag Edmonston-Zargreb vaccine Rota et a l ( 1994a)
Schw Schwarz vaccine Rota et al. ( 1994a)
Hu2 Schwarz-vac. related case/N. Ireland/1971 Taylor et al. (1991)
Mor 1 Moraten vaccine Rota et al. ( 1994a)
Mor 2 Moraten-vac. related case/Netherlands/1990 Taylor et al. (1991)
CAM Vaccine from Tanabe strain/Japan/1968 Rota et al. (1994a)
Len Leningrad-16 strain/Russia/1960 Rota et al. ( 1994a)
S191 Shanghai vaccine/China/1960 Rota et al. (1994a)
Chg Changchun-47 vaccine/China/1957 Rota et al. ( 1994a)
AIK-C Edm-derived vaccine Mori et al. (1993)
Hln Halonen strain/Finland/1962 Rota et al. ( 1994a)
Ph 26 Philadelphia-26 strain/USA/1957 Rota et a l ( 1994a)
Hal Halle SSPE isolate/USA/1971 Buckland et al (1988)
Man Mantooth SSPE strain/USA/1971 Rima et al ( 1995)
HB Horta-Barbosa SSPE strain/USA/1971 Rima et al (1995)
*0077 W i ld-type/Co ventry UK/1993 Outlaw & Pringle 
(1995)
B1 Y22 Wild-type/Cameroon/1983 Taylor et al (1991)
Y14 W ild-type/Cameroon/1983 Rota et al ( 1994b)
B2 R118 Wild-type/Gabon/1984 Taylor et al (1991)
R103 Wild-type/Gabon/1984 Rota et al (1994b)
R113 Wild-type/Gabon/1984 Rota et al (1994b)
R96 Wild-type/Gabon/1984 Rota et al ( 1994b)
Cl MF SSPE case/Europe/early 1970s Rima et al (1995)
S1P3A SSPE case lP3/USA/early 1970s Cattaneo et al ( 1989b)
S(A) SSPE case A/Germany/mid 1980s Cattaneo et al (1989b)
YA SSPE case Yamagata-l/Japan/late 1980s Yosh ikawa et al ( 1990)
SMa81 SSPE case/Madrid/1981/1970 Rima et al (1995)
S(K) SSPE case K/Germany/mid 1980s Rima et al (1995)
Mad78 Wild-type/Madrid/1978 Rima et al (1995)
Mad79 Wild-type/Madrid/1979 Rima et al (1995)
C2 JM Wild-type/Bethesda USA/1977 Taylor et al (1991)
S(B) SSPE case B/Austria/mid 1980s Cattaneo et al (1989b)
WTF Wild-type/Germany/1990 Rima et al (1995)
Bil Wild-type/Netherlands/1991 Rima et al (1995)
DL W i ld-type/Germany/1992 Rima et al (1995)
LB W i ld-type/Germany/1993 Rima et al (1995)
Ma92A Wild-type/Madrid/1992 Rima et a! (1995)
Ma92R Wild-type/Madrid/1992 Rima et al (1995)
Ma93F Wild-type/Madrid/1993 Rima et al (1995)
C3 SBI Wild-type/Bonn Germany/1992 Rima et al (1995)
Dl MVO Wild-type/Bristol UK/1974 Taylor et al (1991)
MVP Wild-type/Bristol UK/1974 Taylor et al (1991)
S33 SSPE/N. Ireland/1983 Taylor et al (1991)
S81 SSPE/N.Ireland/1986 Taylor et al (1991)
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Continuation of Table 1.
Group Name Description Sequence Reference
D2 CL Wild-type/Birmingham UK/1988 Schulz et al (1992)
SE Wild-type/Birmingham UK/1988 Schulz et al (1992)
r r Wild-type Kawasaki case/London/1991 Schulz eta l (1992)
Can Wild-type/Canada/1989 Rota et al (1994b)
Chil Wild-type/Chicago USA/1989 Rota et al (1994b)
Chi2 Wild-type/Chicago USA/1989 Rota et al (1994b)
SD Wild-type/San Diego USA/1989 Rota et al (1994b)
JK MIBE/USA/1990 Rota et al ( l994b)
D3 Ma94B Wild-type/Madrid/1994 Rima e ta l (1995)
E Brx Encephalitis case/Germany/1971 Rima et al (1995)
WFK Wild-type/ Woodfolk USA/early 1970s Rima et al ( 1995)
CM Wild-type/USA/late 1970s Taylor et al (1991)
S(C) MIBE/USA/late 1970s Cattaneo et al (1989b)
F SMa79 SSPE case/Madrid/1979/1967 Rima et a! (1995)
SMa94 SSPE case/Madrid/1994/1968 Rima et al (1995)
G Be83 Wild-type/Berkeley USA/1983 Rota et al ( 1994b)
B083 Wild-type/Boston USA/1983 Rota et a l( \994b)
Adapted from Rima et al, 1995a
* Determined from sequencing the H gene. Four other 1993 Coventry isolates (041, 049, 081 & 105) were 
found to belong to a unique lineage when compared with other measles virus strains whose lineages were 
determined by sequencing the H gene. As this table represents measles virus lineages with respect to the N 
gene it is not appropriate to incorporate the Coventry isolates into the table.
after 1971, thus it seems unlikely that immunisation programmes have been responsible 
for the disappearance of the Edmonston genotype and its replacement by other genotypes. 
Some of the other genotypes appear to have been circulating for at least 15 years, 
suggesting that they represent long established genotypes.
There is no indication that currently used vaccines can not control measles virus infection 
with genotypes different from that of the Edmonston strain. Antibodies to the vaccine 
strain of measles virus can neutralise wild-type virus of a different genotype, suggesting 
that one or several neutralising epitopes are conserved between vaccine and circulating 
wild-type strains. However, differential reactivity patterns of serum from infected 
persons suggest that circulating wild-type virus contains new or modified epitopes that 
are not present on the vaccine strain (Tamin et al, 1994; Rima el al, 1995b). It is not clear
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how this may affect the ability of new wild-type viruses to replicate and be transmitted to 
persons with waning titres of immunity generated by vaccination with a different 
genotype; or what effect it may have on the infection rates in children with waning 
maternal antibody responses generated by vaccination with Edmonston-strain or by 
infection with wild-type viruses of a different genotype.
Very few silent changes are found in comparisons of similar strains, and the number of 
expressed mutation between genotypes is large. This indicates that selective forces are 
operating on the virus, which are not expected to favour silent mutations. To what extent 
the genetic variations observed between the different strains is driven by the immune 
system remains to be determined. It is also impossible to determine which, if any 
mutations observed, are associated with adaptation of the virus to propagation in-vitro.
The groupings described are consistent and independent of the area of the genome 
compared. Comparisons of the H, P, M and N genes show the same pattern of genotypes 
(Taylor et a l,  1991a; Baczko et al., 1991, 1992; Rota et al., 1992, 1994a, b; Outlaw and 
Pringle, 1995). This indicates the absence of recombination between the genotypes.
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I4.Q_Aims
The overall aim of this project was to establish a system whereby the phenomenon of 
biased hypermutation could be reproduced in-vitro, confirming the observation of Wong 
et al. (1989), and to determine whether biased hypermutation could be induced in acute 
disease or vaccine-related measles virus, or in other non-segmented genome RNA viruses 
not normally found in neural tissue. If biased hypermutation could not be induced in- 
vitro in acute disease measles vims, the aim was to establish whether this phenomenon is 
a property specific to SSPE viruses.
Human respiratory syncytial vims was chosen for analysis in this project because it 
belongs to the Paramyxoviridae family of vimses, along with measles vims, and it does 
not involve the CNS during infection. DRADA, whose action has been suggested to play 
a role in the production of hypermutation events, is ubiquitous. It therefore, seems 
unlikely that this enzyme would only target measles virus associated with the CNS. If 
biased hypermutation can be reproduced in-vitro within the genome of respiratory 
syncytial vims, where there is no nuclear involvement in its replicative cycle, this would 
be good evidence of cellular influence on the viral genome, rather than a nuclear- 
associated effect.
Comparisons o f the frequency of biased hypermutation events in vims material 
propagated in cells of neural and non-neural origin would also be determined, as the 
DRADA activity has been shown to be higher in neuroblastoma cells when compared to 
Vero cells.
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Methods
11.1.1 Cell Culture
11.1.1.1 Growth of African Green Monkey Kidney Cells (Vero)
African green monkey kidney cells (Vero), ATCC No. CCL 81, were cultured in 175 cm^ 
plastic flasks at 37°C in Dulbecco's Modification of Eagle's media (DMEM) 
supplemented with L-glutamine (4 mM), penicillin (100 units m l"'), streptomycin (100 p 
g ml *1) and 5% (v/v) foetal calf serum in an atmosphere of 5% CO2 .
Cells were passaged when confluent, typically at 3 day intervals, at a ratio of 1:5. 
Confluent cells were given two washes with 10 ml o f versene, both for approximately 1 
minute at room temperature. Cells were removed from the surface of the flask with 10 ml 
of a 0.25% (w/v) trypsin / versene solution to produce a cell suspension. Two ml of this 
suspension was introduce to a new flask containing 50-75 ml of supplemented DMEM.
11.1.1.2. Growth of Human Lung Fibroblast Cells (MRC-5)
Human lung fibroblast cells (MRC-5), ATCC No. CCL 171, were cultured in 175 cm2 
large plastic flasks at 37°C in Glasgow Modification of Eagle's media (GMEM) 
supplemented with L-glutamine (4 mM), penicillin (100 units ml’ l), streptomycin (100 p 
g ml *1) and 10% (v/v) foetal calf serum in an atmosphere of 5% CO2 .
Cells were passaged when confluent, typically at 4 to 5 day intervals, at a ratio of 1:3.
Confluent cells were given two washes with 10 ml of phosphate buffered saline (PBS),
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the first was for 1 minute at room temperature, the second for 10 minutes at 37°C. Cells 
were finally removed from the flask surface with 10 ml of a 0.25% (w/v) trypsin / PBS 
solution to produce a cell suspension. Approximately 3.3 ml of this suspension was 
introduced to a new flask containing 50-75 ml of supplemented GMEM.
11.1.1.3 Growth of Neuroblastoma Cell Line (IMR-32)
The neuroblastoma cells (IMR-32), ATCC No. CCL 127, were cultured in 175 cm^ large 
flasks at 37°C in Dulbecco's Modification of Eagle's media (DMEM) supplemented with 
L-glutamine (4 mM), penicillin (100 units ml"'), streptomycin (100 pg ml"') and 10% 
(v/v) foetal calf serum in an atmosphere of 5% CO2 .
Cells were passaged when confluent, typically at 2 to 3 day intervals, at a ratio of 1:2. 
Confluent cells were given two washes with 10 ml of PBS, both for 1 minute at room 
temperature. Cells were removed from the surface of the flask by the addition of 10 ml of 
PBS directly to the cell monolayer, producing a cell suspension. Five ml of this 
suspension was introduced to a new flask containing 50-75 ml of supplemented DMEM.
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11.1.1.4 Growth of Neuroblastoma Cell Line (SK-N-SH)
Methods
The neuroblastoma cells (SK-N-SH), kindly provided by Dr. S. Swingler (University of 
Warwick), were cultured in 175 cm^ plastic flasks at 37°C in Dulbecco's Modification of 
Eagle's media (DMEM) supplemented with L-glutamine (4 mM), penicillin (100 units 
ml"l), streptomycin (100 pg m l"l) and 10% (v/v) foetal calf serum in an atmosphere of 
5% C 0 2.
Cells were passaged when confluent, typically at 2 to 3 day intervals, at a ratio of 1:2. 
Confluent cells were given two washes with 10 ml of versene, both for 1 minute at room 
temperature. Cells were removed from the flask surface with 10 ml of a 0.25% (w/v) 
trypsin / versene solution to produce a cell suspension. Five ml of this suspension was 
introduced to a new flask containing 50-75 ml of supplemented DMEM.
11.1.2 Virus Propagation In-Vitro
11.1.2.1 Measles Virus Propagation In-Vitro
The Edmonston strain of measles virus obtained from the American Type Culture 
Collection (ATCC No. VR-24) was used to infect 4 cell lines; 2 neuroblastoma cell lines 
(IMR-32 and SK-N-SH), human diploid lung fibroblast cells (MRC-5) and monkey 
kidney epithelial cells (Vero). The virus had previously been passaged 24 times in human 
kidney cells, followed by 33 passes in human amniotic cells. For this experiment the 
virus was then passaged a further 10 times in each of the cell lines mentioned above.
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After each passage the virus was harvested; 0.2 ml of the harvested virus, diluted 1:100, 
was used for further passage, the remainder was stored in 1 ml aliquots at -70°C until 
required. RNA was extracted (Kumar & Lindberg, 1972) and cDNA synthesised (II.3.1 
& II.3.2) from passages 1 and 10 in preparation for the amplification of the M gene by 
polymerase chain reaction (II.3.3.1).
11.1.2.2 Human Respiratory Syncytial Virus Propagation in-vitro
A non-neurotropic paramyxovirus was required as a control for the passage experiments. 
Respiratory syncytial virus (HuRS virus) was provided by Dr. Patricia Cane (University 
of Warwick). The RSS-2 strain, previously passaged 7 times in MRC-5 cells only, was 
used. This virus was passaged in 3 cell lines; the two neuroblastoma cell lines (IMR-32 
and SK-N-SH) and the human diploid lung fibroblast cells (MRC-5). As for measles 
virus, HuRS virus was passaged 10 times in each of the cell lines. The virus was 
harvested after each passage; 0.2  ml of the harvested virus was used for further passage, 
the remainder was stored in 1 ml aliquots at -70°C until required. RNA was extracted 
(Kumar & Lindberg, 1972) and cDNA synthesised (II.3.1 & 11.3.2) from passages 1 and 
10 in preparation for the amplification of the M gene by polymerase chain reaction 
(II.3.3.1).
Methods
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11.1.2.3 Propagation of Yamagata-1 Virus
Yamagata-1 virus (YM-1), kindly provided by Professor Homma (Yamagata University
School of Medicine, Japan), is a measles virus isolated from the brain of a deceased SSPE
patient by co-cultivation of the brain tissue with monkey kidney epithelial cells (Vero).
Two passage strategies were employed for this experiment.
I: YM-1 virus was passaged directly in the 2 neuroblastoma cell lines (IMR-32 and
SK-N-SH). The virus was passaged up to 5 times in each cell line. One 
Yamagata-1 virus infected flask (25 cm ) was split 1:2 into 25 cm flasks 
containing freshly dispersed cells. One flask was used to harvest total RNA by 
freeze/thawing and aliquoting the cells into 1 ml portions; the infected cell 
monolayer from the remaining flask was harvested by treatment with 
EDTA/trypsin (GIBCO BRL) and split 1:2 for further passage experiments. The 
IMR-32 cells did not need treatment with the EDTA/trypsin in order to disperse 
the cells, gentle rocking of the monolayer sufficed. RNA was extracted (Kumar 
& Lindberg, 1972) from the frozen aliquots and cDNA synthesised (II.3.1 &
II.3.2) from passages 1 and 5 in preparation for the amplification of the M gene 
by polymerase chain reaction (II.3.3.2).
II: This strategy follows the procedure described by Wong et al (1989), who
passaged the YM-1 virus in embryonic lung cells prior to passage in the 
neuroblastoma cell line (IMR-32). To determine if passage in the lung cells 
was important in the development of mutations in the virus genome, the
Methods
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Yamagata-1 virus was initially passaged 3 times in human lung fibroblast cells 
(MRC-5). Virus harvested from passage 3 (as for strategy I) in the MRC-5 cells 
was then used as the inoculum for passage 1 in each of the 2 neuroblastoma cell 
lines (IMR-32 and SK-N-SH). The method of virus passaged was as described for 
strategy I. RNA was extracted (Kumar & Lindberg, 1972) from the frozen virus 
aliquots and cDNA synthesised (II.3.1 & II.3.2) in preparation for amplification of 
the M gene by polymerase chain reaction (II.3.3.2).
11.1.2.4 Plaque Assays
All plaque assays were carried out using Monkey kidney epithelial cells (Vero). Cells 
were grown on 6 well plates. The virus was diluted 10*1, \ q-2^  io*3, 10'4, 10 *^  and 10*
6. The medium was removed from each well, leaving approximately 250 pi which should 
just cover the cell monolayer. Each well was inoculated with 250 pi of either medium, 
for the mock infection, or virus. The virus dilutions were inoculated in duplicate, from 
which the standard error could be calculated. Virus was left to adsorb for up to 1 hour at 
33°C. The inoculum was removed by aspiration and 5 ml of agar overlay (100 ml 2% 
(w/v) agar, 100 ml 2x DMEM [4% foetal calf serum, 8 mM glutamine, 200 pg/ml 
streptomycin and 200 units/ml penicillin]) was added to each well. The infections were 
incubated for 7 days at 33°C. The cells were fixed by adding 2 ml glutaraldehyde (2% 
v/v) to each well and incubating at room temperature for at least 4 hours. The agar 
overlay was removed and the cells were stained using crystal violet (1.5% w/v crystal 
violet in ethanol, diluted 1:20 with water). The plaques could then be counted under the 
microscope.
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11.1,3 Amplification of Genetic Material
Methods
11.1.3.1 Extraction of RNA from Infected Cells
The method of RNA extraction was derived from Kumar & Lindberg, (1972). A 1 ml 
aliquot of passaged virus was centrifuged for 3 mins, at 13,000 rpm in order to pellet the 
cells. The cells were then resuspended in 0.25 ml of ice cold isotonic lysis buffer (150 
mM NaCl, 1.5 m M MgCl2 , 10 mM Tris pH 7.8, 0.65 %Nonidet P40), 0.25 ml of phenol 
extraction buffer ( 7.0 M Urea, 350 mM NaCl, 10 mM EDTA, 1 % SDS, 10 mM Tris pH 
7.8) and 0.5 ml o f equilibrated phenol / chloroform (1:1). The resulting mix was vortexed 
and centrifuged for 10 mins, at 13,000 rpm. The upper aqueous layer was removed and 
re-extracted using 0.5 ml of phenol / chloroform (1:1). The upper aqueous layer was 
retained and 2 times its volume of absolute ethanol was added. This was stored at -20 °C 
until required.
11.1.3.2 Production of cDNA
For each cDNA reaction the RNA extracted from a 1 ml aliquot of infected cells was 
centrifuged for 20 mins, at 13,000 rpm. The pelleted RNA was then washed in 0.5 ml 70 
% ethanol and dried under vacuum. The pellet was then resuspended in 0.5 mM dATP, 
0.5 mM dCTP, 0.5 mM dGTP, 0.5 mM dTTP, 50 mM Tris-HCL (pH 8.3), 40 mM KC1, 1 
mM DTT, 6 mM MgCl2 , 4 pg oligo T primer, and 200U Superscript 11 RNase H" reverse 
transcriptase in a final volume of 50 pi. The reactions were incubated at 37°C for 1 hr, 
and stored at -20°C.
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11.1.3.3 Polymerase Chain Reaction (PCR)
I I .1 .3 .3 .1  M e a s le s  V ir u s  a n d  R e sp ir a to r y  S y n c y tia l V ir u s  M  G en e  
A m p lif ic a t io n
Each PCR reaction was carried out using 0.5 mM of each of the following, dATP, dCTP, 
dGTP and dTTP, 6 pi of cDNA, 0.4 pg o f primer, 0.4 mM DTT, 4 mM MgCl2 , 30 mM 
KCL, 50 mM Tris.HCl (pH 8.3) and 2.5 units of Thermus aquaticus (Taq) DNA 
polymerase in a final volume of 100 pi. The reactions were overlaid with 30 pi of 
paraffin oil to prevent evaporation. Measles virus M gene PCR using the MM01/MM02 
primer pair were thermally cycled at 94°C for 45 secs, 58°C for 45 secs and 74°C for 2 
mins, for a total of 30 cycles; for measles virus M gene amplification using either 
MN01/MM02 or MVMl/oligo T, the cycles used were 94°C for 45 secs, 54°C for 45 
secs and 74°C for 2 mins. (30 cycles). For amplification of the M gene of HuRS virus 
the cycles used were 94°C for 45 secs, 54°C for 45 secs and 74°C for 45 secs for a total 
of 30 cycles.
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11.1 .3 .3 .2  S S P E  (Y a m a g a ta -1 )  v ir u s  M  G e n e  A m p lif ic a t io n
Each PCR reaction was carried out using 0.5 mM of each of the following, dATP, dCTP, 
dGTP, dTTP, 3 pi of cDNA, 10 mM KC1, 10 mM (NH4)2 S 0 4, 20 mM Tris-HCL (pH 
8.0), 2 mM M gS04, 0.2 pg of primer, 0.1% Triton X-100 and 2 units of Thermococcus 
litoralis (Vent) DNA polymerase in a final volume of 50 pi. The reactions were overlaid 
with 20 pi of paraffin oil to prevent evaporation and thermally cycled at 94°C for 45 secs, 
60°C for 45 secs and 74°C for 2 mins, for a total o f 30 cycles.
11.1 .3 .3 .3  S S P E  (Y a m a g a ta -1 )  v ir u s  M  G e n e  A m p lif ic a t io n  u s in g  N ested  P C R
The first PCR reaction (reaction A) was carried out using 0.5 mM of each of the 
following, dATP, dCTP, dGTP, dTTP, 3 pi of cDNA, 0.2 pg of primer, 0.4 mM DTT, 4 
mM MgCl2, 30 mM Tris.HCl (pH 8.3) and 2.5 units Thermus aquaticus(Taq) DNA 
polymerase in final volume of 50 pi. The reactions were overlaid with 20 pi of paraffin 
oil to prevent evaporation and thermally cycled at 94°C for 45 secs, 56°C for 45 secs and 
74°C for 1 min. for a total of 30 cycles.
The second PCR reaction (reaction B) was carried out using 0.5 mM of each of the 
following, dATP, dCTP, dGTP, dTTP, 3 pi of PCR reaction A, 0.2 pg of primer, 0.4 mM 
DTT, 4 mM MgCl2, 30 mM Tris.HCl (pH 8.3) and 2.5 units Thermus aquaticus (Taq) 
DNA polymerase in final volume of 50 pi. The reactions were overlaid with 20 pi of 
paraffin oil to prevent evaporation and thermally cycled at 94°C for 45 secs, 56°C for 45 
secs and 74°C for 1 min. for a total of 30 cycles.
Methods
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111 4 Electrophoresis of DNA
Methods
11.1.4.1 Agarose Gel Electrophoresis
DNA fragments were run on agarose gels in order to analyse the products of PCR 
reactions, restriction digests and to separate fragments for purification. If fragments were 
to be purified from the gel a TAE buffer (40 mM Tris-acetate (pH 7.0), 1 mM EDTA, pH 
8.3) was used, otherwise TBE buffer (100 mM Tris-base, 100 mM boric acid, 160 mM 
EDTA, pH 8.3) was the buffer of choice. To make the gel, agarose at 1% (w/v) was 
dissolved in near boiling buffer, cooled and poured into gel casting trays with well­
forming combs. Ethidium bromide was added to the gel and the running buffer at 0.5 p 
g/ml. DNA samples were supplemented with 20% (v/v) loading buffer (40% (w/v) 
glycerol, 7.5% (w/v) bromophenol blue, 10% (v/v) water) and pipetted into the sample 
wells. The DNA was electrophoresed at 150 mA until the bromophenol blue had 
travelled two thirds of the way down the gel. To determine the size of the 
electrophoresed DNA fragment, a 1 kb marker ladder was run alongside the samples. The 
DNA was visualised under ultraviolet light (365 nm) and photographed using Polaroid 
667 instant black and white film.
11.1.4.2 Polyacrylamide Gel Electrophoresis
The products of sequencing reactions were separated by electrophoresis on
polyacrylamide gels. To make the gel 5.7% (w/v) acrylamide, 0.3% (w/v) N,N’-
methylene-bisacrylamide and 8 M urea were dissolved in 120 ml of 1 x TBE which was
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filtered through No. 1 Whatman filter paper before pouring. Polymerisation of the gel 
was facilitated by the addition of 0.05% (v/v) N,N,N',N'-tetramethylethylenediamine 
(TEMED) and 0.5% ammonium persulphate. The gel was poured between two glass 
plates to form a wedge gel 0.4 mm thick at the top and 1.0 mm thick at the bottom. Short 
tooth combs were inserted at the top of the gel to form a straight gel front. The gel was 
left to polymerise before running. Before samples were loaded, the gel was warmed by 
pre-running at 80 W for 20 min., the samples were loaded on the gel (2.5 pl/well) and 
electrophoresed at 80 W for 1 hr 30 mins, to 8 hrs. The gel was fixed for 40 mins, in 10% 
acetic acid, dried on a heated vacuum drier and autoradiographed using Fuji X-ray film.
Methods
IL1.5 JnzVitrQ Manipulation of PNA
11.1.5.1 Purification of DNA Fragments from Agarose Gels
The PCR products were run out on agarose gels buffered with lx TAE (40 mM Tris- 
Acetate, 1 mM EDTA, pH 8.3). The DNA fragments to be cloned were excised form the 
gel and purified using the Geneclean kit from BIO 101 (United States Biochemicals). 
This involved the addition of 3 volumes of 6 M sodium iodide and incubation at 55°C for 
5 mins, or until the agarose dissolved. Five microlitres of a binding matrix (a silica 
suspension in water) was added, and mixed well before incubating for 5 mins, on ice. 
The binding matrix and DNA was pelleted at 13,000 rpm for 10 secs, and the supernatant 
discarded. The pellet was then washed 3 times with 300 pi of New Wash 
(NaCl/ethanol/water solution buffered with a mixture of Tris-acid and Tris-base to give a
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pH of between 7.0 and 8.5. Information of precise mixture of Tris-acid and Tris-base not 
given by the manufacturer). In between each wash the resuspended matrix bound DNA 
was pelleted at 13,000 rpm for 5 secs, the supernatant was discarded and fresh wash 
solution added. After the final wash the pellet was centrifuged again for 5 secs, at 13,000 
rpm in order to remove any residual supernatant. The DNA was then eluted by 
resuspending the matrix bound DNA in 10 pi of water and incubating for 3.5 minutes at 
55°C. The mixture was then centrifuged at 13,000 rpm for 30 secs., the eluted DNA was 
transferred to a fresh eppendorf tube and the binding matrix was once more resuspended 
in 10 pi of water in order to elute the remaining DNA.
11.1.5.2 Restriction Enzyme Digestion of DNA
Double-stranded DNA was cleaved with a variety of restriction enzymes from a number 
of commercial suppliers. Typically a restriction digest would consist of 4 pi of DNA 
from a 100 pi PCR reaction or from a small scale DNA preparation, the appropriate 
buffer as recommended by the manufacturer and the restriction enzyme(s) as required. 
The restriction digests were incubated for 1 hr at a temperature recommended by the 
suppliers.
Methods
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11.1.5.3 Ligations
Methods
Ligations were carried out in a small volume, typically 20 pi. at 16°C overnight. The 
reaction mix contained the appropriately digested vector (M13 m pl8 or mpl9), T4 DNA 
ligase buffer (50 mM Tris.HCl (pH 7.6), 10 mM MgCl2 , 1 mM ATP, 1 mM DTT, 5% 
(w/v) polyethylene glycol-8000), gel purified digested DNA fragment and 1 unit of T4 
DNA ligase.
11.1.5.4 Cloning intoM13
M l3 m pl8 or mpl9 was digested with the appropriate enzymes (II.5.2) run on TAE 
agarose gels and purified using Geneclean (BIO 101). The purified DNA fragments were 
then ligated into the multiple cloning site of the M13 cloning vector prior to 
transformation into competent bacterial cells.
11.1.5.5 Cloning into TA Vector
Nested PCR products were gel purified and ligated directly into a TA vector (pGEMT 
from Promega) using T4 DNA ligase (II.5.3), prior to transformation into competent 
bacterial cells.
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11.1.6 Transformation of Bacterial Cells with Cloned DNA
Methods
11.1.6.1 Bacterial Strain
Escherichia coli K12 strain TG2 was used for all transformations. The genotype of TG2 
is supE hsdA5 thiA(lac-proAB)A(srl-recA)306::Tnl0(tetr)F'[traD36 proAB+lacIfl lacZA 
M l5]. E. coli strain TG2 was maintained on L-broth plate (1% (w/v) NaCl, 1% (w/v) 
bactotryptone, 0.5% (w/v) yeast extract, 1.5% (w/v) bactoagar). Overnight cultures of E. 
coli strain TG2 were prepared by inoculating 50 ml o f L-broth (0.5% (w/v) NaCl, 1% 
(w/v) bactotryptone, 0.5% (w/v) yeast extract) with a single colony, and shaking at 200 
rpm at 37°C overnight in an orbital shaker.
11.1.6.2 Preparation of Competent Bacterial Cells
One ml of TG2 overnight culture was inoculated into 50 ml of L-broth and shaken at 200 
rpm, at 37°C until the culture gave an optical density reading of 0.5 at 600 nm. The 
culture was then cooled on ice for 30 min. and the cells pelleted at 3000 rpm for 10 min., 
at 4°C. The pellet was resuspended in 5 ml of ice cold 0.1 M MgCl2 and pelleted again 
at 3000 rpm for 5 min., at 4°C. The supernatant was discarded and the pellet resuspended 
in 2 ml of ice cold 0.1 M CaCl2 - The cell suspension was left on ice for a minimum of 30 
min. prior to transformation.
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11.1.6.3 Transformation of Bacteria with the Bacteriophage M13
One hundred microlitres of competent TG2 cells were put into Falcon tubes and mixed 
gently with DNA from ligation reactions (1 to 10 pi). This was incubated on ice for 30 
min., then heat shocked at 42°C for 2 min. before being returned to the ice for a further 
30 min. Three ml of 42°C top agar (0.6% (w/v) bactoagar, 1.6% (w/v) bactotryptone, 1% 
(w/v) yeast extract, 0.5% (w/v) NaCl), 100 pi of early log phase TG2 cells, 15pl 2.4% 
(w/v) IPTG and 30 pi 3% (w/v) X-gal were added to the DNA competent cells. After 
gentle mixing this was poured onto L-broth plates and allowed to set before incubating 
overnight at 37°C. Clear plaques were observed within the lawn of TG2 cells. Isolated 
plaques were picked with a sterile tooth-pick and inoculated into 3 ml of 2YT containing 
90 pi of a TG2 overnight culture.
11.1.6.4 Transformation of Bacteria with the TA Vector pGEMT
Two hundred microlitres of competent TG2 cells were put into Falcon tubes and mixed 
gently with 10 pi DNA from ligation reactions. This was incubated on ice for 30 mins., 
then heat shocked at 42 °C for 2 mins, before being returned to the ice for a further 30 
mins. Two hundred microlitres of L-Broth was added giving a final volume of 410 pi. A 
range of volumes of the transformed cells was spread onto AIX plates (1 % tryptone, 0.5 
% yeast extract, 0.5 % sodium chloride, 1.5 % bactoagar, 100 pg/ml ampicillin, 20 pg/ml 
IPTG, 0.5 ml X-Gal [2%]), and incubated overnight at 37°C.
Methods
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11.1.7 Preparation of Cloned DNA
Methods
11.1.7.1 Preparation of Double Stranded DNA
Single clear plaques were stabbed with sterile tooth picks and transferred to 3 ml of 2YT 
containing 90 pi of a TG2 overnight culture. Cultures were shaken at 200 rpm at 37°C 
for 5 to 6 hrs. The culture was poured into sterile eppendorf tubes and centrifuged at 
13,000 rpm for 3 min. The supernatant was transferred to a fresh eppendorf tube 
containing 250 pi of 2.5 M NaCl, 20% (w/v) PEG6000 solution, gently mixed and 
incubated overnight at 4°C prior to single-stranded DNA preparation (II.7.3).
The pelleted double-stranded DNA was resuspended in 100 pi of resuspension buffer (50 
mM glucose, 10 mM EDTA, 25 mM Tris.HCl [pH 8.0]) and 250 pi of lysis buffer (0.2 M 
NaOH, 1% SDS). The solution was mixed by inverting the tube several times and 
incubated on ice for 5 min. One hundred and fifty microlitres of ice cold neutralisation 
buffer ( 3 M KAc [pH 4.8]) was then added and mixed thoroughly by vortexing for 10 
sec. Nuclear DNA and cell debris was removed by centrifugation at 13,000 rpm for 5 
min. The supernatant was transferred to a fresh eppendorf containing 250 pi of phenol / 
chloroform (1:1), this mixture was vortexed then centrifuged for 5 min. at 13,000 rpm. 
The upper aqueous layer was transferred to a fresh eppendorf tube and the DNA was 
precipitated by the addition of 1 ml of ethanol and a 2 min. incubation at room 
temperature. The DNA was pelleted by centrifugation at 13,000 rpm for 10 min. The 
supernatant was discarded and the pellet washed by the addition of 500 pi of 70% ethanol
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and then dried under vacuum. The DNA was resuspended in 50 pi of sterile TE buffer 
(10 mM Tris.HCl (pH 8.0), 0.1 mM EDTA) and stored at -20°C.
Double-stranded DNA was digested (II.5.2) with either the restriction enzymes used for 
cloning or Pvu II in order to determine if the Ml 3 plaque did contain the cloned M gene. 
Pvu II has sites approximately 100 base pairs either side of the multiple cloning site in 
M13. Therefore the size of a positive M gene clone would be approximately 300 bases 
larger than the expected size of the inserted gene.
11.1.7.2 Preparation of Double-Stranded DNA Silica Particles
I I .1 .7 .2 .1  P r e p a r a tio n  o f  th e  B in d in g  M a tr ix
Twenty five grams of diatomaceous earth was added to 500 ml of water and left to settle 
for approximately 3 hours. The supernatant was aspirated and water was added to a final 
volume of 100 ml. The binding matrix was resuspended and left to settle, giving a final 
concentration of 250 mg/ml. This was stored at room temperature. Prior to DNA 
preparation, 1 ml of the binding matrix was resuspended in 25 ml of matrix resuspension 
buffer (4M guanidine thiocyanate, 50 mM Tris. HC1 [pH 7.0], 20 mM EDTA) and stored 
in the dark (Carter & Milton, 1993).
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II.1 .7 .2 .2  D N A  P rep a ra tio n
One millilitre of an over night culture of bacteria was centrifuged at 13,000 rpm for 2 
mins. The pellet was resuspended in 200 pi of resuspension buffer (50 mM Tris. HC1 
[pH 7.5], 10 mM EDTA, 100 jig/ml RNase A). Two hundred microlitres of cell lysis 
buffer (0.2 M sodium hydroxide, 1 % SDS) was added, and the solution was mixed by 
inversion. A further 200 pi of neutralisation buffer (5M potassium acetate, 11.5 % acetic 
acid) was added, and the solution was mixed by inversion. The solution was centrifuged 
for 5 mins, at 13,000 rpm and the supernatant was transferred to a fresh eppendorf tube. 
One millilitre of binding matrix (250 mg/ml) was added to the supernatant. This was 
incubated for 1 min at room temperature. The binding matrix was pelleted by 
centrifugation at 13,000 rpm for 20 secs. The supernatant was discarded and the pellet 
was washed with 1 ml of 80 % isopropanol, followed by a wash in 1 ml of acetone. The 
pellet was then left to air dry for 5 mins. The binding matrix was then resuspended in 60 
pi of water and the DNA was eluted by incubation at 65 °C for 5 mins. The binding 
matrix was pelleted at 13,000 rpm for 5 mins, and the supernatant was transferred to a 
fresh eppendorf tube (Carter & Milton, 1993).
11.1.7.3 Preparation of Single-Stranded DNA
Single stranded DNA was precipitated overnight at 4°C with a PEG 6000/ NaCl solution 
(II.7.1). The DNA was then pelleted by centrifugation at 13,000 rpm for 10 min. The 
resulting pellet was then resuspended in 120 pi of TE buffer (10 mM Tris.HCl (pH 8.0), 
0.1 mM EDTA) and extracted with 50 pi phenol, then 50 pi chloroform. The upper
Methods
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aqueous layer was removed and the single stranded DNA precipitated by the addition of 
10 pi NaAc and 250 pi of ethanol. This was mixed thoroughly and incubated for 15 min. 
at -70°C. The DNA was pelleted by centrifugation at 13,000 rpm. washed in 500 pi of 
70% ethanol, vacuum dried and resuspended in 30 pi of TE buffer.
11.1.8 Nucleotide Sequencing Methods
11.1.8.1 Nucleotide Sequencing the PCR Product
11.1 .8 .1 .1  A u to m a te d  S e q u e n c in g
PCR products to be sequenced using the 373A DNA Sequencer (Applied Biosystems) 
were extracted from agarose gels using the Geneclean Kit (11.5.1). One microgram of 
DNA and 3.2 pmol of primer were made up to a final volume of 10.5 pi. This was then 
sent for automated sequence analysis by Mrs. L. Ward. Sequencing was carried out using 
the Taq DyeDeoxyTM Terminator Cycle Sequencing Kit (Applied Biosystems) kit. The 
cycles used in these reactions were 96°C for 30 secs.; 50°C for 15 secs.; 60°C for 4 mins, 
for a total of 30 cycles. The dyes were extracted by passage down a Sephadex G50 
column. The eluant was then ethanol precipitated. The resulting pellet was resuspended 
in 4 pi of loading buffer and loaded onto the gel. The gel was run for 12 hrs using 
fluorescence detection of the bases.
11.1 .8 .1 .2  C y c le  S e q u e n c in g
Methods
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Methods
Chain termination cycle sequencing enhances the ability to sequence small amounts of 
template DNA. Sequencing reactions were essentially DNA synthesis reactions carried 
out in the presence of chain-terminating (dideoxy) nucleotides. The United States 
Biochemical A Taq cycle sequencing kit was used for this method of sequencing. The 
first step, the labelling step, was run under conditions where the extension of the primers 
was limited to just a few nucleotides by using only three o f the dNTPs. The labelling 
reaction was made up of the following: 0.5 pmol/pl of primer, 2 |il of reaction buffer (260 
mM Tris.HCl [pH 9.5], 65 mM MgCl2 ), 0.05 pmol DNA, 1 pi dGTP cycle mix, 1 pi 
dCTP cycle mix, 0.5 pi 35s-dATP (10 pCi/pl), 5 pi H2 O and 2 pi A Taq Version 2.0 
DNA Polymerase (diluted 1:8). This was overlaid with 15 pi of paraffin oil and cycled at 
95°C for 45 secs, 48°C for 30 secs and 74°C for 10 secs, for a total of 35 cycles (for 
measles virus); for huRS virus primers RSMla, 3a, 6a. the cycle used was 95°C for 45 
secs, 64°C for 30 secs and 74°C for 10 secs, for a total o f 35 cycles; and form primers 
RSM4a and 5a the cycle used was 95°C for 45 secs, 68°C for 30 secs and 74°C for 10 
secs, for a total of 35 cycles. Termination tubes were set up containing 4 pi of the 
respective termination mixes (15 pM each of dATP, dCTP, dGTP and dTTP along with 
either 22.5 pM ddGTP or 300 pM ddATP or 450 pM ddTTP or 150 pM ddCTP). A 3.5 
pi aliquot of the labelling reaction was added to each termination tube, and overlaid with 
10 pi of paraffin oil to prevent evaporation. The reactions were cycled at 95°C for 45 
secs, 58°C for 45 secs and 70°C for 20 secs, for a total of 30 cycles for measles virus; for 
huRS virus the cycle used was 95°C for 45 secs, 70°C for 45 secs and 74°C for 120 secs, 
for a total of 30 cycles. The reactions were stopped by the addition of 4 pi of stop
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solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue and 0.05% xylene 
cyanol FF.
11.1.8.2 Sequencing of Single-Stranded DNA
The sequencing method used was that of dideoxy chain termination (Sanger et al. 1977) 
and was performed with reagents from US Biochemicals Sequenase Kits. Single-stranded 
DNA was prepared as previously described (II.7.3). Primers were annealed in a 10 pi 
reaction volume containing 7 pi of single-stranded DNA, 60 mM Tris. HC1 (pH 7.5), 20 
mM MgCl2 , 50 mM NaCl and 1 pi of primer (0.4 mg/ml). This reaction was incubated at 
65°C for 10 mins, and then allowed to cool to 45°C. The labelling step was carried out at 
room temperature for 3 mins, with the addition of 1 pi DTT (0.1 M), 2 pi of labelling mix 
(1.5 pM dGTP, 1.5 pM dCTP, 1.5 pM dTTP), 0.5 pi 35S dATP (10 pCi/pl), 2 pi 
Sequenase (1 :8 dilution) to the 10 pi template/primer reaction. Extension and termination 
was carried out for 3 mins, at 37°C by transferring 3.24 pi of the labelling reaction to 
each of 4 pre-warmed termination mixes (2.5 pi in each). The sequencing reaction were 
stopped by the addition of 4 pi of stop solution (95% formamide. 20 mM EDTA, 0.05% 
bromophenol blue and 0.05% xylene cyanol FF) to each termination reaction.
11.1.8.3 Sequencing of Double-Stranded DNA
Double stranded DNA was sequenced using the dideoxy chain termination (Sanger et al,
1977) and was performed with reagents form US Biochemicals Sequenase Kits. Double
stranded DNA was prepared using the Magic Mini prep method previously described
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(11.7.2). Eight microlitres of double-stranded DNA was incubated for 5 mins, at room 
temperature with 2 M sodium hydroxide. To this, 7 pi of primer (20 pmol/pl), 3 pi 
sodium acetate ( 2M [pH 4.5]) and 75 pi of ice cold ethanol was added. The solution was 
then incubated at -70°C for 15 mins, in order to precipitated the annealed primer. The 
DNA was pelleted by centrifugation at 13,000 rpm for 15 mins, and washed with 1 ml of 
70 % ethanol. The resulting pellet was vacuum dried and resuspended in 8 pi water and 2 
pi Sequenase reaction buffer. The labelling reaction was carried out at room temperature 
for 10 mins, with the addition of 1 pi DTT (0.1 M), 2 pi label mix (1.5 pM dGTP. 1.5 p 
M dCTP. 1.5 pM dTTP), 0.5 pi 35s dATP (10 pCi/pl) and 2 pi Sequenase (1:8 dilution) 
to the 10 pi template / primer reaction. Extension and termination was carried out for 30 
mins, at 45°C by transferring 3.5 pi of the labelling reaction to each of 4 pre-warmed 
termination mixes (2.5 pi in each). The sequencing reactions were stopped by the 
addition of 4 pi of stop solution (95 % formamide, 20 mM EDTA, 0.05 % bromophenol 
blue and 0.05 % xylene cyanol FF) to each termination reaction.
Methods
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Materials
11.2.1 Cells and Cell Culture
IMR-32 American Type Culture Collection (No. CCL 127)
MRC-5 American Type Culture Collection (No. CCL 171)
Vero American Ty pe Culture Collection (No. CCL 81)
SK-N-SH Courtesy of Dr. Simon Swingler, University of Warwick.
Escherichia Coli (TG2) Courtesy of Dr. Jaspel Randhawa, University of Warwick
GMEM Prepared by the media preparation unit. University of 
Warwick, Coventry.
DMEM Prepared by the media preparation unit. University of 
Warwick, Coventry.
2x DMEM Prepared by the media preparation unit, University of 
Warwick, Coventry'.
2% Agar Prepared by the media preparation unit. University of 
Warwick, Coventry.
Foetal Calf Serum Sigma
Glutamine Prepared by the media preparation unit, University of 
Warwick. Coventry.
Penicillin/Streptomycin Prepared by the media preparation unit. University of 
Warwick, Coventry.
Tissue Culture Flasks Nunc
6 Well Plates Nunc
EDTA/Trypsin GIBCO BRL
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Materials
Trypsin/versene Prepared by the media preparation unit, University of
Warwick, Coventry.
Phosphate Buffered Saline Prepared by the media preparation unit, University of
Warwick, Coventry.
Crystal Violet Sigma
11.2.2 Viruses
Respiratory Syncytial Vims (RSS-2) Courtesy o f  Dr. Patricia Cane, University of
Warwick, Coventry.
Measles Vims (Edmonston) Courtesy o f  Professor Craig Pringle, University of
Warwick. Coventry.
SSPE Vims (Yamagata-1) Courtesy o f  Professor Homma, Yamagata
University School of Medicine. Japan
11.2.3 Chemicals
11.2.3.1 BDH Laboratory Supplies
Acetic Acid 
Boric Acid 
Bromophenol Blue
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Chloroform (CHCI3)
Dimethylform amide 
Glycerol
Magnesium Chloride (MgCl2)
Magnesium Sulphate (MgSO^j)
Potassium Acetate (KAc)
Sodium Acetate (NaAc)
Sodium Chloride (NaCl2 )
Sodium Hydroxide (NaOH)
T ris(hydroxymethyl)methylamine 
Xylene-Cyanol FF
11.2.3.2 Biorad
N,N,N',N'-Tetramethylethylenediamine
11.2.3.3 DIFCO Laboratories
Tryptone
Bactoagar
Materials
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11.2.3.4 Fisons
Acrylamide
Ammonium Persulphate 
Calcium Chloride (CaCb)
Diaminoethanetetra-Acetic Acid Disodium Sait (EDTA)
Ethanol
Glucose
Hydrochloric Acid (HCl)
Hydrogen Peroxide (H2 O2 )
Methanol 
Paraffin Oil 
Phenol
Potassium Chloride (KCl)
Sodium Dodecyl Sulphate (C ]2 H2 5 0 S0 3 .Na)
Urea
11.2.3.5 GIBCO BRL
Agarose
lkbD N  A Ladder 
Ligase
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Restriction Enzymes: Bam HI
Materials
Hind III 
Kpn I 
Pst I 
PvuII 
Sail
Superscript II
Thermus aquaticus (Taq) DNA Polymerase
11.2.3.6 Miscellaneous
Bacteriophage M13 Courtesy of Mr. Kurt Tolley,
Form amide
University of Warwick. Coventry. 
Fluka Chemica
Geneclean Kit BIO 101
pGEMT Promega
Polyethylene Glycol (PEG) 6000 Prolabo
Primers Prepared at University of Warwick , 
Coventry.
Sequenase Sequencing Kit United States Biochemicals
Taq Cycle Sequencing Kit United States Biochemicals
Vent DNA Polymerase New England Biolabs
X-Gal Rotec
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Materials
Yeast Extract OXOID
11.2.3.7 Sigma
Diatomaceous Earth 
Dithiothreitol (DTT)
Ethidium Bromide
11.2.3.8 Pharmacia
Deoxy-nucleotides
Dideoxy-nucleotides
11.2.4 Apparatus
11.2.4.1 Electrophoresis Apparatus
GIBCO BRL Model 400H 
Life Technologies Inc. Horizon 11.14 
Pharmacia Electrophoresis Apparatus GNA-100 
Pharmacia LKB. ECPS 3000/150
Sequencing plates, spacers and well formers GIBCO BRL
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11.2.4.2 Miscellaneous
Chromatography Paper 
3 73A DNA Sequencer 
Eppendorf Tubes 
Falcon Tubes 
Incubators 
Orbital Shaker 
Petri Dishes
Taq DyeDeoxy Terminator 
Cycle Sequencing Kit 
Vacuum Dryer 
X-Ray Film 
Universals
Whatman
Applied Biosystems 
Sarstedt
Becton Dickinson Labware 
Lab Impex Research 
New Brunswick Scientific 
Sarstedt
Applied Biosystems
Hoefer Scientific Instruments
Fuji
Media
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HLCHAPTER 1
AMPLIFICATION AND SEQUENCING OF THE MATRIX GENE OF 
RESPIRATORY SYNCYTIAL VIRUS
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Results
111.1.1 The Effect of Passage of Human Respiratory Syncytial Virus in 
Neuroblastoma Cells
Human respiratory syncytial virus (huRS virus) belongs to the family Paramyxoviridae. 
Unlike measles virus, however, it has not been shown to involve the CNS during 
infection. It has been hypothesised that biased hypermutation events within the genome 
of measles virus provide some selective advantage for the survival of this virus in the 
CNS (Cattaneo et al, 1988a). Such mutations may be caused by a cellular enzyme i.e., 
double-stranded RNA adenosine deaminase (DRADA), previously referred to as RNA 
unwinding/modifying enzyme (Bass et al, 1989). Propagation of an SSPE virus 
(Yamagata-1) in neuroblastoma cells revealed additional mutational events, particularly 
U-C transitions, when compared to virus propagated in cells of non-neural origin. It was 
suggested that the additional mutations occurred as a consequence of viral growth in the 
neuroblastoma cell lines (Wong et al, 1989). As huRS virus does not naturally infect 
neural cells, propagation of this virus in cells of neural origin should not induce any 
genetic changes if biased hypermutation is an intrinsic property of the viral genome. If, 
however, the mutations observed in the Yamagata-1  virus are due to host cell enzyme 
activity, huRS virus should also be affected. The following experiments were carried out 
in order to determine the effect of passage of huRS virus in neuroblastoma cells.
HuRS virus was passaged 10 times in two neuroblastoma cell lines (IMR-32 and SK-N- 
SH) and 10 times in human lung fibroblast cells (MRC-5) (II.2.2). The aim o f this 
experiment was to determine if biased hypermutation occurred as a result of passage in 
the neuroblastoma cells, using vims passaged in the MRC-5 cells as the control. A
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characteristic of SSPE is that little or no infectious measles virus can be detected in the 
brain tissue of such patients. If  biased hypermutation is involved in the development of a 
persistent infection, and, thus, the change in phenotype of the virus from a lytic infection 
to a cell-associated infection, a drop in titre of the virus might be expected as the number 
of viral passages increases. The titre of huRS virus was determined during sequential 
passage in each of the three cell lines using plaque assays (11.2.4). Table 2 shows the 
titres of huRS virus after each passage.
Results
Table 2. HuRS virus passage titres
Virus Titre (1(P pfu/ml ± SD)
Passage Number MRC-5 IMR-32 SK-N-SH
1 2.09±1.72 0.01 ±0.04 0.01 ±0.003
2 0.23+0.03 0 .2 2 ±0.01 53.20±5.10
3 1.40±0.01 0.31 ±0.07 3.64±0.17
4 0.20±0.04 10.50±2.82 1.43±0.21
5 1.72±0.54 0.15±0.07 13.10± 1.64
6 0.32±0.10 1.06±0.53 7.00±1.98
7 0.38±0.04 0.43±0.17 16.70± 11.72
8 0.18±0.02 0.20±0.05 5.26± 1.52
9 2.55±1.01 1.78±0.35 2.57±0.35
10 0.95±0.37 0.56±0.23 0.63±0.06
HuRS virus was passaged 10 times in two neuroblastoma cell lines (IMR-32 & SK-N-SH) and human lung 
fibroblast cells (MRC-5) (II.2.2). After each sequential passage the virus titre (10^ pfu/ml ± standard 
deviation of the mean [SD]) was determined by plaque assay using Vero cells (11.2.4).
Initially huRS virus did not grow well in the neuroblastoma cells, the titres were
approximately 40-fold lower than that of virus passaged once in MRC-5 cell. However,
adaptation for growth in the neuroblastoma cell lines occurred by the second passage.
The titres of huRS virus passaged twice in IMR-32 cells and in MRC-5 cells are
comparable. The titre for huRS virus passaged twice in the SK-N-SH cells was much
higher and remained higher than the titre of virus passaged in MRC-5 cells. There
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appears to be a more regular cyclical nature to the titres of huRS virus propagated in 
MRC-5 cells, compared to virus passaged in the two neuroblastoma cell lines. Each 
increase in virus titre is followed by a drop in titre, occasionally to a lower titre than that 
determined after passage one i.e., passages 4 and 8. Human RS virus required 2 passages 
in both of the neuroblastoma cell lines to adapt, after which the virus titre fluctuations 
observed were similar to that seen in huRS virus passaged in the MRC-5 cell line.
III.1.1.1 Discussion
Pipetting errors during the plaque assay procedure and / or in the counting of the plaques 
could account for some of the variability observed in the virus titres. However, an 
alternative explanation involves the design of the experiment. Rather than using a 
standard titre of virus for each of the virus passages, a standard volume of virus was used 
as the inoculum instead. This resulted in a variable titre of virus added to each cell 
monolayer. Most viruses develop defective interfering (DI) particles if a multiplicity of 
infection greater than 1 pfu cell is used during propagation, although this has not been 
observed with many strains of huRS virus (Professor C.R. Pringle, personal 
communication). Although the virus titres were shown to increase throughout the 
passage in each of the 3 cell lines, the inoculum for the sequential passage was not diluted 
to minimise the production and accumulation of DI particles. The presence of DI 
particles would interfere with the replication and release of infective virus so reducing the 
titre of the next passage, as such, the cyclical fluctuation in the titres observed could have 
been a consequence of fluctuation in the amount of DI particles present.
Results
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Nonetheless, adaptation for growth of huRS virus in the two neuroblastoma cell lines was 
observed as the titre determined for passage 10 in IMR-32 cells and SK-N-SH cells is 
higher than that for passage one in the respective cell lines. However, conclusive 
evidence for adaptation for growth in these cell lines would require determination of the 
efficiency of plating (EOP) of the virus in these cells. The aim of this experiment was not 
to determine specifically whether huRS virus would need a period of adaptation for 
growth in neuroblastoma cell lines, but to observe any change in phenotype of the virus 
which may occur during propagation in each of the 3 cell lines used. It was, therefore, 
not considered necessary to determine the EOP of the virus in each of the cell lines used.
Biased hypermutation is associated with SSPE viruses, which are a persistent non-lytic 
form of measles virus. Development o f persistence of measles virus in the CNS is 
thought to occur as a consequence of biased hypermutation, along with other cellular 
factors. If huRS virus persistence follows the passage of virus in neural cells, this may be 
indicative of a potential for biased hypermutation. The overall virus titre of huRS virus 
propagated in the two neuroblastoma cells did not fall, therefore, it is unlikely that a 
transition from a lytic phenotype to a more persistent phenotype was occurring. 
However, the development of persistence may require greater than 10 passages, thus, the 
experimental design did not favour the development of a persistent infection. The huRS 
virus infected cell monolayers were harvested by mechanical means when approximately 
50-75% of the monolayer was showing cytopathic effect. It is possible that any cell- 
associated virus present would be destroyed along with the monolayer, therefore, 
released rather than cell-associated virus was propagated further.
Results
106
Results
111.1.2 Amplification by Polymerase Chain Reaction of the M Gene of HuRS 
Virus
Total RNA was extracted from the huRS virus infected cells. mRNA was reverse 
transcribed using initially Avian Myeloblastosis Reverse Transcriptase (AMV-RT), then 
Superscript II, along with an oligo dT primer producing negative sense cDNA. The 
matrix (M) gene of huRS virus was then amplified by polymerase chain reaction (PCR) 
using Thermus aquaticus (Taq) polymerase (II.3.3.1). The published sequence of the 
matrix gene of huRS virus strain A2 (Satake and Venkatesan, 1984) was used to design 
the primers for the amplification as the M gene of the RSS-2 strain of huRS virus had not 
been sequenced. Each primer was designed to include unique restriction endonuclease 
(RE) cleavage sites in order to aid any subsequent cloning procedures. The same set of 
PCR primers was used to amplify M gene sequences from virus passages 1 and 10 in each 
of the three cell lines. The primers used and their amplified PCR products are shown 
below (Table 3 and Figures 10 & 11). The amplified fragment was 917 base pairs in size.
Table 3. PCR primers for the M gene of huRS virus
Name Position Sequence ER
Sites
Tm
°C
RSM1 1 to 22 5' G GGT ACC CGG GGC AAA TAT GGA AAC ATA CG 3' Sma 1 64
RSM2 917 to 900 3’ GGG ATC CTG CAG ACT TGG GAT GAT CTG GG 5’ Pst 1 56
Endonuclease restriction (ER) sites are indicated by bold-type lettering. Two ER sites were included in 
each primer. However, efficient cleavage does not occur if the ER site is at the end of the primer, 
therefore, the internal ER site would be used for cloning reactions. A melting temperature of >54°C was 
employed to improve the specificity o f the annealing reaction.
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Figure 10. Position of the PCR primers within the M gene of huRS virus
Results
RSMl
5 |— 1 -
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The primers were designed so that the complete open reading frame (ORF) of the matrix gene 
could be amplified.
Figure 11. HuRS virus M gene fragments amplified by PCR
L: I kb ladder (GIBCO BRL); 1: negative control (no cDNA); 2 & 5: passages 1 & 10 in IMR-32 cells 
respectively; 3 & 6: passages I & 10 in SK-N-SH cells, respectively; 4 & 7: passages 1 & 10 in MRC-5 
cells, respectively. Half o f the PCR product (50 pi) was electrophoresed on a 1% agarose TAE gel. The 
fragment was excised from the gel and purified using the Geneclean kit (BIO 101) (II.5.1). The purified 
fragment could then be sequenced (II.8.1.1 & 11.8.1.2). The 180 bp fragment may represent non-specific 
binding of the primers to the template.
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ill.1,3 Seqy.encing_theM  Genejof HuRS Virus
Results
The reverse-transcribed, PCR amplified M gene of huRS virus passaged once and 10 
times, in each cell line respectively, was sequenced. The M gene sequence of RSS-2 
virus was established from the sequence obtained from virus passaged once in each cell 
line. This sequence was then used for comparison with sequence data obtained from 
virus passaged 10 times in order to determine whether any mutational events had 
occurred during propagation of the virus in each cell line. The amplified huRS virus M 
gene fragments were subjected to Geneclean (BIO 101) procedures and then sequenced 
directly using the US Biochemicals Taq Polymerase Cycle Sequencing Kit and the 
Applied Biosystems 373A automated sequencer (operated by Lesley Ward). Five internal 
sequencing primers were designed for the Taq polymerase cycle sequencing method, and 
3 additional internal sequencing primers for the 373A automated sequencing method. 
The primers for the automated sequencer were designed before the method of manual 
sequencing had been decided. These primers could not be used for Taq polymerase cycle 
sequencing which requires the primer to be extended in order to incorporate the label 
(35s-dATP). The primers designed for the automated sequencer would not incorporate 
sufficient label to give a strong signal on the gel (II.8.1.2), and as a consequence a further 
set of primers had to be designed. The primers used for sequencing and their positions 
within the M gene can be seen in Tables 4 and 5, and in Figures 12 and 13. The sequence 
obtained was positive sense (5’ to 3’) cDNA, which is identical to the mRNA sequence 
except that the thymine bases will be uracil in the RNA species.
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Table 4. Sequencing primers for Taq polymerase cycle sequencing
Name Position Sequence Tm
°C
RSMla nt. 22 to 44 5' GTG AAC AAG CTT CAC GAA GGC TC 3’ 70
RSM3a nt 207 to 226 5’ GGG ACC TTC ACT AAG AGT CAT G 3' 66
RSM4a nt 346 to 371 5’ GGC ATG TAG TCT AAC ATG CCT AAA AT 3' 72
RSM5a nt 526 to 551 5' CAC ACT TGA AAA TAT AAC AAC CAC TG 3' 70
RSM6a nt 693 to 718 5' GTA TAT ATT ATG TTA CCA CAA ATT GG 3' 66
The sequencing primers were designed from the huRS virus strain A2 M gene sequence (Satake & 
Venkatesan, 1984). They were designed to produce sequence in the 5' to 3' direction (+ sense). The primer 
extension region was designed such that a minimum of 5 35S-deoxy-adenosine residues would be 
incorporated.
Figure 12. Position of 
sequencing
the sequencing primers for Taq polymerase cycle
RSMla RSM4a RSM6a
t ------ 5’----- ► 3- ________ »------
1 r  s--------► i'  9 i 7
RSM3a RSM5a
The sequencing primers were positioned so that sequencing data from the most downstream 
primer would run through the next upstream primer. Cycle sequencing reactions generally 
produce 150-250 bases of sequence. Therefore, the primers have been placed approximately 150 
to 200 bases apart.
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Table 5. Sequencing primers for the 373A automatic sequencer
Name Position Sequence Tm
°C
RSM1 nt 1 to 22 5' GGG GCA AAT ATG GAA ACA TAC G 3’ 64
RSM3 nt 239 to 253 5' GAA GTG GAC TGC TAG 3' 50
RSM4 nt 495 to 510 5' GAT CCA TCA GTG TCA G 3' 52
RSM5 nt 717 to 734 5' GGA AGC ACA CAG CTA CAC 3’ 60
The primers for automated sequencing were also designed from the M gene of the A2 strain of huRS virus 
(Satake & Venkatesan, 1984). The melting temperature of the primers had to be ^ 50°C as this was the 
annealing temperature used by the operator o f the machine.
Figure 13. Position of the sequencing primers for the 373A automated sequencer
RSM1 RSM4
--- ► 3' --- ► 3*
1 r ► r 5'----- ► 3'
RSM3 RSM5
As before, these primers were positioned so that the sequencing data from the most downstream 
primer would run through to next stream primer. Automated cycle sequencing generally produced 
250-400 bases of sequence depending on the quality of the DNA in the sample. Therefore, these 
sequencing primers were positioned approximately 200-250 bases apart.
From Figures 12 and 13 it can be seen that the sequencing primers are facing in the same 
direction i.e., 5' to 3'. As the PCR product is double-stranded another set of primers could 
have been used which would have enabled the second strand of the PCR product to be 
sequenced. Determining the sequence of both strands of the PCR product would make it 
easier to distinguish polymerase errors generated during the primer extension or cycle 
amplification of the M gene, from genuine base changes when compared to the M gene of 
the A2 strain of huRS virus and errors generated during the reverse transcriptase-PCR 
step. However, the absence of significant changes in the M gene sequence as a 
consequence of passage in neuroblastoma cells did not warrant the additional expenditure111
on additional primers. The sequence data from the cycle sequencing reactions is 
generally more ambiguous than that from a clone. Often signals of equal intensity occur 
at a particular position making it impossible to assign the correct base. Had the second 
strand of the PCR product been sequenced these ambiguities would have been resolved 
more easily. As this method was not employed an additional sequencing reaction had to 
be carried out using a different aliquot of the PCR product and a second gel 
electrophoresed to verify the sequence. This was a more laborious approach which 
resulted in more gels being processed than was really necessary. When the a ‘problem’ 
base had been identified it had to be confirmed either by manual sequencing or automated 
sequencing. Figures 14 and 15 show base determinations using both methods of 
sequencing.
Results
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Figure 14. Determination of sequencing ambiguities using Taq polymerase cycle 
sequencing
Results
The sequencing reaction is from huRS virus passaged 10 times in MRC-5 cells. Taq polymerase cycle 
sequencing reaction was carried out according to the manufacturer’s protocol. The primer RSMIa was 
used. A 2.5 pi aliquot of the reaction was electrophoresed on a polyacrylamide gel for 1.5-2 hrs (11.4.2). A: autoradiograph showing undetermined bases at positions 154, 155, 157-159. B: autoradiograph 
showing the determined bases at positions 154, 155, 157-159.
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Results
Figure 15. Determination of sequence ambiguities using automated sequencing
A.
B.
i---------------------------1
T T. A C ^ A  T A T G Q Q T G ^ C  C A T G T
The sequence is from huRS virus passaged once in SK-N-SH cells. A. Taq polymerase cycle sequencing 
was used according to the manufacturer’s protocol, along with the RSMIa primer. A 2.5 pi aliquot of the 
reaction was electrophoresed on a polyacrylamide gel (11.4.2). The undetermined bases are at positions 
111, 113 and 119. B. One microgram of DNA and 3.2 pmol of RSMI primer were made up to a final 
volume of 10.5 pi. This was then sent to the operator of the automated sequencer. Bases at positions 111, 
113 and 119 have been determined.
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III.1.4 The Sequence of the HuRS Virus M Gene
Results
III.1.4.1 The Sequence of the RSS-2 M Gene Determined from Virus 
Passaged Once in MRC-5, IMR-32 and SK-N-SH Cells
The M gene sequence derived from huRS virus passaged once in the three cell types, 
MRC-5, IMR-32 and SK-N-SH, was sequenced at least twice to ensure any base changes 
observed were not due to sequencing errors. The M gene sequence derived from huRS 
virus passaged once in each of the 3 cell lines was found to be identical. This sequence 
could then be used for comparison with M gene sequence data obtained from huRS virus 
passaged 10 times in each of the 3 cell lines. Comparison of the M gene sequence of 
strain RSS-2 with that of the A-2 strain (Satake and Venkatesan, 1984) revealed a total of 
30 base changes. Seventeen o f the changes were within the coding region; however, they 
did not result in any amino acid replacements. The remaining 13 bases changes were 
located in the non-coding region (Figure 16). Of the 30 differences present, 24 represent 
transitions, 16 of which were either U-C or C-U; the remaining 6 changes were 
transversion, resulting in a ratio of 4:1 of transitions over transversions. The first 22 
nucleotides of the M gene of huRS virus in each of the virus passages was not determined 
because this region was defined by the sequence of the 5’ primer.
Homology of the matrix gene of the RSA-2 and RSS-2 strain at the nucleotide level was 
96.83%. At the predicted amino acid level homology between the M protein o f the two 
huRS virus strains was 100%.
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Figure 16. Nucleotide sequence comparison of the M gene of the RSA-2 and RSS- 
2 strains of huRS virus
Results
RSA-2 AUG GAA ACA UAC GUG AAC AAG CUU CAC GAA GGC UCC ACA UAC ACA 54
RSS-2 ......... A .................................
RSA-2 GCU GCU GUU CAA UAC AAU GUC UUA GAA AAA GAC GAU GAC ecu GCA 99
RSS-2
RSA-2 UCA CUU ACA AUA UGG GUG CCC AUG uuc CAA UCA ucu AUG CCA GCA 144
RSS-2
RSA-2 GAU UUA CUU AUA AAA GAA CUA GCU AAU GUC AAC AUA CUA GUG AAA 189
RSS-2
RSA-2 CAA AUA UCC ACA ccc AAG GGA ecu UCA CUA AGA GUC AUG AUA AAC 234
RSS-2
RSA-2 UCA AGA AGU GCA GUG CUA GCA CAA AUG CCC AGC AAA uuu ACC AUA 279
RSS-2
RSA-2 UGC GCU AAU GUG UCC UUG GAU GAA AGA AGC AAA CUA GCA UAU GAU 324
RSS-2 . .u
RSA-2 GUA ACC ACA ccc UGU GAA AUC AAG GCA UGU AGU CUA ACA UGC CUA 369
RSS-2
RSA-2 AAA UCA AAA AAU AUG UUG ACU ACA GUU AAA GAU cue ACU AUG AAG 414
RSS-2
RSA-2 ACA cue AAC ecu ACA CAU GAU AUU AUU GCU UUA UGU GAA UUU GAA 459
RSS-2
RSA-2 AAC AUA GUA ACA UCA AAA AAA GUC AUA AUA CCA ACA UAC CUA AGA 504
RSS-2 . .u
RSA-2 UCC AUC AGU GUC AGA AAU AAA GAU CUG AAC ACA CUU GAA AAU AUA 549
RSS-2
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RSA-2 ACA ACC ACU GAA UUC AAA AAU GCU AUC ACA AAU GCA AAA AUC AUC
R S S - 2 ................................ C ...........................
594
RSA-2 CCU UAC UCA GGA UUA CUA UUA GUC AUC ACA GUG ACU GAC AAC AAA 
R S S - 2 ....................... G ....................................
639
RSA-2 GGA GCA UUC AAA UAC AUA AAG CCA CAA AGU CAA UUC AUA GUA GAU 
R S S - 2 ..................................................U . . . .
684
RSA-2 CUU GGA GCU UAC CUA GAA AAA GAA AGU AUA UAU UAU GUU ACC ACA 
R S S - 2 ...........................................................A . . .
729
RSA-2 AAU UGG AAG CAC ACA GCU ACA CGA UUU GCA AUC AAA CCC AUG GAA
RSS-2 ..............................................................
774
RSA-2 GAU UAA CCUUUUUCCUCUACAUCAGUGUGUUAAUUCAUACAAACUUUCUACCUACAU 
RSS-2 .................U ............ A. . .G....................................................
831
RSA- 2 UCUUCACUUCACCAUCACAAUCACAAACACUCUGUGGUUCAACCAAUCAAACAAAACUU 
RSS-2 ............ A. . . .U...... C...C...............U ..............CC
890
RSA-2 AUCUGAAGUCCCAGAUCAUCCCAAGUC 
RSS-2 .... G..C.U................ C
917
The M gene sequence of the RSS-2 strain of huRS virus was determined by Taq polymerase cycle 
sequencing (USB), following the manufacturer’s protocol; or by 373A automated cycle sequencing. A 
consensus sequence was determined by comparing sequence obtained from huRS virus passaged once in 
IMR-32 cells, SK-N-SH cells and MRC-5 cells. The sequence is displayed as mRNA (5’ to 3’ sense). 
However, the sequence determined was positive sense cDNA, which is identical to the mRNA of the M 
gene except that uracil residues would read as thymine on the sequencing gels.
AUG: translation start codon 
UAA: translation stop codon
Results
111.1.4.2 Comparison of the Nucleotide Sequence of the M Gene of the 
RSS-2 Strain of HuRS Virus Passaged Once and Ten Times in 
MRC-5, IMR-32 and SK-N-SH Cells
The M gene sequences of the RSS-2 strain of huRS virus passaged 10 times in each of the 
three cell lines, MRC-5 (human lung fibroblast cells), IMR-32 and SK-N-SH (both 
neuroblastoma cells), were compared with the sequence for the M gene of RSS-2 
determined from virus passaged once in each of the 3 cell lines (III. 1.4.1). No additional 
base changes were revealed.
111.1.4.3 Discussion
Limited propagation of huRS virus in neuroblastoma cell lines did not result in the 
accumulation of mutations in the M gene. Adenosine to guanine (A-G) hypermutations in 
the genomic sense (U-C in mRNA) have been identified in two escape mutants of huRS 
virus in the G gene (Rueda et al., 1994). It was suggested that these transitions had 
occurred via the double-stranded RNA adenosine deaminase (DRADA) activity, although 
this has not been proven. The fact that escape mutants have been isolated which do 
contain U-C mutations does suggest that the viral genome may be susceptible to biased 
hypermutations, and so possibly a substrate for DRADA.
The experiment described in this thesis shows that hypermutation is not seen in the 
predominant M gene population. Preparing a cDNA library and screening for M gene 
clones using hybridisation techniques would give a more representative view of the M
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gene population and would reveal whether hypermutation does occur in a small sub­
population. However, using an M gene oligonucleotide as a probe is likely to result in the 
identification many potentially positive clones. Screening each o f these clones by 
sequencing would have been very time consuming. Although such a method may result 
in a more realistic representation of the M gene population, it would have taken too long 
with respect to the time constraints of a 3 year research project, considering that ADD- 
MV passaged material would have to be treated in the same way. It was considered, 
therefore, adequate to sequence the PCR product. An advantage to sequencing the PCR 
product is that any errors in the sequence which are a result o f polymerase mis- 
incorporation during the M gene amplification step can be visualised. Such errors will 
show on the autoradiograph as signals of equal intensity in each of the 4 nucleotide tracks 
(Figure 14a). Polymerase errors which occur at later stages during the amplification of 
the M gene will not be perpetuated and so should not influence the sequence of the 
predominant M gene population. However, a disadvantage of sequencing the PCR 
product is that minor sequences will not be amplified as readily and will not, therefore, 
contribute to the sequence.
Although the initial vims stock used was not plaque purified, the sequence obtained 
represents that of the majority component of the population. The data indicate that there 
was no significant change in the predominant component of the population as a 
consequence of passage. There is no evidence to suggest, therefore, that passage of 
plaque-purified virus would have resulted in the observation of hypermutated M gene
Results
species.
III.CHAPTER 2
Results
AMPLIFICATION AND SEQUENCING OF THE MATRIX GENE OF ACUTE- 
DISEASE DERIVED MEASLES VIRUS
1 2 0
Results
111.2.1 The Effect of Passage of Acute-Disease Derived Measles Virus in 
Neuroblastoma Cells
The Edmonston strain of acute-disease derived measles virus (ADD-MV) was passaged 
10 times in 4 cell lines; IMR-32 and SK-N-SH (both human neuroblastoma cell lines), 
MRC-5 cells (human diploid lung fibroblast cells) and Vero cells (monkey kidney 
epithelial cells). The virus stock (6x10s pfu/ml) was diluted 1:100 to give a titre of 6xl03 
pfu/ml, and 0.25 ml of this was used to infect a 25 cm^ flask of cells (approximately 
1.9xl06 cells) (II.2.1). The virus from passage 1 was harvested and diluted 1:100, 0.25 ml 
of this was used as the inoculum for passage 2, and so on. For each passage the same 
volume o f diluted virus, rather than the same number of plaque forming units per cell, 
was added to the cells. The vims stock was diluted in order to reduce the inhibitory effect 
on replication of any DI particles which may have been present in the original inoculum 
or generated during passage. Progeny vims was harvested at 6 to 7 days post infection. 
Determining the optimum time of harvest of vims passaged in the neuroblastoma cell line 
was difficult as syncytia were rarely visible. The time of harvest was determined by the 
amount of cell death observed. Virus was harvested from the neuroblastoma cell cultures 
when approximately 50 - 75% of the cell monolayer became detached. For cultures in 
which syncytia were seen (Vero and MRC-5 cells), vims was harvested when the 
monolayer was showing 50 - 75% syncytia. The neuroblastoma cell line IMR-32 was 
difficult to grow. These cells grew slowly and cultures were vulnerable to infection with 
bacteria and yeasts. The addition o f kanamycin and fungizone to the medium had a 
detrimental effect on the growth of these cells, such that passage and titration of the vims 
in this cell line was difficult. The virus passages from each cell line were titred on Vero
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cells. The titres of the ADD-MV passaged 10 times in each of the 4 cell lines are shown 
in Table 6.
Results
Table 6. ADD-MV passage titres
Virus Titre ( x l(P± SD pfu/ml)
Passage No. Vero MRC-5 IMR-32 SK-N-SH
1 6.8011.60 0.0610.01 0.2310.01 0.1710.04
2 3.50+0.31 0.2210.07 1.4810.06 0.2310.03
3 4.36+2.60 0.4510.02 0.0210.003 0.3310.02
4 11.610.79 2.0810.45 0.0610.003 0.4910.03
5 4.4611.91 2.5310.71 0.0410.001 0.5610.04
6 0.2010.14 16.617.50 0.3910.06 1.8210.08
7 0.0210.007 5.0512.76 3.6511.28 2.2010.28
8 0.0210.01 1.0210.03 1.1010.86 3.8812.09
9 0.7710.23 0.1310.04 1.8210.44 0.2310.18
10 0.1910.02 0.2610.03 1.2310.95 0.9210.17
ADD-MV stock was diluted 1:100 and 0.25 ml of this was used to inoculate a 25 cm^ flask of each of the 4 
cell lines. Virus was harvested by mechanical destruction of the monolayer and the resulting virus progeny 
was diluted 1:100 and used as the inoculum for further passage (11.2.1). Each passage was titred on Vero 
cells as the neuroblastoma cell lines did not produce syncytia, thus titre determination using these cells was 
difficult. SD: standard deviation of the mean.
The original virus stock was inoculated into and subsequently passaged in human diploid 
cells only. No adaptation would be expected during further passage of ADD-MV in this 
cell line. Nonetheless, the titres of ADD-MV passaged in MRC-5 cells increased to a 
peak at passage 6 (16.60x10s pfu/ml). The standard deviation of the mean for this 
passage is quite high. This could be due to the high number of plaques present in the 
wells corresponding to the lower dilutions used in the virus titre protocol. Due to the 
difficulty in counting dense populations of plaques, only a small portion of the monolayer 
is counted. The total number of plaques from that dilution is determined by multiplying 
up i.e., if plaques from a quarter of the monolayer was counted, then that number would 
be multiplied by 4 to give the total number of plaques for that dilution. This method
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amplifies any error made in the counting, which would account for the high standard 
deviation calculated. The titre of virus MRC-5 cells then fell to 0.13xl05 pfu/ml, before 
slightly rising to 0.26xl05 pfu/ml. The subsequent fall in titre could have been in 
response to an increasing concentration of defective interfering (DI) particles.
Vero cells are permissive for measles virus infection and there did not appear to be any 
adaptation for viral growth in this cell line. The virus titres throughout the 10 passages 
fluctuated greatly. Again, this could be due to the variable presence of DI particles in the 
inoculum.
ADD-MV had not previously been propagated in neuroblastoma cells, therefore some 
adaptation for growth in these cell lines might be expected. The titres from passage one 
in SK-N-SH cells and IMR-32 cells are low, but not as low as the titre for passage one in 
MRC-5 cells. The titres from sequential passages were determined with peak titres in 
IMR-32 cells at passage 7, and in SK-N-SH cells at passage 8.
Some of the fluctuation in virus titres observed could be due to pipetting errors during the 
plaque assay procedure, or counting error. More consistent results might have been 
obtained if a standard multiplicity of infection (MOI) rather than an arbitrary dilution had 
been used.
Results
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Results
III.2.1.1 Conclusions
It has been suggested that DI particles play a role in the establishment of persistent 
infections (Huang & Baltimore, 1970). The passaged virus used in these experiments was 
diluted 1:100 in order to reduce the concentration of DI particles in the inoculum, 
however, it has been shown that virus stocks o f measles virus should be diluted 1:10,000 
in order to obtain measles virus preparations that are minimally contaminated with DI 
particles (Rima el al., 1977). The MOI to produce such measles virus preparations was 
not evaluated, however, the titres of measles virus preparations used in the study of Rima 
et al. (1977) were approximately l-4 x l0 5 pfu/ml, on monolayers containing 
approximately 5xl06 cells. Therefore, the MOI of virus diluted 1:104 was approximately 
2-8x1 O'6 pfu/cell. The original inoculum used in the experiments described in this thesis 
had a titre of 6xl03 pfu/ml, which was diluted 1:100 and only 0.25 ml was used to infect a 
monolayer containing approximately 1.9xl06 cells, therefore the MOI used was 3x10'5 
pfu/cell. This dilution factor should have reduced the probability of interference by DI 
particles.
There is no overall fall in the titre of ADD-MV in MRC-5 cells, nor virus passaged in 
IMR-32 and SK-N-SH cells. When comparing the virus titres of ADD-MV passaged in 
the neuroblastoma cell lines, with those determined from virus passaged in the MRC-5 
cells, there is no obvious difference in the range of titres observed. ADD-MV did not 
required any adaptation for growth in the MRC-5 cells. The titres of virus passaged in the 
neuroblastoma cell lines are not significantly different when compared to virus passaged
124
in MRC-5 cells, which could suggest that no adaptation was required by the ADD-MV 
virus for propagation in the neuroblastoma cell lines.
111.2.2 Amplification by Polymerase Chain Reaction of the M Gene of 
ADD-MV
Total RNA was extracted from the infected cells of passages 1 and 10 in each of the cell 
lines. The RNA was then reverse transcribed initially using Avian Myeloblastosis Virus 
Reverse Transcriptase (AMV-RT), and subsequently using Superscript II, which became 
available in December 1994. The primer used for reverse transcription was the oligo dT 
primer, which would prime on the poly A tail of mRNA producing (-) sense cDNA. The 
matrix gene (M) of ADD-MV was then amplified by polymerase chain reaction (PCR) 
using Thermus aquaticus (Taq) polymerase. The published sequence of the M gene for 
the Edmonston strain of measles virus (Bellini et al, 1986), hereafter referred to as EdM, 
was used to design the primers for the amplifications. Each primer was designed to 
include endonuclease restriction (ER) cleavage sites to aid any subsequent cloning 
procedures. The aim of the experiment was to amplify the entire M gene of ADD-MV 
even though only the 5 -end 750 bases would be sufficient for the sequence comparisons
(III.2.3). This region of the M gene was chosen because excess hypermutations observed 
in the SSPE virus (Yamagata-1) passaged in 1MR-32 cells by Wong et al. (1989) 
occurred within the first 550 bases. Two primers MMOl and MM02 were designed for 
this purpose (Table 7) and their positions on the M gene are shown in Figure 17.
Results
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Table 7. PCR primers for ADD-MV M gene
Results
Name Position Sequence ER Sites Tm
°C
MMOl 1404 to 1387 3' GGG ATC CAC CTC GGT CGC TTG TGC 5’ Bam HI 60
MM02 25 to 44 5’ C TCT CGA GTT CCA CAA TGA CAG AGA TC 3' Xho 1 58
The primers were designed using the published M gene sequence of the Edmonston strain of measles virus 
(Bellini et al, 1986). Endonuclease restriction (ER) sites, indicated by bold-type lettering, were included at 
the 5’ ends of each primer to aid any further cloning reactions. A melting temperature of >54°C was 
employed to improve the specificity of the annealing reaction.
Figure 17. Position of the PCR primers within the M gene of ADD-MV
ORF
1466 
-----------1 3-
r  — >•
MMOl
The primers were designed so that the entire M gene, minus a few bases in the non-coding regions at the 5’ 
and 3’ ends, could be amplified. The amplified fragment was expected to be 1379 bases.
MM02
5' ---►!'
5' I--------
1
Total RNA extracted from ADD-MV stock, plaque-purified in BS-C-1 cells 
(SL92/16/MV), was used to determine the most suitable cycle parameters for efficient 
amplification of the M gene. These were found to be 30 cycles of: 94°C for 45 secs, 
56°C for 45 secs and 74°C for 2 mins. Figure 18 shows the amplified 1379 base M gene 
using the MM01/MM02 primer pair. Two primers designed to amplify a 300 base 
fragment of the NP gene of ADD-MV, MNOl (108/ 5 AGA TGG CCA CAC TTT TAA 
GG 3' /127) and MN02 (425/ 3' CTG GAC AAC CTC TAA CAG CC 5 /406) were used 
as controls for the PCR reaction. Transcription of genomic RNA occurs sequentially 
from the 3 terminus, which leads to a polar accumulation of mRNAs. The NP gene is the 
first gene to be transcribed and its mRNA will be more abundant. Therefore, 
amplification of a small region of this gene was chosen as the PCR control.
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Figure 18. M gene amplification o f  SL92/16/MV using MM01/MM02 primers
L 1 2 3 4 5 6 7
L: I kb ladder (GIBCO BRL); 1-4: PCR amplifications using 0.2 pi Taq polymerase; 5-7: PCR reactions 
using 0.4 pi Taq polymerase; 1+5: SL92/16/MV using MM01/MM02 primers; 2+6: mock infected BS-C- 
1 cells using MM01/MM02; 3+7: SL92/16/MV using MN01/MN02 primers; 4: mock infected BS-C-I 
cells using MN01/MN02 primers. MNOI and MN02 primers were designed to amplify a 300 base 
fragment of the N gene, to be used as controls for the PCR reaction. The cycle parameters used were 
94°Cx45 secs, 54°Cx45 secs and 74°Cx2 mins for 30 cycles. A 10 pi aliquot of each PCR product was 
subjected to electrophoresis on a 1% TBE agarose gel (11.4.1).
The 1379 base fragment of the M gene could be amplified using the MM01/MM02 
primer pair (Figures 19A). However, in later experiments amplification of the M gene 
from ADD-MV passages, of both plaque purified virus and non-plaque purified virus, 
resulted in an 800 base fragment in place of the expected 1379 base fragment. To 
improve the stringency of the annealing reaction, the annealing temperature of the PCR 
cycle was increased to 58°C for 45 secs, and, as a result the 1379 base fragment was once 
again amplified (Figure 19B).
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Figure 19. Amplification of the M gene of ADD-MV passaged once and 10 times 
using the MM01/MM02 primers
Results
B.
L: 1 kb ladder; A. I: ADD-MV passaged once in SK-N-SH cells; 2: ADD-MV passaged once in IMR-32 
cells; 3: ADD-MV passaged once in MRC-5 cells; 4: ADD-MV passaged once in Vero cells. Cycle 
parameter: 94°Cx45 secs, 54°Cx45 secs and 74°Cx2 mins (30 cycles). B. 1: mock infected SK-N-SH cells 
passaged 10; 2: ADD-MV passaged 10 times in SK-N-SH cells; 3: plaque purified ADD-MV passaged 10 
times in SK-N-SH cells; 4: mock infected IMR-32 cells passage 10; 5: plaque purified ADD-MV passaged 
10 times in IMR-32 cells. Cycle parameters: 94°Cx45 secs, 58°Cx45 secs and 74°Cx2 mins (30 cycles). A 
10 pi aliquot of each PCR product was subjected to electrophoresis on a 1% TBE agarose gel. The smaller 
fragments (approx. 200 bp) may represent non-specific binding of the primers to the template.
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Amplification of the expected 1379 base fragment was achieved consistently for a further 
6 months, until, again, only a 750-800 base fragment of the M gene could be amplified 
using the MMO1/MM02 primer pair in all passaged virus, irrespective of passage history 
or the passage number. This coincided with a change from using AMV-RT to Superscript
II. It was possible that the change in reverse transcriptase may have affected the 
annealing specificity of the two primers. To test this, total RNA from cells infected with 
ADD-MV was extracted and resuspended in 5 pi of distilled water. Half of this material 
was reverse transcribed using Superscript II and the other half using AMV-RT. The 
resulting cDNA, prepared using the oligo dT primer, was amplified using the 
MM01/MM02 primers. Figure 20 shows that both the 1379 and the 750-800 base 
fragments were amplified regardless of the reverse transcriptase used, although the 1379 
bp fragment amplified from cDNA synthesised using AMV-RT is faint. 1'his result 
suggests that both primers were annealing to the intended sequences and that the 800 base 
fragment might represent a truncated version of the M gene. The vims used in this 
experiment was derived from the original ADD-MV used in the passage experiment, 
therefore, if the M gene was truncated then the original virus stock used for the vims 
passage would also contain the tmncated M gene. Alternatively, one or both of the 
primers may have been mis-priming. However, since there is no obvious homology 
between other regions of the M gene and the two primers this seems an unlikely 
explanation for the amplification of the smaller M gene fragment.
In order to determine whether the 5 -end 750 bases required for this experiment had been 
amplified, the 800 base fragment was gel purified and sequenced by Taq polymerase 
cycle sequencing. The results of the sequencing experiments confirmed that the first 750
5
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bases were present within the 800 base fragment, and the subsequent analysis was derived 
from sequencing this fragment.
Results
Figure 20. Comparison of the PCR products from cDNA synthesised using AMV- 
RT and Superscript II
L: 1 kb ladder; I: negative control (no cDNA); 2: ADD-MV (AMV-RT); 3: ADD-MV (Superscript II). 
Total RNA, extracted from ADD-MV infected cells, was reverse transcribed using AMV-RT and priming 
the mRNA with oligo dT, or Superscript II (II.3.2) and oligo dT. The resulting cDNA was amplified using 
MM01/MM02 primers. Cycle parameters: 94°Cx45 secs, 58°Cx45 secs and 74°Cx2 mins for 30 cycles. A 
10 pi aliquot of the reaction was subjected to electrophoresis on a 1% TBE agarose gel.
Total RNA was extracted from stored aliquots of ADD-MV infected cells. Freshly diluted 
oligo dT primer was used for cDNA synthesis and primers MM01/MM02 used for PCR, 
along with new enzyme and buffer to determine whether degradation of cDNA or any of 
the materials used during the cDNA synthesis and PCR procedures affected the 
amplification of the 1379 base fragment. However, only the 800 base fragment could be 
amplified reproducibly. Occasionally the 1379 base fragment would be amplified, but
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this was not reproducible on a regular basis. A new 5' primer was designed, MVM1 (1/ 5' 
AGG AGC AAA GTG ATT GCC TC 3‘ /20 Tm: 60°C). The aim was to use this primer 
in conjunction with the oligo dT primer to amplify the entire M gene (1466 bases) of 
ADD-MV. However, when the oligo dT/MVMl primer pair were used together on both 
plaque purified virus and non-purified passaged virus a fragment of approximately 750 
bases was amplified (Figure 21).
Figure 21. Amplification of ADD-MV using the MVMl/oligo dT primer pair
Results
L: I kb ladder; 1: ADD-MV plaque purified (pp) once in MRC-5 cells; 2: ADD-MV passage 10 in SK-N- 
SH cells; 3: ppADD-MV passage 10 in SK-N-SH cells; 4: ADD-MV passage 10 in IMR-32 cells; 5: 
ppADD-MV passage 10 in IMR-32 cells; 6: ADD-MV passage 1 in MRC-5 cells; 7: ADD-MV passage 10 
in MRC-5 cells; 8: ADD-MV passage 1 in Vero cells; 9: ADD-MV passage 10 in Vero cells; 10: ppADD- 
MV passage 1 in Vero cells. Cycle parameters used are 94°Cx45 secs, 54°Cx45 secs and 74°Cx2 mins for 
30 cycles. A 10 pi aliquot of each PCR product was subjected to electrophoresis on a 1% TBE agarose gel.
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From figure 21 it can be seen that several fragments of various sizes have been amplified. 
The most prominent fragment was that corresponding to approximately 750-800 bases 
which suggests that the oligo dT primer was annealing to the sequence 743/ 5 AAA ATG 
AAA ATC GAA AA 3’ /759 in the M gene. Other smaller fragments and occasionally 
one of approximately 1 kb was observed, although these were less well defined. The 
amplification of smaller fragments could have been prevented by altering the cycle 
parameters. For example, the melting temperature of MVM1 and oligo dT is 60°C, 
therefore, the annealing temperature of the PCR cycle could be increased to 59°C. This 
would increase the fidelity of primer annealing so fewer fragments would be amplified 
and the PCR product would be expected to more specific. If the annealing temperature 
was increased it was possible that the oligo dT primer would not base pair with the 743- 
759 base region of the gene because 5 out of the 17 bases are miss-matched. There are 
other areas of the M gene where the oligo dT primer may have some homology e.g., 
nucleotide positions 1006-1034 and 1101-1121, but there was no other region where 12 
out of 17 bases were complementary; therefore, it was possible to conclude that PCR 
amplification using the MVMl/oligo dT primer pair produced the 5'-end 759 bases of the 
M gene. As already stated, this was the region of the gene required for the sequence 
analysis, as such the amplification products of the MVMl/oligo dT primers were suitable 
for this experiment.
Essentially three PCR products of the M gene of passaged ADD-MV have been used in 
sequencing reactions. Initial PCR amplifications using the MM01/MM02 primer 
yielded the 1379 base fragment of the M gene which was expected and was subsequently 
used for sequence analysis of the 5’ 750 bases. Later, only a 800 base fragment could be
Results
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generated. This was shown to contain the 5 -region of the M gene required for the 
sequence analysis and so these products were used for cycle sequencing reactions. 
Finally, the 743 base fragment amplified by the MVMl/oligo dT primers also yielded a 
product which could be used for sequencing.
The positions of all the primers used to amplify the M gene of ADD-MV are shown in 
Figure 22 below.
Results
Figure 22. Nucleotide sequence of the ADD-MV M gene and the positions of the 
PCR primers
mRNA 5 ' AGGAGCAAAGUGAUUGCCUCCCAAGUUCCACAAUGACAGAGAUCUACGAC 50 
MVM1 AGGAGCAAAGTGATTGCCTC - *
cDNA 3 ' TCCTCGTTTCACTAACGGAGGGTTCAAGGTGTTACTGTCTCTAGATGCTG
MM02 GTTCCACAATGACAGAGATC ->
mRNA
CDNA
UUCGACAAGUCGGCAUGGGACAUCAAAGGGUCGAUCGCUCCGAUACAACC
AAGCTGTTCAGCCGTACCCTGTAGTTTCCCAGCTAGCGAGGCTATGTTGG
100
mRNA
CDNA
CACCACCUACAGUGAUGGCAGGCUGGUGCCCCAGGUCAGAGUCAUAGAUC
GTGGTGGATGTCACTACCGTCCGACCACGGGGTCCAGTCTCAGTATCTAG
150
mRNA
cDNA
CUGGUCUAGGCGACAGGAAGGAUGAAUGCUUUAUGUACAUGUUUCUGCUG
GACCAGATCCGCTGTCCTTCCTACTTACGAAATACATGTACAAAGACGAC
200
mRNA
cDNA
GGGGUUGUUGAGGACAGCGAUCCCCUAGGGCCUCCAAUCGGGCGAGCAUU
CCCCAACAACTCCTGTCGCTAGGGGATCCCGGAGGTTAGCCCGCTCGTAA
250
mRNA
cDNA
UGGGUCCCUGCCCUUAGGUGUUGGCAGAUCCACAGCAAAGCCCGAAAAAC
ACCCAGGGACGGGAATCCACAACCGTCTAGGTGTCGTTTCGGGCTTTTTG
300
mRNA
cDNA
UCCUCAAAGAGGCCACUGAGCUUGACAUAGUUGUUAGACGUACAGCAGGG
AGGAGTTTCTCCGGTGACTCGAACTGTATCAACAATCTGCATGTCGTCCC
350
mRNA
cDNA
CUCAAUGAAAAACUGGUGUUCUACAACAACACCCCACUAACUCUCCUCAC
GAGTTACTTTTTGACCACAAGATGTTGTTGTGGGGTGATTGAGAGGAGTG
400
mRNA
cDNA
ACCUUGGAGAAAGGUCCUAACAACAGGGAGUGUCUUCAACGCAAACCAAG
TGGAACCTCTTTCCAGGATTGTTGTCCCTCACAGAAGTTGCGTTTGGTTG
450
mRNA
cDNA
UGUGCAGUGCGGUUAAUCUGAUACCGCUCGAUACCCCGCAGAGGUUCCCU
ACACGTCACGCCAATTAGACTATGGCGAGCTATGGGGCGTCTCCAAGGGA
500
mRNA
cDNA
GUUGUUUAUAUGAGCAUCACCCGUCUUUCGGAUAACGGGUAUUACACCGU
CAACAAATATACTCGTAGTGGGCAGAAAGCCTATTGCCCATAATGTGGCT
550
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mRNA UCCUAGAAGAAUGCUGGAAUUCAGAUCGGUCAAUGCAGUGGCCUUCAACC 600
CDNA AGGATCTTCTTACGACCTTAAGTCTAGCCAGTTACGTCACCGGAAGTTGG
mRNA UGCUGGUGACCCUUAGGAUUGACAAGGCGAUAGGCCCUGGGAAGAUCAUC 650
CDNA ACGACCACTGGGAATCCTAACTGTTCCGCTATCCGGGACCCTTCTAGTAG
mRNA GACAAUACAGAGCAACUUCCUGAGGCAACAUUUAUGGUCCACAUCGGGAA 700
CDNA CTGTTATGTCTCGTTGAAGGACTCCGTTGTAAATACCAGGTGTAGCCCTT
<—  TTTTTTT
mRNA CUUCAGGAGAAAGAAGAGUGAAGUCUACUCUGCCGAUUAUUGCAAAAUGA 7 50
CDNA GAAGTCCTCTTTCTTCTCACTTCAGATGAGACGGCTAATAACGTTTTACT
TTTTTTTTTT Oligo dT
mRNA AAAUCGAAAAGAUGGGCCUGGUUUUUGCACUUGGUGGGAUAGGGGGCACC 800
CDNA TTTAGCTTTTCTACCCGGACCAAAAACGTGAACCACCCTATCCCCCGTGG
—
mRNA GCAGCCGACGGCAAGCGCGAACACCAGGCGGCCCCAGCACAGAACAGCC 12 00
CDNA CGTCGGCTGCCGTTCGCGCTTGTGGTCCGCCGGGGTCGTGTCTTGTCGG
mRNA CUGACACAAGGCCACCACCAGCCACCCCAAUCUGCAUCCUCCUCGUGGGA 12 50
CDNA GACTGTGTTCCGGTGGTGGTCGGTGGGGTTAGACGTAGGAGGAGCACCCT
mRNA CCCCCGAGGACCAACCCCCGGAGCUGCCCCCGAUCCAAACCACCAACCGC 1300
CDNA GGGGGCTCCTGGTTGGGGGCCTCGACGGGGGCTAGGTTTGGTGGTTGGCG
mRNA ACCCCCACCACCCCCGGGAAAGAAACCCCCAGCAAUUGGAAGGCCCCUCC 1350
CDNA TGGGGGTGGGTGGGGCCCTTTCTTTGGGGGTCGTTAACCTTCCGGGGAGG
* -  CGTCTTCGCTGGCT
mRNA CCCUCUUCCUCAACACAAGAACUCCACAACCGAACCGCACAAGCGACCGA 14 00
CDNA GGGAGAAGGAGTTGTGTTCTTGAGGTGTTGGCTTGGCGTGTTCGCTGGCT
CCAC MMOl
mRNA GGUGACCCAACCGCGCGGCAUCCGACUCCCUAGACAGAUCCUCUCUCCCC 14 50
CDNA CCACTGGGTTGGCGCGCCGTAGGCTGAGGGATCTGTCTAGGAGAGAGGGG
mRNA GGCAAACUAAACAAAA 3' 1466
CDNA CCGTTTGATTTGTTTT 5 '
mRNAxDNA hybrid duplex formed during the reverse transcriptase reaction. M gene sequence 
determined by Bellini el al. (1986). Amplification primers (indicated by bold-type lettering) MM02 and 
MVMI anneal to the negative sense cDNA, while oligo dT and MMOl anneal to the mRNA. The resulting 
amplified products should be MM01/MM02: 1379 base pairs; MVMl/oligo T: 743 base pairs.
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111.2.3 Sequencing the 5'-end 750 Bases of the M Gene of ADD-MV
Results
III.2.3.1 Sequencing the PCR Product
Initially, it was intended that the M genes of ADD-MV passaged once and 10 times 
would be sequenced in order to determine if biased hypermutation had occurred during 
propagation in cultured cells, and if this type of mutation occurred at a higher frequency 
in virus passaged in neuroblastoma cells compared to cells of non-neural origin. Had 
there been a high frequency of mutations in the M gene of ADD-MV passaged 10 times 
compared to that passage only once, the M gene from intermediate passages would have 
been sequenced to determine if the mutations occurred gradually during cell passage, or 
as a single event as suggested by Wong et al. (1989). As this would require a large 
amount of sequencing the method of preference was cycle sequencing. This sequencing 
method eliminated the need to clone the M genes into a Bluescribe vector, for double- 
stranded sequencing; or phage M l3 for single-stranded sequencing, as the PCR product 
could be sequenced directly. The PCR products were gel purified then sequenced using 
both the US Biochemicals Taq Polymerase Cycle Sequencing Kit and the Applied 
Biosystems 3 73A automated sequencer.
In order to sequence the entire 5 -750 bases of the M gene it was necessary to design 3 
internal sequencing primers for the Taq polymerase sequencing kit, and 3 internal 
sequencing primers for the 373A automated sequencer. The primers were designed from 
EdM (III.2.2), the resulting sequence will be (+) sense cDNA, which corresponds to the 
M gene mRNA sequence except that thymine bases in cDNA are uracil bases in mRNA.
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They were positioned within the gene so that sequencing data from the most downstream 
primer would run through the next upstream primer. The nucleotide sequence and 
position of the sequencing primers within the M gene are shown in Tables 8 and 9, and 
Figures 23 and 24.
Results
Table 8. Sequencing primers for Taq polymerase cycle sequencing
Name Position Sequence Tm
°C
MM02a nt. 48 to 69 5' GAC TTC GAC AAG TCG GCA TGG G 3' 70
MM03a nt 267 to 287 5’ GGT GTT GGC ACA TCC ACA GCA 3' 66
MM04a nt 530 to 553 5’ GGA TAA CGG GTA TTA CAC CGT TCC 3' 72
The primers were designed using the published M gene sequence of the Edmonston strain of measles virus 
(Bellini et a!., 1886). They were designed so that at least 5 adenosine residues would be labelled during the 
primer extension reaction of cycle sequencing.
Figure 23. Position of the sequencing primers for Taq cycle sequencing
MM02a
MM03a
MM04a
!•
T -
750
H  3
1379
Approximately 200-250 bases of sequence can be determined from a 2 hr electrophoresis. Further 
runs o f 3.5-4 hrs were necessary to produce sequence data that run from MM02a through to 
MM03a, and from MM03a through to MM04a
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Table 9. Sequencing primers for the 373A automated sequencer
Name Position Sequence Tm
OC
MM02 nt. 25 to 44 5' GTT CCA CAA TGA CAG AGA TC 3' 58
MM04 nt. 552 to 567 5' CCT AGA AGA ATG CTG G 3' 48
MM07 nt 134 to 151 5' GGT CAG AGT CAT AGA TCC 3' 54
Primers were designed using the published M gene sequence of the Edmonston strain of measles virus 
(Bellini el a!., 1986), and were designed such that sequence data from the most downstream primer would 
run through the next upstream primer.
Figure 24. Position of the sequencing primers for 373A automated sequencing 
MM02 MM04
s r—T— . y~ " 3' ,----------------------------------13'
1 MM07 750 1379
Approximately 250-400 bases can be determined using the automated sequencing machine depending on 
the quality of the DNA. Therefore the primers were positioned a maximum of 400 bases apart.
The sequencing primers for the 373A automated sequencer were designed before the 
method of manual sequencing had been determined. The primers required for cycle 
sequencing have to be positioned so that 10-20 bases from the annealing site of the primer 
can be extended with the incorporation of at least 5 35S-dATP bases. The primers for the 
automated sequencer were not positioned where labelling of the primer would result in 
the incorporation of enough 35S-dATP label to produce a strong signal, and so new 
primers were designed.
The primers are all facing in the same direction, thus only one strand of the double-
stranded PCR product was sequenced. Determining the sequence of both strands of the
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PCR product would have made it much easier to distinguish polymerase errors occurring 
as a result of the sequencing reaction, from genuine base changes when compared to the 
M gene of EdM. In order to resolve ambiguities the method of base determination used 
was to repeat the sequencing reactions and run a second gel, or to send DNA to the 
automated sequencer in order to verify which base was actually present (Figures 25 and 
26). Once the base had been determined a third confirmatory reaction was carried out.
I
Results
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Figure 25. ADD-MV base determination using Taq cycle sequencing
Results
A.
B.
MM03a primer sequencing reaction o f ADD-MV passaged 10 times in IMR-32 cells. A: The following 
bases can not be determined from this reaction, 383-386. B: The sequencing reaction was repeated and the 
undetermined bases were resolved. The reactions were carried out following the manufacturer’s protocol 
(II.8 .1.2) and 2.5 pi was electrophoresed on a polyacrylamide gel (11.4.2).
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Figure 26. ADD-MV base determination using the 373A automated sequencing 
machine
Results
A.
Sequencing reactions of ADD-MV passaged once in MRC-5 cells. A: Cycle sequencing reaction using the 
MM02a primer. Bases 144, 146, 149, 152 and 153 can not be determined from this reaction. The reaction 
was carried out using the manufacturer’s protocol (11.8.1.2). A 2.5 pi aliquot o f the reaction was 
electrophoresed on a polyacrylamide gel (11.4.2). B: Automated sequencing reaction using the MM02 
primer. The previously undetermined bases were resolved. A gel purified DNA and primer were sent to 
the automated sequencer in a final volume of 10.5 pi (11.8.1.1).
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III.2.3.2 The Sequence of the 5'-end 750 Bases of the ADD-MV M Gene
Before sequence comparisons between low and high passaged virus could be carried out, 
any M gene sequence differences between virus passaged only once needed to be 
determined. If the M gene sequence did diverge then a consensus sequence for the 5’-end 
750 bases of the M gene of ADD-MV would have had to be determined. The M gene of 
ADD-MV passaged once in all 4 cell types, namely, MRC-5, Vero, IMR-32 and SK-N- 
SH cells was sequenced at least twice to ensure any base changes observed were not the 
result of sequencing errors. The resulting M gene sequence from each of the passaged 
viruses was identical. When comparing the sequence obtained with that of EdM (III.2.2), 
two base changes were observed. One was at nucleotide position 222 (Figure 27). This is 
a cytosine to uracil (C-U) change, which induces a predicted amino acid change from 
proline to serine. The second base change was at nucleotide position 457 (Figure 28). 
This was a guanine to adenosine (G-A) mutation, producing a serine to asparagine amino 
acid change. (Table 10).
Table 10. Base changes observed in passage one of ADD-MV
Cell Line Nucleotide Position Mutation Coding Change
SK-N-SH 222 C -U Pro - Ser
457 G -A Ser - Asn
IMR-32 222 C -U Pro - Ser
457 G -A Ser - Asn
MRC-5 222 C -U Pro - Ser
457 G -A Ser - Asn
VERO 222 C -U Pro - Ser
457 G -A Ser - Asn
The 5'-end 743 base region o f the M gene of ADD-MV passaged in each o f the four cell lines once was 
determined by Taq polymerase cycle sequencing (II.8.1.2) and 373A automated sequencing (11.8.1.1). The 
table shows the changes observed between the published M gene sequence and the M gene sequence of 
ADD-MV. 141
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111.2.3.3_____ Sequence Comparison of ADD-MV Passaged 1 and 10 Times
The sequence data obtained from the M gene of ADD-MV passaged 10 times in each of 
the four cell lines was compared to that determine from passage one (II.2.3.2). The M 
gene of ADD-MV passaged 10 times in IMR-32 cells and Vero cells did not show any 
nucleotide changes, however, virus passaged 10 times in SK-N-SH cells contained one 
change. This occurred in the coding region at nucleotide position 222. A uracil to 
cytosine change producing a serine to proline substitution, which restores the sequence to 
that of EdM (III.2.2). Virus passaged in MRC-5 cells exhibited' two base changes at 
passage 10. The first change was at nucleotide position 215. This was a cytosine to 
guanine change producing a serine to arginine coding change. The second base change 
was at position 222, a uracil to cytosine change causing a serine to proline coding change 
(Table 11), which was identical to that change observed in SK-N-SH cells and returned 
the sequence to EdM (III.2.2).
Table 11. Base changes observed in the M gene of ADD-MV passaged 10
times
Cell Type Nucleotide Position Mutation Coding Change
SK-N-SH 222 U -C Ser- Pro
MRC-5 215 C -G Ser - Arg
222 U -C Ser - Pro
The 743 base region at the 5’-end of the M gene of ADD-MV passaged in all four cell lines 10 times was 
compared with that determined from virus passaged once (III.2.3.2). The table shows the changes observed 
between passage 10 and passage one. The sequence was determined by Taq polymerase cycle sequencing 
(11.8.1.2) and 373A automated sequencing (II.8.1.1).
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Figure 27. Nucleotide sequence of ADD-MV M gene showing the C-U base 
change at position 222
Results
MM02a cycle sequencing reaction of ADD-MV passaged once in SK-N-SH cells. The reaction was 
carried out according to the manufacturer’s protocol (II .8.1.2). A 2.5 pi aliquot of the reaction was 
electrophoresed on a polyacrylamide gel (II.4.2).
Figure 28. Nucleotide sequence of ADD-MV M gene showing the G-A base 
change at position 457
nt457
MM03a cycle sequencing reaction of ADD-MV passaged 10 times in IMR-32 cells. The reaction was 
carried out in accordance with the manufacturer’s protocol (11.8.1.2). A 2.5pl aliquot of the reaction was 
electrophoresed on a polyacrylamide gel (II.4.2).
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The M gene of the ADD-MV stock used to infect the four cell lines used in this 
experiment, differed by two base changes (I1I.2.3.2) from EdM (III.2.2). Comparison of 
the sequence of the M gene of ADD-MV after 10 passages in either SK-N-SH or MRC-5 
cells revealed a single nucleotide change at nucleotide position 222; reversion of a uracil 
to a cytosine residue, producing a coding change of serine to proline. The passage history 
of the ADD-MV used for these experiments is short amounting to a total of only 57 
passages in human diploid cells from the original clinical isolate. The passage history of 
the Edmonston strain of measles virus used in the study carried out by Bellini el al. 
(1986) is unknown. What is known is that the measles virus used in Bellini’s study 
(1986) was propagated in Vero cells, not human diploid cells, although the number of 
passages in this cell line was not stated. It is possible that the cytosine at position 222, 
and the loss of the serine codon, may be a consequence of the passage history of the virus 
subsequent to propagation in human diploid cells or perhaps to the number of passages 
in-vitro.
The aim of this experiment was to determine whether biased hypermutation occurred as a 
consequence of virus passage in neuroblastoma cells. The data obtained indicates that 
biased hypermutation did not occur during the propagation of ADD-MV in 
neuroblastoma cells.
Why the PCR reaction using the MMO1/MM02 primer pair resulted in the amplification 
of an 800 base fragment after originally producing the expected size of 1379 bases has not
III.2.3.4 Sequence of ADD-MV Passaged Once and 10 Times: Conclusions
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been fully resolved. This change did occur in conjunction with a change from using 
AMV-RT to Superscript II to synthesize cDNA, however, there was no corresponding 
change in the ability of the RSM1/RSM2 primers to amplify the 900 base fragment of 
huRS virus. Complementary DNA synthesised by both enzymes resulted in the 
amplification of both 1379 and 800 base fragments (Figure 20), therefore, it is unlikely 
that the Superscript II enzyme was the sole cause for the change in the PCR product. It 
would have been necessary to carry out more robust investigation of the PCR cycles used 
i.e., changes in the annealing temperature and the duration of time spent at that 
temperature; changes in the extension time . However, the 800 base fragment appeared to 
contain the 5'-end sequence required for sequence analysis. As this was the main 
requirement of the PCR product the reduced size of the fragment was not considered 
detrimental to the project.
Results
111.2.4 Clpning and Sequencing pf ADD-MV Passaged 9 Times in IMR-32 
Cells
The products of PCR reactions are heterogeneous in nature. Sequencing the PCR product 
using the chain termination cycle sequencing method results in the sequence of the most 
abundant molecule in the population being obtained. It is possible that M gene sub­
populations may be present, but only at low levels which would not be detected by cycle 
sequencing. To explore this possibility, the M gene of ADD-MV passaged 9 times in 
IMR-32 cells was cloned and sequenced. A high passage number in neuroblastoma cells 
was examined because if any mutational events had occurred, they would be expected to 
be present at a greater frequency in virus with a longer passage history. Virus passaged in
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IMR-32 cells was used because Wong el al. (1989) found that Yamagata-1 (SSPE) virus 
was vulnerable to hypermutation events when passaged in this cell type. Passage 9 was 
used because virus passaged 10 times in IMR-32 cells had been exhausted.
III.2.4.1 Cloning into the Bacteriophage M13
Total RNA was isolated from ADD-MV material passaged 9 times in IMR-32 cells. This 
material was reverse transcribed using Superscript II and oligo dT, synthesizing cDNA 
from the mRNA present. The M gene was amplified using the MM01/MM02 primer 
pair, as described previously (II.3.3.1). As before, the full length of the M gene could not 
be obtained, only a fragment of approximately 800 bases was amplified. This fragment 
was cloned into the bacteriophage M13mpl8 using the ER cleavage sites inserted at the 
ends of the fragment during amplification, namely BamHI and Xhol. The BamHI 
restriction site was present in the multiple cloning site of M13mpl8, however, Xhol was 
not, therefore, the vector was digested with BamHI and Sal I. Sal I digest results in 
comparable 5 ends as Xhol digests, therefore cloning could proceed. To determine 
whether clones did contain the M gene insert, the dsDNA replicative form of M l3 was 
digested with Pvu II. This enzyme digests the vector approximately 100 bases either side 
i.e., 3 and 5 , to the multiple cloning site. Positive clones would be expected to contain 
an insert of approximately 1 kb in size after digestion with Pvu II. Single-stranded DNA 
was extracted from positive clones and then sequenced. Figure 29 shows the positive 
Ml 3 clones of the M gene of ADD-MV passaged 9 times in IMR-32 cells.
Results
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Figure 29. M gene clones from ADD-MV passaged 9 times in 1MR-32 cells
L; 1 kb ladder; numbers 90-212: clone identification numbers. M gene fragments amplified using the 
MM01/MM02 primers were cloned into M13mpl8. Potential clones were digested with Pvu II, this 
enzyme digests M13 approx. 100 bases 5 and 3 of the MCS, therefore, the actual size of the clones are 
approx. 200 bp smaller than indicated by figure 29. The variation in size of the clones on the upper panel 
are discussed further (III.2.4.3).
III.2.4.2 Single-Stranded Sequencing of the M Gene Fragments Cloned into 
M13
Eighty-one M gene clones from ADD-MV passaged 9 times in IMR-32 cells, were 
sequenced to determine if biased hypermutation was occurring at such a low frequency 
that it escaped detection by sequencing the PCR product. The clones were sequenced
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using the -40 primer supplied with the US Biochemicals Sequenase v2.0 sequencing kit 
(111.2.4.2) and three internal primers (Table 12). EdM (III.2.2) was used to design the 
internal sequencing primers, which were positioned within the gene so that sequencing 
data from the most downstream primer would run through the next upstream primer. The 
position of the sequencing primers within the M gene can be seen in Figure 30.
Results
Table 12. Sequencing primers for single-stranded DNA sequencing
Name Position (nt) Sequence Tm°
C
-40 -40 nt into 
vector
5’ CAG CAC TGA CCC TTT TG 3' 52
MM 04 552 to 567 5’ CCT AGA AGA ATG CTG G 3' 48
MM07 134 to 151 5' GGT CAG AGT CAT AGA TCC 3' 54
MM 10 427 to 442 5' GGA GTG TCT TCA ACG C 3’ 50
The -40 primer was provided with the Sequenase sequencing kit (USB) and primes 40 bases downstream 
from the MCS of M l3. The internal primers were designed using the published M gene sequence for the 
Edmonston strain of measles virus (Bellini, el a!., 1986).
Figure 30. Position of the sequencing primers for single-stranded DNA 
sequencing in M13mp 18
Bam HI MM04 MM07 Sal 1
.  I y - r n - 9  r  —  r .  r 4 0 ,  V
M13 (  I —  r  5 ^  MI3
I 3, ^ 5. I
800 MM10 1
The primers were positioned so that sequence data from the most upstream primer ran through the next 
downstream primer. Approximately 200-250 bases can be determined from a sequencing reaction 
electrophoresed for 1.5-2 hrs. Therefore, the sequence reactions from primers MM07 and MM04 had to 
undergo electrophoresis for both 1.5-2 hrs and 6-8 hrs.
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III.2.4.3 Sequence of the M Gene Clones of ADD-MV Passage 9 Times
in IMR-32 Cells
A method for quickly determining whether any hypermutational events had occurred in 
the clones is to sequence using a single termination mix. By definition in SSPE viruses, 
biased hypermutation is a uracil (U) to cytosine (C) change, therefore, either C or T-track 
sequencing would indicate whether any uracil or cytosine residues had been mutated. 
This approach was investigated using the cytosine termination mix only, however, very 
rarely did every C-track reaction produce sequence so comparison was difficult. In those 
clones where sequence was observed, the resulting C-tracks were comparable when using 
the -40 primer, but when the internal M gene primers were used unaligned sequence was 
observed. It was therefore difficult to compare clones. It would have been possible to 
initially screen the clones using the C-track and the -40 primer to determine whether any 
base changes had occurred within the 5'-end 200-250 bases, however, out of 41 reactions 
only half worked well enough for comparison at any one time. It would have been 
necessary for the reactions to have been repeated, probably several times, before the C- 
track of all the generated clones had been determined. It proved quicker, and less wasteful 
of 35 S-dATP label, to sequence each clone using the -40 primer in full i.e., all 4 
termination mixes were used. Nine times out of 10 each reaction worked well and did 
not, therefore, have to be repeated. A total of 81 M13 mpl8 clones of the M gene of 
ADD-MV passage 9 times in IMR-32 cell were sequenced with the -40 primer providing 
approximately 200 bases o f sequence in a 1.5-2 hr electrophoresis run. Within this region 
of the M gene of Yamagata-1 (SSPE) vims Wong et al. (1989) observed a total of 19 base 
changes, thus, the frequency of mutation was approximately 1 in 10. It was presumed,
therefore, that if any hypermutational events had occurred during passage of the ADD-
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MV there would be changes within the first 200 bases. The results of the initial 
sequencing reactions determined whether the clones were either, (i) ADD-MV-like i.e. 
the sequence contained no base changes when compared to that determined from vims 
passaged once in all four cell types (III.2.3.2), (ii) mutated ADD-MV. i.e. the sequence 
contained a few base changes when compared to the sequence of vims passaged once, or 
(iii) the clones were not derived from the ADD-MV M gene. Twenty-one of the 81 
clones (25.9%) did not resemble the measles vims M gene and were presumed to be the 
result of mis-priming or some other artefact of the amplification and cloning procedures. 
Of the remaining 60 clones, 39 (65%) were identical to ADD-MV. The remaining 21 
(35%) contained one or two mutations when compared to the sequence for the M gene of 
ADD-MV passaged once in all four cell lines. All 21 clones which contained base 
changes within the first 200 bases of the M gene were sequenced in full. Three of the 
clones which produced 200 bases of sequence identical to that of the ADD-MV M gene 
from vims passaged once were also sequenced in full for comparison.
As the full length of the M gene could not be amplified, it was suspected that either a 
large portion of the M gene had been deleted or that the MMOl primer had mis-primed 
during amplification. The sequencing results suggest that a deletion in the M gene was, 
in fact, responsible for the smaller fragment. The size of the deletions, found in all 24 
clones that were sequenced in full, i.e., the 3 clones which did not and the 21 clones 
which did contain mutations, ranged from 1008 bases to 622 bases. Thirteen of the 21 
mutated M genes also contained a 50 base insertion at the 3' end (Figure 31). Each 
insertion occurred at the same site and contained the same sequence. However, the 
additional base changes throughout the remainder of the gene varied. Eight of the 13
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clones that contained the inserted sequence also contained 4 additional base changes 
which were identical. The remaining 5 clones containing the insertion also had one or 
two of the additional changes, but not all four. Table 13 and Figure 32 summarises these 
results.
III.2.4.3 ADD-MV Passaged 9 Times in IMR-32 Cells: Conclusions
When comparing the sequence obtained for each o f the clones of ADD-MV M gene 
passaged 9 times in IMR-32 (neuroblastoma) cells to the M gene sequence of ADD-MV 
passaged once (III.2.3.2) a total of 21 additional base changes was observed. It should be 
noted that only a maximum of 5 of these base changes was seen in any one clone. Of the 
21 changes seen. 76% were transitions, the remaining 24% being transversions. Although 
more mutations were observed in the cloned material than the M gene sequence of ADD- 
MV passaged once, determined by sequencing the PCR product, there was still no 
evidence that biased hypermutation had occurred as a consequence of propagation in the 
neuroblastoma cell line, IMR-32.
The cloning and sequencing results of ADD-MV passaged 9 times in IMR-32 cells 
indicates that this material contained a high proportion o f virus with defective M mRNA. 
None of the translation initiation codons (AUG) were mutated in the 24 clones sequenced. 
It is possible, therefore, that the M gene of these clones could be translated. The extent of 
the translatable open reading frames of the clones varied. The coding region for the 13
Results
151
Table 13. Summary of the sequencing results of ADD-MV passaged 9 times in 
IMR-32 cells
Results
Clone Fragment Size Deletion Base Changes Insertion Single Base 
Deletions
95 ** 396 310-1318 - .
96** 626 627-1404 - -
232 ** 752 628-1279 1302 C-U - -
77 476 407-1335 98 A-U . _
90 446 398-1356 211 A-G . .
133 753 715-1366 108 U-A
595 U-C
- -
135 482 421-1343 199 U-A - .
163 646 647-1404 255 U-C . .
171
173
178
186
192
196
199
201
782 671-1348 169 A-G 
364 U-A 
1359C-U 
1367A-C
50 BASES 1361 C
174 782 671-1348 169 A-G 
364 U-A 
360 C-U 
1367 A-C
50 BASES 1361 C
181 782 671-1348 309 G-A 
364 U-A 
1359C-U 
1367A-C
50 BASES 1361 C
184 730 637-1311 158 A-G
303 C-U
- -
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Continuation of Table 13
Clone Fragment Size Deletion Base Changes Insertion Single Base 
Deletions
191 782 671-1348 169 A-G 
364 U-A 
609 A-G 
1359C-U 
1367A-C
50 BASES 1361 C
202 730 637-1311 289 A-G 
336 A-G 
451 U-C
'
211 782 671-1348 169 A-G 
466 A-G 
604 U-C 
1359C-U 
1367A-C
50 BASES 1361 C
212 782 671-1348 107 C-U 
1359C-U 
1367A-C
50 BASES 1361 C
274 445 398-1357 169 A-G 
211 A-G
- -
The 24 clones sequenced in full are represented in this table. The clones were sequenced using the 
Sequenase kit (USB) (II.8.2), -40 primer provided with the kit and internal M gene primers (Tablel3). ** 
indicate clones in which no mutations were detected within the first 200 nucleotides when compared with 
the M gene sequence of ADD-MV passaged once in four cell lines (III.2.3.2).
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Figure 31. Sequence of the 50 base insertion
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Clone 171 was sequenced using the Sequenase kit and the MM04 primer. A 2.5 pi aliquot of the reaction 
was electrophoresed for 1.5-2 hrs. Figure 31 shows the sequence of the inserted sequence determined in 
this clone and 12 other clones.
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Figure 32. Clones of the M gene of ADD-MV passaged 9 times in IMR-32 
cells represented diagrammatically
232 P-------------
96 P-------------
95 P-------------
ADD-MV t ---------
,
77 P~1—
90 P---------41
133 P- - -
135 P- - - *-
163 P
|* r. i i
--------------------------- 1
1
t _____ ___G-G__ __ C____________
274 P— ^
I —
702
s in F
J— I
gene
---- 1
1404
-* l
171, 173 £ ____G.
178. 186 
192, 196 
199, 201
CGGAGCCCGGCAAUUGCAUAAAAUUUAAAAUUUUAAAACCAGAGGUUCAA
181 P- - -
211 p__a
212 I* T
191 p _ a
174 p _ a
A__ L
CGGAGCCCGGCAAUUGCAUAAAAUUUAAAAUUUUAAAACCAGAGGUUCAA
CGGAGCCCGGCAAUUGCAUAAAAUUUAAAAUUUUAAAACCAGAGGUUCAA
A
CGGAGCCCGGCAAUUGCAUAAAAUUUAAAAUUUUAAAACCAGAGGUUCAA
CGGAGCCCGGCAAUUGCAUAAAAUUUAAAAUUUUAAAACCAGAGGUUCAA
The 24 clones sequenced in full are represented diagrammatically. The clones were sequenced using the 
USB Sequenase kit, the -40 primer provided with the kit and internal M gene primers. 232, 96 & 95: 
clones which were identical to ADD-MV (III.2.3.2) when the first 200 bp were sequenced initially. *: 
translation initiation codon; S: translation stop codon, s in F gene: ORF of these clones continues through 
the intergenic region to the F gene.
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clones containing the 50 base insertion continued for 6 amino acids into the insertion and 
then terminated by a UAA stop codon (Figure 32). The 6 inserted amino acids were 
arginine, serine, proline, alanine, isoleucine and alanine. This leaves a 146 base pair 
untranslated region at the 3' end of the clones. Six clones (77, 95, 133, 135, 184 and 202) 
which did not contain the 50 base insertion but did have a large region of the M gene 
deleted, also maintained in-frame stop codons. For these clones the translatable region 
continued up to a UGA termination codon at nucleotides 1403-1405, leaving only 59 
nucleotides untranslated at the 3' end of the gene. The normal stop codon in the M gene 
of measles vims is a UAG codon at nucleotide position 1038-1041. Clones 163 and 96 
contained only the 5' 650 nucleotides of the M gene. Although the translation initiation 
codon was not destroyed, it is unlikely that these clones could be translated as the M gene 
sequence is truncated in mid-codon. It is possible, however, that the coding region for 
these clones could continue through the M-F intergenic region into the 5'-end of the F 
gene, so producing a novel protein. Clone 232 can, potentially, be translated even though 
a large proportion of the gene is deleted; however, the stop codon for this clone would be 
in the transcription start site of the F gene (Figure 33).
Figure 33. Position of the stop codon for clone 232
M GENE CLONE 232 w „ . F GENEM-F intergenic
|--------------------------/  / -----CUUAGG----------- //----------- 1
1 « 8  1279 Translation . 2370
Stop Codon
Clone 232 was generated from PCR using M M 0I/M M 02 primers (11.3.3.1). The 750-800 base fragment 
was cloned directly into M13 using BamHI. Xhol and Sal I digests (II.5.4). Sequencing results showed a 
651 base deletion had occurred within the 3’-end of the clone. The ORF was maintained, terminating 
within the M-F intergenic region.
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For clones 274 and 90, again the mRNA could possibly be translated even though a large 
region of the gene in each clone is deleted; however, the translation stop codon would be 
at position 585-587 (UGA) in the coding region of the F gene. Thus, the M gene for these 
clones would continue to be translated through the intergenic region of the M and F gene, 
and the 5' untranslated 573 nucleotide region of the F gene, assuming that the mRNA is 
bicistronic. An additional 191 amino acids would be translated from the F gene 5' non­
coding region (Figure 34).
The insertion of 50 bases observed in 13 of the clones could be evidence of 
recombination of measles virus during replication. The inserted sequence was screened in 
the Blast database, and was found to have 86% identity with human and bovine 
mitochondrial Leu transfer RNA (tRNALeu). It is possible, therefore, that non- 
homologous recombination has occurred between mitochondrial RNA and the measles 
virus M gene during the measles virus replication.
There does not appear to be any sequence homology between the 5’ or the 3 end of the 
inserted sequence and that of EdM (III.2.2). The sequence abruptly changes from 
measles virus to the inserted sequence after position 672 in the M gene, and from the 
inserted sequence to EdM at nucleotide position 1348. This would be expected from a 
cross-over event associated with non-homologous recombination, however, if the inserted 
sequence was the result of a PCR artefact no homologous region would be observed 
either. The possibility of recombination verses PCR artefact will be considered further in 
the discussion (III.2.5).
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It should be noted that in the clones which contained it, the inserted sequence had the 
same orientation and position in each clone. As these clones were generated from PCR 
the large number of clones containing the insert was probably a consequence of the 
amplification of the same cDNA species. The slight variation in the number of base 
changes in the regions flanking the inserts probably reflects polymerase errors that 
occurred during the amplification stage.
The PCR product cloned was 750-800 bases in size. However, some of the resulting 
clones (95, 96, 77, 90, 135, 163 & 274) contained fragments of 396-646 bases only (Table 
13 & Figure 32). The simplest explanation for this is that the amplified M gene contained 
base changes which resulted in the formation of the ER sites which were used for the 
cloning reaction i.e., BamHI and/or Xhol. If two such changes occurred the result could 
be a large deletion. The primer sequence for MMOl could be determined from all clones 
except 96 and 163. It is possible that in these clones only one additional ER site was 
formed (at position 626 for clone 69, and position 646 for clone 163), therefore, the 
cloned product would be missing the entire 3 region of the M gene, including the MMOl 
primer sequence.
The remaining clones appeared to be 750-800 bases in length, determined by digestion 
with Pvu II (Figure 29) and yielded sequence of approximately 730 bases (excluding the 
inserted sequence). Again, the MMOl primer sequence was observed, therefore, it is 
unlikely that this primer was mis-priming, and so the amplification o f the smaller 
fragment was due to the presence of deleted M gene species within the virus preparation 
used for these experiments.
Results
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III.2.5 Discussion
III.2.5.1 ADD-MV Passage Experiment
Biased hypermutation is hypothesised to occur as a consequence of the development of a
persistent infection in the CNS by measles virus. The aim of the passage of ADD-MV in
the neuroblastoma cell lines and the two control cell lines was to develop an in-vitro
system which would induce hypermutational events. If biased hypermutation is
associated with a change in phenotype one could hypothesise that the titre would fall as
the degree of hypermutational events had increased. The titre of ADD-MV passaged in
each of the 4 cell lines was determined in order to correlated any fall in virus titre with the
identification of biased hypermutations. The passage experiments have shown an overall
fall in titre from 11.6xl0? pfu/ml at passage 4. to 0.19xl05 pfu/mi at passage 10 in ADD-
MV passaged in Vero cells. This may be indicative of a change in phenotype from a lytic
to a persistent phenotype. Rima et al (1977) demonstrated that after only 5 passages of
undiluted Edmonston B strain of measles virus in Vero cells, the cells had become
persistently infected with the virus, therefore, 10 passages of 1:100 diluted virus may be
sufficient to initiate a persistent infection. A change in the morphology of the plaques
occurs when a persistent infection develops i.e., from large spreading plaque, to a small
strand-forming type of c.p.e (Oddo, et al, 1961), this change in morphology was not
observed in the Vero cells infected with ADD-MV. Persistent measles virus has been
shown to produce a low infectivity titre. but maintain a high haemagglutinin titre (Rima et
al, 1977). Unfortunately, the HA titre of ADD-MV from passage 10 in Vero cells was
not determined. The sequence data comparing the M gene of ADD-MV passaged 10
times with that determined from virus passaged only once did not reveal any biased
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hypermutations (III.2.3.3), therefore, there is no unequivocal evidence of a transition to a 
persistent mode of infection of ADD-MV propagated in Vero cells. The virus titres in the 
remaining cell lines did not reveal an overall fall in titre, thus, there is no evidence of the 
development of a persistent phenotype in virus passaged in any o f the cell lines used.
The method of virus propagation and harvesting i.e., mechanically destroying the 
monolayer, would possibly select for lytic virus as any cell associated virus would be 
destroyed along with the cells, thus arguing against the development of a persistent 
infection. To determine whether this was indeed occurring cell dispersal mechanisms 
which destroy the monolayer should be compared with enzymatic dispersal methods i.e., 
EDTA/trypsin. Virus, harvested using each method, would be used to infect sub­
confluent cell monolayers at an MOI of <1. Cells would be passaged upto 5 times, 
depending on the percentage of cells surviving. Those cells which survived would be 
used in immunofluorescence experiments to determine whether measles virus antigen was 
present and. thus, whether measles virus persistence had occurred.
The titres determined from virus passage in each of the cell lines used do fluctuate. The 
most obvious reason for this would be pipetting errors and/or counting errors that were 
incurred during the plaque assay procedure. Due to the design o f the experiment different 
concentrations of virus were used for each passage as an arbitrary dilution, rather than a 
standard MOI was used as the inoculum. If a constant MOI had been used any increase 
or fall in titre could then be attributed to the growth characteristics of the virus in each of 
the cell lines, rather than the possible increase in DI concentration.
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To demonstrate whether DI particles are present in the passaged virus the ability of the 
passaged virus to reduce virus yield in a mixed infection with standard virus w'ould need 
to be determined. One millilitre of passaged virus would be mixed with 1 ml of standard 
virus (the concentration of each virus stock must be known) and used to infect a cell 
monolayer. As a control 2 ml of the standard virus alone would be used as the inoculum. 
The titre from each infection would be carried out 3-5 days post-infection. The influence 
of Dl particles would result in a reduced virus titre when compared to the standard virus. 
Another approach would be to utilize the fact that the effect of Dl particles can be diluted 
out. If a cell monolayer is infected with undiluted virus and another with diluted virus 
(1:103), the titre determined from the diluted virus would be expected to be higher than 
the undiluted inoculum if DI particles were present in the original stock.
III.2.5.2 ADD-MV Passaged Once and 10 Times
A study carried out by Wong el al. (1989) revealed that the passage of an SSPE virus 
(Yamagata-1) in the neuroblastoma cell line, IMR-32, resulted in the accumulation of 
additional biased hypermutations which were not observed in virus passaged in cells of 
non-neural origin. It has been suggested that DRADA is responsible for such 
hypermutations. It is generally accepted that the initial infective material in the CNS of 
SSPE and M1BE patients is acute measles virus. If this assumption is correct, then acute 
measles virus must be a substrate for this enzyme to account for the accumulation of 
biased hypermutations associated with ‘SSPE viruses’. Therefore, the aim of this 
experiment was to determine whether passage of acute measles virus (ADD-MV) in 
neuroblastoma cell lines was sufficient to induce biased hypermutational events. The
Results
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results of this experiment have shown that propagation of ADD-MV in cell lines of neural 
origin is not sufficient to induce biased hypermutations in-vitro. SSPE develops in the 
brain, which is a very complex organ. The results of passage of ADD-MV in 
neuroblastoma cells can not be extrapolated to events that may occur in the brain as the 
cellular environments are very different. However, it has been shown that measles virus 
double-stranded RNA is a substrate for DRADA (Ecker et al., 1995). What should be 
noted here is the requirement of double-stranded RNA as a substrate for DRADA. 
Double-stranded RNA is not an intermediate in measles virus replication and is only 
likely to occur as a result of local collapse of mRNA on the negative strand template 
during synthesis (Bass et ai, 1989). Therefore, the development of double-stranded RNA 
during measles virus replication may occur only rarely. Other factors in the CNS may be 
involved in increasing the propensity of double-stranded RNA formation during 
replication which are not present in the in-vitro environment associated with the 
experiment described here. This may explain the lack of biased hypermutation observed 
in this experiment.
Originally, ADD-MV plaque-purified in MRC-5 cells was passaged in the 4 cell lines 
and. as for the non-purified virus, 1:100 diluted stock was used for the inoculum. 
Preliminar)' sequencing data from this virus passaged once indicated the presence of both 
of the base changes (C-U at position 222 and G-A at position 457) observed in the non- 
purified virus. It was, therefore, considered unnecessary to continue with the passage of 
this virus. In retrospect, it would have been more appropriate to continue the passage of 
plaque-purified virus and to terminate the passage of non-purified virus. Plaque-purified 
virus is a more homogeneous population of virus, therefore, any base changes observed in
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more frequently passaged virus could be attributed to mutational events, rather than the 
selection of pre-existing variants in the virus population. However, the method of 
sequencing was Taq polymerase cycle sequencing which will produce sequence of the 
most predominant population. Plaque-purification would, in all probability, result in a 
homogeneous virus which represents the predominant virus, therefore, one might not 
expect the results using plaque-purified virus to be any different from the heterogeneous 
population.
Mis-priming as an explanation for the amplification of the 750-800 base M gene fragment 
is unlikely. The results o f the cloning reactions of ADD-MV passaged 9 times in IMR-32 
cells, described in section III.2.4.2, have shown that in all but two of the clones (No. 96 & 
163, see Table 13) the sequence of the MMOl primer is at the 3' region of the clone, and 
is not followed by ADD-MV M gene sequence which would be indicative of a mis- 
priming event. Some clones were produced with 600-700 bases of the 5 -end region of M 
gene intact i.e., clones 133, 184 and 202. Thus, it is possible that deletion of the M gene 
was indeed the reason for the 750-800 base fragment. The sequence from the passaged 
ADD-MV was 743 bases in total, however, not all of the deleted M gene clones (see 
111.2.4.2) contained the full 5 -end 743 bases. The amplified fragments used for 
sequencing were either 1379 bases from MM01/MM02 (full length M gene), 750-800 
bases from MM01/MM02 (deleted M gene, containing variable length of the 5 region of 
the gene) or 750 bases amplified from the MVMl/oligo dT primer pair. In retrospect, this 
was not an ideal situation. It would have been sufficient to have sequenced only the 1379 
base fragment and once that was not able to be amplified, the MVMl/oligo dT fragment. 
The position where the oligo dT annealed was determined, therefore, the amplified
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product was of a defined region, whereas the length of the sequence from the 5'-end of the 
deleted M gene was variable.
Why was the 1379 base fragment able to be amplified originally? The change in the 
fragment size produced did not occur in response to increased passage numbers, but 
occurred abruptly regardless of passage number. The only change in the methodology of 
the experiment was the use of the Superscript II enzyme. It is possible that this enzyme, 
in some way, favoured deleted M gene products during cDNA production. Polymerase 
chain reaction will amplify the most dominant species present in the cDNA pool, hence 
the amplification of the 800 base fragment.
III.2.5.3 ADD-MV Passaged 9 Times in IMR-32 Cells
Cloning from the PCR product has the disadvantage that it will not give a true 
representation of the sub-populations of M gene present within a heterogeneous virus 
population, as PCR itself will amplify the predominant species. A method which will 
give a more realistic view of the M gene population would involve the production of 
cDNA library. M gene clones could be identified by making synthetic M gene probes. 
Confirmation of positive clones would require sequencing. A disadvantage of this 
method is that hybridisation techniques will identify many clones, each of which would 
have to be sequenced to confirm that the clone is the required M gene. Due to the time 
constraints of the project, this method was not considered practical as both ADD-MV 
passaged material and huRS virus would have to be treated in the same way.
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In total 13 clones were found to contain the 50 base insertion, and in each clone the 
insertion was in the same position. This was presumed to be a consequence of cloning 
from the PCR product. The fact that there was some variation in the M gene sequence 
surrounding the insert could represent polymerase errors during the amplification step or 
pre-existing variants of the M gene. The inserted sequence was found to have high 
identity with mitochondrial tRNA, suggesting that non-homologous recombination has 
taken place. If the base changes did represent pre-existing variants then non-homologous 
recombination could be occurring in 35% of the M gene population. However, it is 
possible that the PCR conditions are strongly biased towards amplification of short 
fragments, therefore, full length M gene sequences would be under-represented and over 
estimation of the abundance of the inserted form could occur. A cross-over event 
between mitochondrial tRNA and the M gene of ADD-MV, would require regions of 
homology at the ends of both the insert and the region of the M gene. Indeed, some 
degree of homology is seen between the 3 end of the inserted sequence and the M gene. 
Non-homologous recombination is thought to be responsible for the presence of a 
modified cellular tRNAAsp at the 5 terminus of naturally-occurring DI RNA of plus 
strand Sindbis virus (Monroe & Schlefmger, 1983). The possibility that the 50 base 
insertion identified in these clones is a PCR artefact can not be ruled out. However, the 
fact that other cellular genes have been observed inserted into other virus genomes e.g., 
28S ribosomal RNA in influenza virus (Khatchikian et al., 1989) and ubiquitin in bovine 
virus diarrhoea virus (BVDV) (Meyers et al., 1991) suggests that recombination may also 
possible in virus containing a negative sense non-segmented RNA genome.
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No intact, full length M gene was detected among the clones characterised, each clone 
contained a deletion ranging from 622 to 1008 bases. The cloned M gene was, on 
occasion, smaller than expected from the amplified PCR product. This could have been 
caused by base changes which may introduce ER sites for the enzymes used during the 
cloning procedure. However, other clones, when sequenced, were of the expected size 
(750-800 bases), thus, homogeneous modification of the amplified material had not taken 
place and a deletion in the M gene is still a possible explanation.
Another possible explanation for the deletion could involve the production of a stem loop 
structure. If regions of the M gene were homologous it is possible that they could base 
pair. Such secondary structure within the cDNA would result in the formation of a loop. 
During amplification the polymerase may not continue along the cDNA loop, but, either 
miss out the secondary structure completely and continue along the single-stranded 
cDNA region, or dissociate from the template. As a possible illustration o f this 
mechanism a deletion mutant of the coronavirus mouse hepatitis virus (MHV) N gene 
(Alb4) has been isolated. This mutant has a deletion of 87 nucleotides at the 3 -end of the 
coding region, resulting in an in-frame deletion of 29 amino acids (Koetzner el al„ 1992). 
This result is similar to the data present here for measles virus, except that coronavirus, 
while it has a single-stranded RNA genome, has a positive polarity. The genome is also 
twice the size of measles virus and has been shown to be very amenable to recombination 
events, unlike measles virus.
Finally, a mutation (T-A) within the H gene o f measles virus isolates from the Coventry 
area has been reported to create an early translation termination signal in that gene,
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providing evidence for natural measles virus variability. The expressed protein is 
predicted to be truncated by 35 amino acids at the C-terminus, which could result in the 
loss of a neutralising epitope (Outlaw & Pringle, 1995). Thus, the deleted genes detected 
in the experiments described here may represent variants of measles virus present within a 
quasispecies population.
In most of the clones sequenced in full the majority of the 3‘ region of the M gene is 
deleted, and yet 22 of the 24 clones maintain ORFs. It is possible, therefore, that 
functional proteins can be produced. Such 3’-end deletions in the M gene of measles 
virus have also been isolated from the brain of a deceased SSPE patient (Baczko et al., 
1993). In Baczko’s study 73 cDNA clones of the M gene were generated, 15 of which 
were full length, the remaining clones contained 3’ deletions. This was presumed to be 
caused by non-specific priming, but was not investigated further. Baczko el al. (1993) 
identified both wild-type-like and hypermutated M gene sequences. Of the deleted M 
gene population, 15.25% contained wild-type-like sequence, the remainder had 
hypermutated M gene sequence.
It may be that these deleted M gene products are derived from defective virions which 
could act as defective interfering particles. However, the ability to amplify these M gene 
variants was not confined to more highly passaged virus where the concentration of DI 
particles would be expected to be greater; virus passaged only once also contained these 
variants. The virus harvested from IMR-32 cells passaged 9 times was still infectious as 
it was used as the inoculum for passage 10; and it retained plaque-forming activity, 
therefore, virus with intact M genes was likely to be present at passage 9; from the
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number of clones studied here, the frequency o f intact M genes in this virus population 
can be estimated at 1:60 or below.
Results
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Since biased hypermutation was not observed during propagation of ADD-MV in 
neuroblastoma cells, it is unlikely that a cellular component is responsible for the 
mutations seen in measles virus genomes isolated from SSPE patients. In order to 
examine the possible role of the viral genome, virus originally isolated from an SSPE 
patient was subjected to the same type of analysis.
Results
The Yamagata-1 strain of SSPE virus was kindly provided by Professor M. Homma 
(Department of Bacteriology, Yamagata University School of Medicine, Yamagata Zao- 
Iida, Yamagata). It was isolated from brain tissue taken from a 12 year old male patient, 
who had contracted acute measles virus at the age of 8 months, prior to vaccination. Two 
portions of the brain material were mechanically treated to disperse the cells, another two 
portions were treated with EDTA and trypsin. The cell suspensions of the two trypsinised 
portions and a mechanically treated portion were co-cultivated with uninfected Vero cells 
in Eagle's minimal essential medium (MEM) supplemented with 10% foetal calf serum 
(FCS); the second cell suspension derived by mechanical means was centrifuged and the 
supernatant was used to infect a monolayer of Vero cells. After one day of incubation at 
37°C, 1-2 small syncytia were seen in all of the co-cultured cell flasks. Subsequently, the 
infected cells were passed every 3-6 days by co-cultivation with twice the number of 
uninfected Vero cells (Homma el al., 1982). The Yamagata-1 virus provided by 
Professor Homma had been passaged 97 times in Vero cells. This was passaged a further 
5 times in Vero cells after receipt and designated YM-V.
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In the following experiments two passage protocols (Figure 35) were used. One protocol 
(Figure 35: branches b & c) was similar to that described by Wong et al. (1989). YM-V 
was passaged three times in human lung fibroblast cells (MRC-5) prior to five passages in 
neuroblastoma cells (IMR-32 & SK-N-SH). This protocol differs from that described by 
Wong et al. (1989) in that a second neuroblastoma cell line, SK-N-SH cells, was used in 
addition to IMR-32 cells. Also, the initial Yamagata-1 virus stock had been propagated 
in Vero cells, then human embryonic lung cells, not MRC-5 cells. The second protocol 
(Figure 35: branches a & d) involved the passage of YM-V directly in the two 
neuroblastoma cells (IMR-32 & SK-N-SH) without prior passage in MRC-5 cells. A 25 
cm2 flask of YM-V was dispersed by EDTA/Trypsin (G1BCO BRL) treatment. Half of 
the infected Vero cells were used to inoculate freshly dispersed neuroblastoma cells or 
MRC-5 cells. These were then incubated at 37°C to produce passage one. For each 
passage two 25 cm2 flasks were inoculated. One flask was harvested by EDTA/Trypsin 
treatment and used for further passages, the remaining flask was freeze/thawed and 
aliquoted into 1 ml portions for RNA extraction. Total RNA was extracted after passages 
1 and 5 in each cell line and reverse transcribed using Superscript II and oligo dT. The 
matrix gene was amplified by PCR (III.3.1), cloned into M13 (III.3.2) and sequenced
(III.3.3).
Results
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Results
Figure 35. Yamagata-1 virus passage protocols
Yamagata-l virus stock ■ 
P97
Yamagata-1 virus 
+ 5 passages in Vero cells (YM-V)
1/
Passaged 5 x in 
IMR-32 cells
Passages 1 & 5 
amplified and sequenced 
(I PI & I P5)
(a) Passaged 5 x in IMR-32 cells
\
V
Passaged 3 x in 
MRC-5 cells
Passaged 5 x in 
SK-N-SH cells
\
i / \
Passaged 5 x in 
SK-N-SH cells
Passages 3 & 5 
amplified and sequenced 
(S P3 & S P5)
(d )
Passages 1 & 5 
amplified and sequenced 
(Ml PI & MI P5)
(b)
4
Passages 1 & S 
amplified and sequenced 
(MS PI & MS P5)
(c)
YM-I virus previously propagated in Vero cells only was used to infect either IMR-32 cells, SK-N-NS or 
MRC-5 cells as outlined above. All virus was harvested for passage using EDTA/trypsin except IMR-32 
cells. The monolayer of these cells could be disrupted by gentle rocking in PBS. Note: Branch (b) mimics 
the conditions employed by Wong el al., 1989; virus passaged 3 times in SK-N-SH cells was cloned and 
sequenced instead of passage 1 due to accidental loss of the earlier samples (III.3.5.1).
III.3.1 Polymerase Chain Reaction
Total RNA was extracted from virus passaged once and 5 times in each o f the cell lines 
and mRNA was reverse transcribed using Superscript II and the primer oligo dT. The 
primers designed to amplify the M gene of ADD-MV did not amplify the M gene of the 
SSPE virus, presumably as a consequence of a difference in the sequence. Therefore a 
new set of primers were designed, such that only the first 1000 bases o f the M gene 
mRNA would be amplified. Previous analysis of ADD-MV revealed that the M gene
population was heterogeneous with a high proportion of variants which had the 3’ region
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deleted (III.2.4.2). It was possible that the YM-V also contained a high frequency of 3’- 
end deletions, since Baczko et al. (1993) have described M gene variants isolated directly 
from different regions o f the brain of a deceased SSPE patient. However, there have been 
no reports of 3’-end deleted M gene variants from YM-V, therefore, positioning the YM2 
primer 1000 bases downstream from the translation initiation codon of the M gene was 
not considered an unreasonable approach. The upstream primer (YMP) was located at the 
5'-end of the P gene on the assumption that bicistronic mRNA is sufficiently abundant to 
be reverse transcribed to bicistronic cDNA. This is a hypervariable region o f the M gene, 
where mutational change would be expected and easily detected (III.2.2). Each primer 
was designed to include unique ER cleavage sites to aid any subsequent cloning 
procedures. The YMP/YM2 primer pair was used to amplify the M gene from virus 
passages 1 and 5 in each cell line, for both passage protocols. Using Taq polymerase 
resulted in the amplification of only faint 1 kilobase (lkb) fragments. To try to increase 
the concentration of M gene amplified, Vent polymerase was used under the following 
conditions: 94°Cx45 sec, 56°Cx45 sec and 74°Cx 2 mins for 30 cycles. This did 
produced a much stronger 1 kb fragment, therefore, this polymerase was used for 
subsequent reactions. The primers used and the resulting PCR products obtained are 
outlined below (Table 14; Figures 36 & 37). The minor fragments that have been 
amplified along with the expected 1 kb fragment may represent non-specific binding of 
the primers to the template. The very small fragments at the bottom of the gel (< 50 bp) 
are primer dimers.
Results
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Table 14. PCR primers for the M gene of YM-V
Results
Name Position (nt) Sequence ER
Sites
Tm
°C
YMP -73 to -54 5' TCT AGA AGC TTA CAG CTC AAC TTA CCT GCC 3' Hind III 60
YM2 1000 to 982 3' CCC GGG TCG ACA CGT CGT CGT AAA TGC GG 5' Sail 60
The primers were designed using the published sequences of the M and P genes of the Edmonston strain of 
measles virus (Bellini el ai, 1986; Bellini et al., 1985). YMP was position at the 3’-end UTR of the P 
gene. YM2 was positioned 1000 bases downstream of the translation initiation codon of the M gene. 
Endonuclease restriction (ER) sites were included in the design of the primers. To ensure efficient 
cleavage the sites used for cloning were positioned 4-5 bases from the end of the primer sequence.
Figure 36. Position of the PCR primers within the M gene of YM-V
M gene ORF
YMP
S' — ►S' 5’
< ------ *-
P gene *
The 1000 base fragment amplified covers a hypervariable region of the M gene where mutational change 
would be expected and easily detected (III.2.2).
The majority of the amplified products are of the predicted size i.e., 1 kb. However, the 
product from YM-V passaged 5 times in IMR-32 cells and virus passaged in MRC-5 cells 
followed by 5 passages in SK-N-SH appears to be approximately 50 bases smaller, 
indicating that either the primers are mis-priming or that the M gene of this passaged 
virus contained a small deletion. These products were cloned into the bacteriophage M l3 
and sequenced using the USB Sequenase kit, and were found to be an ‘unknown 
sequence’ (Appendix A) which was reproducibly amplified using the YMP/YM2 primer 
pair presumably as a consequence of mis-priming. Subsequently it was found that virus
1001 
—i__
YM2
1466
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Results
Figure 37. Y M -V  M gene fragments amplified by PCR
L: 1 kb ladder; C: negative control; YM-V: initial virus stock; I P I : virus passaged once in 1MR-32 cells; I 
P5: virus passaged 5 times in IMR-32 cells; MI PI: virus propagated in MRC-5 cells, followed by one 
passage in IMR-32 cells; MI P5: virus propagated in MRC-5 cells, followed by 5 passages in IMR-32 cells; 
S P3: virus passaged 3 times in SK-N-SH cells; S P5: virus passaged 5 times in SK-N-SH cells; MS PI: 
virus propagated in MRC-5 cells, followed by once passaged in SK-N-SH cells; MS P5: virus propagated 
in MRC-5 cells, followed by 5 passages in SK-N-SH cells. The PCR amplification was carried out as 
previously described (II.3.3.2). Half of the PCR product (50 pi) was electrophoresed on a 1% agarose TAE 
gel. The I kb fragment was excised from the gel and subjected to Geneclean procedures (11.5.1), following 
the manufacturer’s protocol, prior to cloning.
passaged in IMR-32 cells once, and virus passaged in MRC-5 cells followed by 5 
passages in IMR-32 cells also yielded this ‘unknown sequence’, although not resolved as 
a shorter amplification product. The unknown sequence was screened using the Blast 
Nucleotide Sequence Database, however, no positive identification was found. This 
sequence did not have any homology with any nucleotide sequence stored in the database 
(upto January 1996).
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III.3.2 Cloning into the Bacteriophage M13
Results
It was considered necessary to clone the amplified M gene fragments as the cloning of the 
ADD-MV indicated that the M gene mRNA exists as a heterogeneous population
(III.2.4). The resulting M gene fragments were gel purified using the Geneclean II (BIO 
101) protocol (II.5.1) and cloned into the bacteriophage M13 (II.5.4).
The M gene was cloned into the bacteriophage M13mpl8 using the ER sites inserted at 
both the 3' and 5' ends of the fragment during amplification, namely Sal I and Hind III. 
Both of these restriction sites are present in the multiple cloning site of M13mpl8 and 
mpl9. Inadvertently, the cloning reactions were carried out using a stock of m pl8 that 
was contaminated with mpl9. During the cloning reactions some of PCR products 
ligated with the mpl9 vector. Thus, some of the inserted sequences were in the opposite 
orientation to those cloned into the m pl8 vector. Figure 38 shows positive M13 clones of 
the M gene of YM-V. Clone 2 of Yamagata-1 virus passaged 5 times in SK-N-SH cells 
(S P5) is obviously smaller than the expected 1 kb insert. Likewise, clone 15 of virus 
passaged 5 times in IMR-32 cells (I P5), clone 2 of virus passaged in MRC-5 cells prior 
to one passaged in IMR-32 cells (MI PI), and clone 8 of virus passaged in MRC-5 cells 
followed by 5 passages in IMR-32 cells (MI P5) are all slightly smaller than the predicted 
1 kb insert. These observations are discussed in further detail elsewhere (III.3.5.3; 
III3.5.4; III.3.6.1; III.3.6.4). The resulting single-stranded DNA was then sequenced.
177
Figure 38. Positive M l 3 clones of the M gene of Y M -V
Results
I Pi I P5 Ml PI Ml P5
1635—
1018—
51 6—
1 0 0 0 0 0 0 . 1 0 0 0 * -  — 0 1 . 1  oo
i ----Z.____i ._______ Zj i_____  . ,_______ Zj
S P3 S P5 MS PI MS P5
L: I kb ladder; 24 etc.: clone ID numbers; I PI: clones from virus passaged once in IMR-32 cells; I P5: 
clones from virus passaged 5 times in IMR-32 cells; MI PI: clones from virus propagated in MRC-5 cells, 
followed by one passage in IMR-32 cells; Ml P5: clones from virus propagated in MRC-5 cells, followed 
by 5 passages in IMR-32 cells; S P3: clones from virus passaged 3 times in SK-N-SH cells; S P5: clones 
from virus passaged 5 times in SK-N-SH cells; MS PI: clones from virus propagated in MRC-5 cells, 
followed by once passaged in SK-N-SH cells; MS P5: clones from virus propagated in MRC-5 cells, 
followed by 5 passages in SK-N-SH cells. Amplified M gene clones were ligated into M13 vector. Both 
single-stranded and double-stranded DNA was isolated from overnight cultures of clones. Double-stranded 
DNA was digested with Sal I and Hind 111 to determine which clones contained the correct insert (1 kb).
11.3.3 Sequencing the 1 kb Fragment of the M Gene of YM-V
The single-stranded DNA produced from 3 clones derived from passages 1 and 5 in each 
cell line was sequenced using US Biochemicals Sequenase v2.0 sequencing kit. Five 
internal sequencing primers were designed in order to sequence the full 1 kb fragment of 
the M gene, along with the -40 primer supplied with the Sequenase kit. The primers used
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for sequencing and their positions within the M gene can be seen in Table 15, and in 
Figures 39 & 40, below.
Results
Table 15. Sequencing primers for single-stranded DNA sequencing
Name Position Sequence Tm
°C
-40 -40 nt into 
vector
5' CAG CAC TGA CCC TTT TG 3' 52
MM04 nt 552 to 567 5' CCT AGA AGA ATG CTG G 3' 48
MM07 nt 134 to 151 5' GGT CAG AGT CAT AGA TCC 3' 54
MM08 nt 151 to 134 3' GGA TCT ATG ACT CTG ACC 5’ 48
MM09 nt 567 to 552 3' CCA GCA TTC TTC TAG G 5' 54
MM10 nt 427 to 442 5' GGA GTG TCT TCA ACG C 3' 50
The -40 primer was provided with the Sequenase sequencing kit (USB) and primes 40 bases downstream 
from the MCS of the vector. The internal primers were designed using the published M gene sequence for 
the Edmonston strain of measles virus (Bellini et al., 1986). Primer MM08 is complementary to MM07 
and MM09 is complementary to MM04. These primers are used to sequence the M gene products cloned 
into MI3mpl9.
Figure 39. Position o f the sequencing primers for single-stranded DNA 
sequencing in M13 m pl9
Hind III MM08 MM09 Sal I
y  |  r  ^  5’ r 5' v .
M13 ^  I ^  M13
I 1001
The primers were positioned so that sequence data from the most upstream primer will run through the next 
downstream primer. Approximately 200-250 bases can be sequenced when the reactions are 
electrophoresed for 1.5-2 hrs. In order to sequence the 5’ region o f M gene products cloned into mpl9, 
reactions from the MM08 primer had to electrophoresed for both 1.5-2 hrs and 6-8 hrs in order to sequence 
to the beginning of the M gene.
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Results
Figure 40. Position of the sequencing primers for single-stranded DNA 
sequencing in M13 m pl8
MM04 MM07
r ---y
-40
1001 
Sal I
j. — f
MM 10
Hind III
The primers were designed so that sequence data from the most upstream primer ran through the next 
downstream primer. Approximately 200-250 bases can be determined from a reaction electrophoresed for 
1.5-2 hrs, therefore, to determine the 3’ region of the M gene inserted into mpl8, reactions using the 
MM04 primer had to be electrophoresed for 1.5-2 hrs and 6-8 hrs.
Hi.3,4 M Gene 1 Kb Fragment Sequence of YM-V
The supernatant from Vero cells infected with YM-V (passage 96) was titred using Vero 
cells to determine whether any lytic virus was produced. The titre was found to be very 
low, 980 pfu/ml. This is in accordance with the observations of Homma et al., (1982), 
who found that less than 1000 pfu of infectious virus could be recovered from the 
supernatants of freeze/thawed preparations of the cells
The M gene of YM-V virus was amplified, cloned and sequenced initially to confirm the 
presence of the mutated M gene described previously by Wong et al. (1989). Three 
clones of YM-V were sequenced. Whereas two of the three clones, clones 4 and 7, 
resembled EdM (III.2.2), one clone, clone 5, resembled the M gene sequence of 
Yamagata-1 virus described by Wong et al. (1989).
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Figure 41. Y M -V  M gene sequence data from clones 4, 5 & 7
Results
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
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4
7
5
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EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
AGGAGCAAAGUGAUUGCCUCCCAAGUUCCACAAUGACAGAGAUCUACGACUUCGACAAGU
................................................c .............c ...................c .........c .................
................................................c .............c ...................c .........c .................
CGGCAUGGGACAUCAAAGGGUCGAUCGCUCCGAUACAACCCACCACCUACAGUGAUGGCA 
U...........................................................................................................................
..................................... G................................................... G...................C ........................G.
..................................... G................................................... G...................C ........................G.
GGCUGGUGCCCCAGGUCAGAGUCAUAGAUCCUGGUCUAGGCGACAGGAAGGAUGAAUGCU
......................................................................................................c ...........c
UUAUGUACAUGUUUCUGCUGGGGGUUGUUGAGGACAGCGAUCCCCUAGGGCCUCCAAUCG 
....................................................................................................U............................................
.....................................................................................u .....................................
• C ..............................................................................................................................................
GGCGAGCAUUUGGGUCCCUGCCCUUAGGUGUUGGCAGAUCCACAGCAAAGCCCGAAAAAC
........................................................................................................................A ............. G. . .
........................................................................................................................A ............. G. . .
UCCUCAAAGAGGCCACUGAGCUUGACAUAGUUGUUAGAGCUACAGCAGGGCUCAAUGAAA
................................................G. .A ....................................................................... U...........
................................................G . .A ......................................................................................
AACUGGUGUCUACAACAACACCCCACUAACUCUCCUCACACCUUGGAGAAAGGUCCUAA
..........................................................................................................................................C. .
.............................................................................................................. c . .
CAACAGGGAGUGUCUUCAACGCAAACCAAGUGUGCAGUGCGGUUAAUCUGAUACCGCUCG
....................................................................................... A.........................................................
....................................................................................... A .........................................................
....................................................................................... A ............................... G................ G.
....................................................................................... A ............................... G................ G.
AUACCCCGCAGAGGUUCCGUGUUGUUUAUAUGAGCAUCACCCGUCUUUCGGAUAACGGGU
• C........................................................C . .C ...................................... C C .U ...C
. C ........................................................C . .C ...................................... C C .U ...C
6 0
120
1 8 0
2 4 0
3 0 0
3 6 0
4 2 0
4 8 0
5 4 0
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EdM
4
7
5
YM-1
EdM
4
7
5 
Y
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
EdM
4
7
5
YM-1
AUUACACCGUUCCUAGAAGAAUGCUGGAAUUCAGAUCGGUCAAUGCAGUGGCCUUCAACC 600
Results
• C......................... C .................................................G..............................................................
• C......................... C .................................................G..............................................................
UGCUGGUGACCCUUAGGAUUGACAAGGCGAUAGGCCCUGGGAAGAUCAUCGACAAUACAG 660
...................................... A ................................. U........................................................... G. . .
...................................... A ................................. U........................................................... G. . .
AGCAACUUCCUGAGGCAACAUUUAUGGUCCACAUCGGGAACUUCAGGAGAAAGAAGAGUG 720
............................................................................................. G...................................................
............................................................................................. G...................................................
AAGUCUACUCUGCCGAUUAUUGCAAAAUGAAAAUCGAAAAGAUGGGCCUGGUUUUUGCAC 7 80
............................................................. G....................................................................................
............................................................. G....................................................................................
UUGGUGGGAUAGGGGGCACCAGUCUUCACAUUAGAAGCACAGGCAAAAUGAGCAAGACUC 8 4 0
..........................................................................C .......................................................................
...............................................................c .............................................................
UCCAUGCACAACUCGGGUUCAAGAAGACCUUAUGUUACCCGCUGAUGGAUAUCAAUGAAG 900
..........................................................................C .....................A .CA.......................................
..........................................................................C .....................A .CA.......................................
ACCUUAAUCGAUUACUCUGGAGGAGCAGAUGCAAGAUAGUAAGAAUCCAGGCAGUUUUGC 960
. .  . c c ............................................................... c .............................. c . . .
.. . c c ............................................................... c .............................. c . . .
AGCCAUCAGUUCCUCAAGAAUUCCGCAUUUACGACGACGUG 1001
C .............C
C .............C
EdM corresponds to the published Edmonston measles virus M gene sequence (Bellini et al, 1986); 4,7 and 
5 correspond to the three clones of the YM-V M gene sequence; YM-1 is the M gene sequence of 
Yamagata-1 virus propagated in Vero cells only, described by Wong et al, 1989. AUG represents the 
translation initiation codon. The 1 kb fragment amplified using the YMP/YM2 primer pair was cloned into 
M13. Three resulting clones were sequenced using the Sequenase v2.0 sequencing kit (USB).
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Figure 41 shows that clones 4 and 7 differ from EdM (III.2.2) at two sites only; a C-U 
substitution at position 222 and a G-A substitution at position 457. Clone 4 contains an 
additional nucleotide change at position 61 (C-U) (Table 16).
Results
Table 16. Comparison of YM-V clones 4 & 7 with EdM
Clone 4 Clone 7
Position Base Change Position Base Change
61 C-U - -
2 2 2 C-U 2 22 C-U
457 G-A 457 G-A
The M gene of YM-V was cloned into the bacteriophage M l3. The sequence of 3 clones was determined 
using the Sequenase sequencing kit (USB). Comparison of the sequence from clones 4 and 7 with the 
published M gene sequence (Bellini et at., 1986) revealed the base changes tabulated above.
Clone 5, however, is highly mutated when compared to EdM. A total of 43 base changes 
were observed between clone 5 and EdM (III.2.2); 37 were transitions, 24 of which were 
either U-C or C -U, indicative of biased hypermutation. The remaining 6 base changes 
were transversions, either C-G or A-U. This clone differs only at positions 173, 180 and 
182 from that described by Wong et al. (1989); the U-C base changes at these positions 
are not present. This clone contains an additional base change not observed by Wong et 
al. (1989) at position 354 (A-U) (Table 17). The translation initiation codon of clone 5 is 
destroyed by U-C transition at position 34, as described by Wong et al. (1989).
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Table 17. Base differences observed between the M gene of YM-V clone 5, the M 
gene of Yamagata-1 virus described by Wong et al. (1989) and EdM
Results
Nucleotide Position YM-V Clone 5 Yamagata-1 EdM
26 C C U
34 C C U
45 c c U
51 c c U
77 G G A
99 G G C
108 C C u
119 G G c
173 U U u
180 u u u
182 u u u
290 A A G
297 G G A
321 G G C
324 A A G
354 U A A
418 C C U
457 A A G
471 G G A
479 G G C
482 C C u
506 C C u
509 C C u
526 C C u
527 C C u
529 u u c
533 c c u
542 c c u
554 c c u
575 G G A
617 A A G
632 U U A
657 G G A
699 G G A
746 G G U
811 C C U
871 C C u
881 A A G
883 C C U
884 A A G
904 C C U
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Results
Continuation of Table 17
Nucleotide Position YM-V Clone 5 Yamagata-1 EdM
905 C C U
940 C C U
957 c c U
974 c c u
981 c c u
Comparison of the sequence from clone 5 with the M gene sequence of Yamagata-1 virus passaged in Vero 
cells (Wong et al., 1989) and EdM (Bellini et al„ 1989) revealed the base changes tabulated above.
III.3.5 The Sequence of the 1 kb Fragment of YM-V From Early Passage in 
Neuroblastoma Cells
III.3.5.1 M Gene Sequence of YM-V Passage 3 Times In SK-N-SH Cells
The M gene of YM-V passaged 3 times in the SK-N-SH neuroblastoma cell line was 
cloned into M13mpl9 and sequenced. Originally, virus passaged only once was to be 
sequenced, however, due to accidental loss of the earlier samples virus passaged 3 times 
was the earliest passage material available for cloning. Eleven clones were sequenced 
using the -40 primer which produced approximately 250 bases of sequence, and all were 
found to be similar to EdM (III.2.2). Three clones (nos. 8,10 and 18) were sequenced in 
full. All three clones contained two base changes when compared to EdM (III.2.2), 
namely a C-U nucleotide transition at position 222, and a G-A change at position 457. 
Clone 18 contained one additional base change at position 225. This was a C-U 
transition and is a silent mutation. Table 18 shows the sequence differences between the 
three clones and EdM (III.2.2).
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Results
Table 18. Comparison of YM-V passaged 3 times in SK-N-SH cells with 
EdM
Clone 8 Clone 10 Clone 18
Position Base Change Position Base Change Position Base Change
2 22 C-U 222 C-U 222 C-U
- - - - 225 C-U
457 G-A 457 G-A 457 G-A
The M gene of YM-V passaged 3 times in SK-N-SH cells was cloned into the bacteriophage M l3. The 
sequence of 3 clones was determined using the Sequenase sequencing kit (USB). Comparison o f the 
sequence of each clone with the published M gene sequence of the Gdmonston strain of measles virus 
(Bellini et a!., 1986) revealed the base changes tabulated above.
It should also be noted that the size of the cloned sequence is smaller than expected 
(Figure 37). The amplified M gene fragment was approximately 1000 bases, however, 
the inserted sequence was only 743 bases in length. Possible explanations are discussed 
later (III.3.9). Sequence data from the -40 primer should correspond to the 3’-end if the 
PCR fragment is cloned into m pl9. A 2 hr run of this sequencing reaction produced 
approximately 250 bases of sequence. A poly A tail of 15 adenosine residues was found 
prior to the M gene sequence (Figure 42). However, the 15 bases preceding the oligo T 
tail do not correspond with measles virus M gene sequence after nucleotide position 760. 
The exact reason for this result has not been fully resolved. However, contamination of 
the vector stock with ADD-MV M gene is the most likely explanation as ADD-MV 
amplified using the MVMl/oligo dT primer pair produced sequence of 743 bases in 
length, due to the priming of oligo dT at positions 743-759 (III.2.2; Figure 21).
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Figure 42. The 3'-end sequence of YM-V Passaged 3 Times in 
SK-N-SH cells
Results
The sequence reaction using the -40 primer provided with the Sequenase sequencing kit. Clone 10 of the 
M gene of YM-V passaged 3 times in SK-N-SH cells. The poly A tail can be seen preceding the M gene 
sequence from position 743. A 1 kb fragment of the M gene was amplified using the YMP/YM2 primer 
pair and subsequently cloned in the bacteriophage M l3.
III.3.5.2 M Gene Sequence of YM-V Propagated in MRC-5 Cells Followed by 
One Passage in SK-N-SH
The M gene of YM-V passage 3 times in MRC-5 then once in the neuroblastoma cell 
line, SK-N-SH (Figure 35), was cloned into M l3. A total of 10 clones were sequenced 
with the -40 primer. Five of these were found to resemble the M gene of measles virus, 
one of the remaining clones was the unknown sequence (Appendix A) and the remaining
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4 clones were not related to measles virus or the previously isolated unknown sequence, 
and were presumed to be artefacts produced during the cloning process. Three of the 5 
measles virus clones were then sequenced in full (960 bases). The amplified fragment of 
clone 1 was ligated into M13mpl8, while the amplified fragments o f clones 11 and 14 
were ligated into M13mpl9. Clone 1 produced sequence which resembled EdM. (Table 
19). The other two clones, 11 and 14, were identical to the M gene sequence of 
Yamagata-1 virus described by Wong el al. (1989), except that three U-C transitions at 
positions 173, 180 and 182 are not present (Table 20).
Results
Table 19. Comparison of clone 1 from YM-V propagated in MRC-5 cells 
followed by one passaged in SK-N-SH cells, with EdM
Clone 1
Position Base Change
2 2 2 C-U
457 G-A
The M gene of YM-V passaged in MRC-5 cells followed by one passage in SK-N-SH cells was cloned into 
the bacteriophage M l3. The sequence of 3 clones was determined using the Sequenase sequencing kit 
(USB). Comparison of the sequence from clone 1 with the published M gene sequence (Bellini et al..
1986) revealed the base changes tabulated above.
Table 20. Comparison of clones 11 and 14 of YM-V propagated in MRC-5 cells 
followed by one passaged in SK-N-SH cells with the M gene sequence of 
Yamagata-1 virus described by Wong el al. (1989)
Clone 11 Clone 14
Position Base Change Position Base Change
173 C-U 173 C-U
180 C-U 180 C-U
182 C-U 182 C-U
The M gene of YM-V passaged in MRC-5 cells followed by one passaged in SK-N-SH cells was cloned 
into the bacteriophage M l3. The sequence of 3 clones was determined using the Sequenase sequencing kit 
(USB). Comparison of the sequence from clones 11 and 14 with the M gene sequence of Yamagata-1 virus 
propagated in Vero cells only (Wong et al., 1989) revealed the base changes tabulated above.
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111.3.5.3 M Gene Sequence of YM-V Passaged Once in IMR-32 Cells
The M gene of YM-V passaged once in the neuroblastoma cell line IMR-32 was cloned 
into M13mpl8. The intention was to sequence three clones. However, the sequence 
amplified from this material using the same primers as before (YMP and YM2) was the 
unknown sequence described in Appendix A.. A total of 25 clones was sequenced from 
three separate cloning reactions. The PCR fragment was of the expected size i.e., 1 kb, as 
were the digest products o f the clones when screening for positive clones. The PCR 
reactions were repeated using uninfected cells; no fragment was amplified, therefore, it is 
unlikely that the cloned sequence is an artefact of cellular origin.
111.3.5.4 M Gene Sequence of YM-V Propagated for One Passage in IMR-32 
Cells Preceded by three passages in MRC-5 Cells
The M gene of YM-V passaged 3 times in MRC-5 cells, followed by one passage in 
IMR-32 cells (Figure 35; branch b) was cloned into M13mpl8. Four clones were 
sequenced with the -40 primer and found to be positive for the M gene of measles virus. 
Three clones (1,2 and 6) were then sequenced in full (960 bases). All three clones 
possessed a sequence which was similar to that described by Wong et al. (1989). Table 
21 summaries the base changes observed when the sequence of the three clones are 
compared with the M gene sequence of Yamagata-1 virus (Wong et al., 1989).
Results
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Table 21. Comparison of clones 1, 2 and 6 of YM-V propagated in MRC-5 cells 
followed by a single passage in IMR-32 cells with the M gene of Yamagata-1 
virus described by Wong et al. (1989)
Clone 1 Clone 2 Clone 6
Position Base Change Position Base Change Position Base Change
45 C-U 26 C-U - -
51 C-U - - - -
173 C-U 173 C-U 173 C-U
180 C-U 180 C-U 180 C-U
182 C-U 182 C-U 182 C-U
The M gene o f YM-V passaged in MRC-5 cells followed by one passage in IMR-32 cells was cloned into 
the bacteriophage M l3. The sequence of 3 clones was determined using the Sequenase sequencing kit 
(USB). Comparison of the sequence from clones 1,2 and 3 with the M gene sequence of Yamagata-1 virus 
passaged in Vero cells only (Wong el al., 1989) revealed the base changes tabulated above.
The 3 clones differed from the M gene sequence described by Wong et al. (1989) at 
positions 173, 180 and 182. Clone 1 does not contain the U-C transitions at positions 45 
and 51 which were described by Wong et al. (1989); and clone 2 does not contain the U- 
C transition at position 26, however, all three clones do contain the U-C mutation at 
position 34 which destroys the translation initiation codon, thus, preventing the 
translation o f M protein.
111,3.6 Sequence of the 1 kb M Gene Fragment of YM-V Passaged 5 Times in 
the Neuroblastoma Cells
III.3.6.1 M Gene Sequence of YM-V Passaged 5 Times in SK-N-SH Cells
The M gene of YM-V passaged 5 times in SK-N-SH cells was cloned into M13mpl8. A 
total of 19 clones were sequenced using the -40 primer. Fifteen of these clones were
190
found to be the unknown sequence (Appendix A), the remaining 4 clones resembled the 
M gene of EdM (III.2.2). Three of these four clones (nos. 2, 5 and 18) were sequenced in 
full (clones 2 & 5 produced 726 bases of sequence; clone 18 produced 960 bases of 
sequence). The reduced M gene fragment sequenced from clones 2 and 5 is the result of a 
base change at position 726, which results in the formation of a Sal I ER site. This 
enzyme is used in the cloning process, resulting in the truncation of the M gene clone. 
The sequence determined from each of the 3 clones resembled EdM (III.2.2). Table 22 
summaries the base differences between the 3 clones and EdM (III.2.2).
Results
Table 22. Comparison of clones 2, 5 and 18 of YM-V passaged 5 times in 
SK-N-SH with EdM
Clone 2 Clone 5 Clone 18
Position Base Change Position Base Change Position Base Change
9 A-G - - 61 C-U
222 C-U 222 C-U 222 C-U
457 G-A 457 G-A 457 G-A
*726 U-G *726 U-G - -
- - - - 542 u-c
- - - - 543 u-c
- - - - 545 C-A
The M gene of YM-V passaged 5 times in SK-N-SH was cloned into the bacteriophage M l3. The 
sequence of 3 clones was determined using the Sequenase sequencing kit (USB). Comparison of the 
sequence from clones 2, 5 and 18 with the published M gene sequence (Bellini et al., 1986) revealed the 
base changes tabulated above. * indicates the position of the base change which introduces a Sal I 
restriction site. This enzyme was used in the cloning procedure, so explaining the smaller size of the 
inserted M gene fragment.
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111.3.6.2 M Gene Sequence of YM-V Passaged in MRC-5 Cells Followed by 5 
Passages in SK-N-SH Cells
The M gene of YM-V passaged three times in MRC-5, then 5 times in the neuroblastoma 
cells, SK-N-SH (Figure 35; branch c), was cloned into M13mpl8. A total of 29 clones, 
generated from 3 separate cloning reactions, were sequenced with the -40 primer, all of 
which yielded the unknown sequence describe in Appendix A. The PCR reactions were 
repeated using uninfected SK-N-SH cells, no fragment was amplified, therefore it seems 
unlikely that this sequence is an artefact o f cellular origin.
111.3.6.3 M Gene Sequence of YM-V Passaged 5 Times in IMR-32 Cells
The M gene of YM-V passaged 5 times in IMR-32 cells was amplified by PCR and 
cloned in M13mpl8. A total of 18 clones, generated in three separated cloning reactions, 
was sequenced using the -40 primer. The sequence obtained from all of the clones was 
the unknown sequence described in Appendix A. The PCR reactions were repeated using 
uninfected IMR-32 cells, again, no fragment was amplified, therefore, it seems unlikely 
that this sequence is an artefact of cellular origin.
Results
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III.3.6.4 M Gene Sequence of YM-V Passaged in MRC-5 Cells Followed by 
Passage 5 Times in IMR-32 Cells
The M gene of YM-V passaged 3 times in MRC-5 cells, followed by 5 passages in IMR- 
32 cells was amplified by PCR and cloned into M13mpl8. A total of 21 clones, 
generated in three separated cloning reactions, was sequenced with the -40 primer. 
Nineteen of the 21 clones were the unknown sequence described in Appendix A. The 
sequence obtained from one of the remaining two clones showed high identity with 
several Homo sapiens cDNA clones ranging from 66% identity to 73% when searched 
through the Blast Database. The final clone showed high identity (71%) with the 
Haemophilus influenzae recF, dnaN, dnaA, tbpl-A and tbp2-B genes from bases 1052980 
to 1063176 when screened through the Blast database. The primer sequence could not be 
read from the gel of the clones which have identity with Homo sapiens cDNA clones and 
H. influenzae genes which suggests the these sequences are in no way specific to measles 
virus infections. It is likely that they are simply artefacts of the cloning reactions.
111.3.7 Amplification and Cloning of the M gene of YM-V Passage Material 
From. Which Only Unknown Sequence Had Been Recovered
III.3.7.1 Nested Polymerase Chain Reaction
Nested PCR is a more specific method because two reactions, using different primer 
pairs, are required to amplify the material in question. The increased specificity was 
required to determine whether measles virus sequence could be recovered from the YM-V
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passaged material where only the unknown sequence (Appendix A) had been recovered 
previously.
Results
The two sets of primers used are detailed in Table 23 and Figure 43. The EdM sequence 
(III.2.2) was used to design the primers used for the amplifications. The first set of 
primers (YM5 and YM2) was designed to amplify a 1000 base fragment of the M gene 
(PCR A). The second set of primers (MM02 and YM6) was designed so that they anneal 
at 5' and 3' regions of the 1000 base fragment previously amplified, thus the second PCR 
reaction should amplify a fragment of approximately 900 bases (PCR B) (Figures 44 & 
45). Amplification of the M gene had been previously carried out using Vent polymerase, 
and the nested PCR reactions were initially tried using this enzyme. However, the 
controls for PCR B (see below) repeatedly produced a fragment of the expected size, 
therefore, amplification reactions using Taq polymerase were tried. The controls for PCR 
B remained clear, thus, the amplified products using Taq polymerase were cloned.
Table 23. Nested PCR primers for the YM-V M gene
Name Position Sequence Restriction
Sites
Tm
°C
YM5 5 -2 2 5’ GCA AAG TGA TTG CCT CCC 3' Pst 1 56
YM2 1000-982 3' CCG CAT TTA CGA CGA CGT G 5’ Sal 1 60
MM02 22-44 5' GTT CCA CAA TGA CAG AGA TC 3' Xho 1 58
YM6 925 - 908 3' GCT CCT CCA GAG TAA TCG 5' Ava 1 56
The primers were designed using the published M gene for the Edmonston strain of measles virus (Bellini 
et a/., 1986). Restriction sites were included in the primers to aid any subsequent cloning reactions. The 
cycle used for each PCR reaction was 94°Cx45 secs, 56°Cx45 secs and 74°Cxl min (30 cycles).
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Figure 43. Position of the primers within the M gene for the nested PCR
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Nested PCR was required to increase the sensitivity of the reaction. YM5/YM2 primer pairs were 
positioned to initially amplify a I kb fragment. The resulting PCR reaction was then amplified using the 
MM02/YM6 primer pair. This primer pair was positioned just inside the 5’ and 3’ ends of the 1 kb 
fragment, resulting in the amplification of a 900 base fragment.
Figure 44. M gene fragments amplified by PCR with primers YM5 and YM2
L: 1 kb ladder; C: negative control; E: ADD-MV, positive control; I PI: virus passaged once in IMR-32 
cells; I P5: virus passaged 5 times in IMR-32 cells; MI P5: virus grown in MRC-5 cells followed by 5 
passages in IMR-32 cells: MS P5: virus grown in MRC-5 cells, followed by 5 passages in SK-N-SH cells. 
PCR reaction A using the YM5/YM2 primer pair (11.3.3.3). Cycle used: 94°Cx45 secs, 56°Cx45 secs and 
74°Cxl min (30 cycles). A 3 pi aliquot of the completed PCR product was used in PCR B.
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PCR A was tried using the MMOl/YMP primer pair. This pairing would rely on the
Results
amplification of bicistronic cDNA as YMP primes in the UTR o f the P gene. This 
reaction did not work well presumably due to base changes at 3’ region of the YM-V M 
gene which prevented the MMOl primer annealing or low abundance of bicistronic 
cDNA. Therefore, the YM5/YM2 primer pair was used for subsequent reactions.
A negative control i.e. no cDNA was run for each PCR reaction. For PCR B a further 
control was run using the PCR product of the negative control for PCR A. This ensured
Figure 45. M gene fragments amplified by PCR with primers MM02 and YM6
PI P5
_  CM _  CO
L U  U  E I I £  £
m *
900 ----------1018
516 —
L: 1 kb ladder; C l: negative control for this reaction; C2: negative control from PCR A; E: ADD-MV, 
positive control; I PI: virus passaged once in IMR-32 cells; I P5: virus passaged 5 times in IMR-32 cells; 
Ml P5: virus grown in MRC-5 cells followed by 5 passages in IMR-32 cells: MS P5: virus grown in MRC- 
5 cells, followed by 5 passages in SK-N-SH cells. PCR B used the MM02/YM6 primer pair and cycle 
used was 94°Cx45 secs, 56°Cx45 secs and 74°Cxl min (30 cycles) (II.3.3.3). Half of the PCR product (50 
pi) was electrophoresed on a 1% agarose TAE gel. The 900 base fragment was excised from the and 
underwent Geneclean II procedure prior to cloning into the TA vector.
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that there was no low level contamination of the PCR reagents used in the experiment. 
ADD-MV propagated in Vero cells was used as a positive control. From Figure 44, 
showing the results of PCR A, it can be seen that the positive control amplifies a fragment 
of 1000 bases as expected. The 4 samples of YM-V produce a number of smaller 
fragments, the largest and by far the clearest fragment being approximately 900 bases. 
The PCR products obtained from PCR B are much cleaner (Figure 45). No fragments 
were amplified from the negative controls and all 4 YM-V samples and the positive 
control have show fragments of approximately 900 bases as expected. The M gene of 
YM-V passaged once and 5 times in IMR-32 cells; YM-V passaged in MRC-5 cells 
followed by 5 passages in IMR-32 cells, and YM-V passaged in MRC-5 cells followed by 
5 passages in SK-N-SH cells were then cloned into the TA vector (Promega).
III.3.7.2 Cloning the M Gene of YM-V into the TA Vector
The TA vector, pGEMT (Promega), was used for this experiment. PCR using Taq DNA 
polymerase generates an overhanging A nucleotide at the end of the PCR product. TA 
vectors have a complementary T base which base pairs with the overhanging A on the 
PCR product, as such, there is no need to digest the PCR product or the vector prior to 
cloning. The PCR products were subjected to gel purification procedures and the cleaned 
products were ligated into the vector. Positive clones were grown up overnight and the 
double-stranded DNA was prepared using the silica particle method (II.7.2). The double- 
stranded DNA was digested with Pvu II to determine which clones contained the insert. 
Figure 46 shows the positive pGEMT clones o f the M gene of YM-V passaged once and
Results
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five times in IMR-32 cells; propagated in MRC-5 cells prior to five passages in IMR-32 
cells, and propagated in MRC-5 cells prior to five passages in SK-N-SH cells.
Results
III.3.7.3 Sequencing of the M gene pGEMT Clones
The internal primers used for sequencing the double-stranded DNA have already been 
described (III.2.4.1) The primers used were -40, MM04 and MM07.
Figure 46. Positive pGEMT clones of the M gene of YM-V
L: I kb ladder; I P I: virus passaged once in IMR-32 cells; I P5: virus passaged 5 times in IMR-32 cells; MI 
P5: virus grown in MRC-5 cells, followed by 5 passages in IMR-32 cells; MS P5: virus grown in MRC-5 
cells, followed by 5 passages in SK-N-SH cells. 101 etc.: clone ID number. The PCR products were 
cloned into the pGEMT vector by virtue of the A overhang produced from the Taq polymerase 
amplification. DNA from clones were prepared by the silica particle method (II.7.2) and digested with Pvu 
II, therefore, actual size of clone is approx. 200 bp smaller than that represented on figure 46.
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Three clones of each of the passaged virus M gene were sequenced once in full using the 
double-stranded sequencing method (II.8.3), and once in full using the automated 
sequencer (II.8.1.1). Double-stranded DNA was sequenced, therefore, primers that anneal 
to the other strand could have been used. However, as the two methods of sequencing 
i.e., automated sequencing and manual double-stranded sequencing were employed, 
confirmation of the sequence did not need to be done using the second strand, the 
alternative sequencing method sufficed.
III.3.7.4 M Gene Sequence of YM-V Passaged Once in IMR-32 Cells
The M gene of YM-V passaged once in IMR-32 cells was amplified by nested PCR, 
cloned into the pGEMT vector and three o f the resulting clones were sequenced (900 
bases). Each of the three M gene clones (nos. 101, 102 & 103) contained sequence 
resembling the M gene of Yamagata-1 virus described by Wong et al. (1989), except for 
the U-C base transition at positions 26, 34, 173, 180 and 182. The U-C transition 
described by Wong et al. (1989) at position 34 mutates the translational start codon. 
However, these three clones have a normal initiation codon, thus, a full length M protein 
could be translated, although the amino acid sequence will be different from that of acute 
measles virus M gene. The mutation which destroys the translation initiation codon, 
however, is present in the M gene fragments that were cloned into M13mpl8 (III.3.5.4), 
whereas the U-C transitions observed by Wong et al. (1989) at positions 173, 180 and 
182 do not occur in YM-V M gene fragments cloned into either M13mpl8 (III.3.5.4) or
Results
pGEMT.
Clone 101 contains 3 additional base changes not described by Wong et al. (1989). These 
are at positions 494, a G-A transition, 751, an A-G transition, and 802, an A-G change 
(Table 24).
Results
Clone 102 also contains the G-A base transition at position 494, and the U-C transition at 
position 108 that was present in clones 101 and 102, was not seen in clone 103 (Table 
24).
Table 24. Sequence changes observed when comparing clones 101, 102 and 103 
of YM-V passaged once in IMR-32 cells with the M gene of Yamagata-1 virus 
described by Wong et al. (1989)
Clone 101 Clone 102 Clone 103
Position Base Change Position Base Change Position Base Change
26 C-U 26 C-U 26 C-U
34 C-U 34 C-U 34 C-U
45 C-U - - 45 C-U
- - - - 108 C-U
173 C-U 173 C-U 173 C-U
180 C-U 180 C-U 180 C-U
182 C-U 182 C-U 182 C-U
494 G-A 494 G-A - -
751 A-G - - - -
802 A-G - - - -
The M gene of YM-V passaged once in IMR-32 cells was amplified by nested PCR and cloned into the 
pGEMT vector. Three clones were sequenced using manual and automated sequencing methods. The 
sequence of the 3 clones was compared with the M gene of Yamagata-1 virus propagated in Vero cells only 
(Wong et al., 1989) and the base changes observed are tabulated above.
III.3.7.5 M Gene Sequence of YM-V passaged 5 Times in IMR-32 Cells
The M gene of YM-V passaged 5 times in IMR-32 cells was amplified by nested PCR, 
cloned and sequenced. Three clones (nos. 202, 203 & 204) were sequenced in full (900 
bases). Clone 204 contains most of the base changes described by Wong et al. (1989)
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(Table 25), except that three base changes are present that were not previously, namely a 
C-A nucleotide substitution at position 755, a G-A transition at position 493, and an A-U 
transversion at position 354. The uracil to cytosine transition at positions 173, 180 and 
181 are not present in these three clones either, nor is the U-C transition at position 34, 
which destroys the translation start codon. The intact translation initiation codon suggests 
that a full length M protein could be translated from these clones. These three clones are 
also missing the U-C base transition at position 26 which Wong et al. (1989) observed.
Clones 202 and 203 are exceptional in that they appear to be chimeras of Yamagata-1 
virus M gene and EdM. Clone 202 contains the M gene sequence of Yamagata-1 virus up 
to position 457, after this position the sequence reverts to that of EdM (III.2.2). This 
clone also contains 4 additional base changes at positions 104 (C-U), 354 (A-U), 425 (A- 
G) and at position 514 (G-A). Clone 203 contains the base changes observed in the 
Yamagata-1 virus up to position 746, then the M gene sequence resembles EdM except 
for the U-C transition at position 883, which was described by Wong el al. (1989) in the 
Yamagata-1 virus. This clone contains one additional base changes at position 493 (G- 
A). Figure 47 shows the sequence obtained from the three clones.
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Table 25. Comparison of the sequences of the three clones from YM-V passaged 5 
times in 1MR-32 with the M gene of Yamagata-1 virus described by Wong el al. 
(1989)
Clone 202 Clone 203 Clone 204
Position Base Change Position Base Change Position Base Change
26 C-U 26 C-U 26 C-U
34 c-u 34 C-U 34 C-U
45 C-U 45 C-U - -
104 c-u - - - -
173 c-u 173 C-U 173 C-U
180 c-u 180 c-u 180 c-u
182 c-u 182 c-u 182 c-u
354 A-U 493 G-A 354 A-U
425 A-G - - 493 G-A
*457 *G-A - - 755 C-A
479 G-C - - - -
482 C-U - - - -
506 c-u - - - -
509 c-u - - - -
514 G-A - - - -
526 C-U - - - -
527 C-U - - - -
529 U-C - - - -
533 C-U - - - -
542 C-U - - - -
554 C-U - - - -
575 G-A - - - -
617 A-G - - - -
632 U-A - - - -
657 G-A - - - -
699 G-A - - - -
746 G-A * * - -
811 C-U 811 C-U - -
871 C-U 871 c-u - -
881 A-G 881 A-G - -
883 C-U - - - -
884 A-G 884 A-G - -
904 C-U 904 C-U - -
905 C-U 905 C-U - -
The M gene of YM-V passaged 5 times in IMR-32 cells was amplified by nested PCR and cloned 
into the pGEMT vector. Three clones were sequenced using manual and automated sequencing 
methods. The sequence of the 3 clones was compared with the M gene of Yamagata-1 virus 
propagated in Vero cells only (Wong el a!., 1989) and the base changes observed are tabulated 
above. * Denotes position in clone where the sequence reverts to that of EdM.
202
Figure 47. M gene sequence of YM-V passaged 5 times in IMR-32 cells
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EdM AGGAGCAAAGUGAUUGCCUCCCAAGUUCCACAAIISACAGAGAUCUACGACUUCGACAAGU 6 0
202 .........AHS................C .........
203 .........AHS................C .........
204 .........AUG......... C .....C .........
YM-1 .......................... C ....... C .......... C .....C .........
EdM CGGCAUGGGACAUCAAAGGGUCGAUCGCUCCGAUACAACCCACCACCUACAGUGAUGGCA 120
202 .................G ...................... G....U...C.......... G.
203 .G ......................G ....... C .......... G.
204 .G ......................G ....... C .......... G.
YM-1 .................G ....................... G ....... C .......... G.
EdM GGCUGGUGCCCCAGGUCAGAGUCAUAGAUCCUGGUCUAGGCGACAGGAAGGAUGAAUGCU 18 0
202  
203 .................................................................
204 .................................................................
YM-1 ........................................................ C ......C
EdM UUAUGUACAUGUUUCUGCUGGGGGUUGUUGAGGACAGCGAUCCCCUAGGGCCUCCAAUCG 24 0
202  
203 .................................................................
204 .................................................................
YM-1 .C................................................................
EdM GGCGAGCAUUUGGGUCCCUGCCCUUAGGUGUUGGCAGAUCCACAGCAAAGCCCGAAAAAC 3 00
202 .A .....G...
203 .A .....G...
204 .A .....G...
YM-1 ..................................................... A ...... G...
EdM UCCUCAAAGAGGCCACUGAGCUUGACAUAGUUGUUAGACGUACAGCAGGGCUCAAUGAAA 360
202 ..................... G..A............................... U ......
203 ..................... G..A.......................................
204 ..................... G..A............................... U ......
YM-1 ..................... G. .A.......................................
EdM AACUGGUGUUCUACAACAACACCCCACUAACUCUCCUCACACCUUGGAGAAAGGUCCUAA 420
202 .C..
203 .C..
204 .C..
YM-1 .C..
EdM CAACAGGGAGUGUCUUCAACGCAAACCAAGUGUGCAGUGCGGUUAAUCUGAUACCGCUCG 480
202 ....G................................. A .........................
203 .A ............ G ....... G.
204 .A ............ G ....... G.
YM-1 .......................................A ..............G ....... G.
EdM AUACCCCGCAGAGGUUCCGUGUUGUUUAUAUGAGCAUCACCCGUCUUUCGGAUAACGGGU 54 0
202 ....................................A ............................
203 .C..........A ............ C..C................. CC.U...C.......
204 .C..........A ............ C..C................. CC.U...C.......
YM-1 .C........................ C. .C................. CC.U. . .C.......
203
EdM AUUACACCGUUCCUAGAAGAAUGCUGGAAUUCAGAUCGGUCAAUGCAGUGGCCUUCAACC 6 00
2 0 2   
203 .C............C ..................... G ...........................
204 .C........... C ..................... G ...........................
YM-1 .C............ C ..................... G ...........................
Results
EdM UGCUGGUGACCCUUAGGAUUGACAAGGCGAUAGGCCCUGGGAAGAUCAUCGACAAUACAG 660
2 0 2   
203 .A .............. U ......................... G. . .
204 .A .............. U ......................... G...
YM-1 .................A ............... U ......................... G...
EdM
2 0 2
203
204 
YM-1
AGCAACUUCCUGAGGCAACAUUUAUGGUCCACAUCGGGAACUUCAGGAGAAAGAAGAGUG 72 0
G
G
G
EdM AAGUCUACUCUGCCGAUUAUUGCAAAAUGAAAAUCGAAAAGAUGGGCCUGGUUUUUGCAC 780
2 0 2   
203 ...........................G .....................................
204 ...........................G ........ A ...........................
YM-1 ...........................G .....................................
EdM UUGGUGGGAUAGGGGGCACCAGUCUUCACAUUAGAAGCACAGGCAAAAUGAGCAAGACUC 84 0
2 0 2   
203 ..................................................................
204 ................................ C ................................
YM-1 ................................ C ................................
EdM UCCAUGCACAACUCGGGUUCAAGAAGACCUUAUGUUACCCGCUGAUGGAUAUCAAUGAAG 900
2 0 2   
203 ..............................................C ..................
204 ................................ C ......... A.CA.................
YM-1 ................................ C ......... A.CA.................
EdM AC CUUAAUCGAUUACU CUGG AGG AGC 926
2 0 2   
203 ............................
204 ...CC......................
YM-1 ...CC......................
EdM correspond to the published M gene sequence (Bellini el al., 1986). 202, 203 and 204 are the 3 clones 
sequences of YM-V passaged 5 times in IMR-32 cells, and YM-1 is the M gene of Yamagata-1 virus 
passaged in Vero cells only observed by Wong el a l (1989). Clones 202 and 203 are chimeras containing 
both EdM and YM-1 sequence. The sequence was determined using both manual and automated 
sequencing methods. ADG is the translation initiation codon. The open reading frame extends past the 
960 bases sequence, therefore, it is presumed that a full length M protein is translated.
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The M gene of YM-V passaged 3 times in MRC-5 cells followed by 5 passaged in IMR- 
32 cells was amplified by nested PCR. cloned into pGEMT and sequenced. Three clones 
(301, 302 & 302) o f  this passaged virus were sequenced in full (900 bases). The U-C 
base transition at position 34, which destroys the translation initiation codon, in the M 
gene Yamagata-1 virus (Wong el al., 1989) was not observed in any of these clones. 
Clone 301 resembles the M gene Yamagata-1 virus (Wong el al., 1989), except that the 
five U-C transitions at positions 26, 45, 173, 180 and 182 were not present. Two 
additional mutations were observed; one was at position 345 (G-A), and the other was at 
position 797 (C-A). Clone 302 appears to be a chimera having sequence resembling EdM 
up to position 457 (G-A), beyond which the sequence reverts to that described by Wong 
el al. (1989). This clone contains 3 additional mutations, one at position 220 (A-G), one 
at position 741 (U-C), and one at position 831 (A-G). Clone 303 contains sequence 
which resembles EdM. Figure 48 shows the sequence of these 3 clones; Table 26 
summarises the base differences when clones 301 and 302 are compared to the M gene of 
Yamagata-1 virus determined by Wong el al. (1989).
Results
III.3.7.6 M Gene Sequence of YM-V Propagated in MRC-5 Cells Followed by
5 P a ssag es in IMR-32 Cells
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EdM AGGAGCAAAGUGAUUGCCUCCCAAGUUCCACAAUGACAGAGAUCUACGACUUCGACAAGU 6 0
301 ......... ACS................C .........
302 .........ADG...........................
303 .........AUG...........................
YM-1 .......................... C ....... C .......... C .....C .........
EdM CGGCAUGGGACAUCAAAGGGUCGAUCGCUCCGAUACAACCCACCACCUACAGUGAUGGCA 120
301 .................G ...................... G .........C .......... G.
302 ..................................................................
303 ..................................................................
YM-1 .................G ...................... G ........ C .......... G.
EdM GGCUGGUGCCCCAGGUCAGAGUCAUAGAUCCUGGUCUAGGCGACAGGAAGGAUGAAUGCU 180
301 ..................................................................
302 ..................................................................
303 ..................................................................
YM-1 .........................................................C ......C
EdM UUAUGUACAUGUUUCUGCUGGGGGUUGUUGAGGACAGCGAUCCCCUAGGGCCUCCAAUCG 24 0
301 ..................................................................
302 .......................................... G.U....................
303 .............................................U ...................
YM-1 .C...............................................................
EdM GGCGAGCAUUUGGGUCCCUGCCCUUAGGUGUUGGCAGAUCCACAGCAAAGCCCGAAAAAC 300
301 ..................................................... A ......G. . .
302 ..................................................................
303 ..................................................................
YM-1 ..................................................... A ......G...
EdM UCCUCAAAGAGGCCACUGAGCUUGACAUAGUUGUUAGACGUACAGCAGGGCUCAAUGAAA 360
301 ..................... G..A..................... A ................
302 ..................................................................
303 ..................................................................
YM-1 ..................... G. .A.......................................
EdM AACUGGUGUUCUACAACAACACCCCACUAACUCUCCUCACACCUUGGAGAAAGGUCCUAA 420
301 .C..
302 .C..
303 ..................................................................
YM-1 .C..
EdM CAACAGGGAGUGUCUUCAACGCAAACCAAGUGUGCAGUGCGGUUAAUCUGAUACCGCUCG 480
301  A ... G .G.
302  A ... G .G.
303 ....................................... A .........................
YM-1 ....................................... A ............. G ....... G.
Results
Figure 48. M gene sequence of YM-V passaged in MRC-5 cells followed by 5
passages in IMR-32 cells
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EdM AUACCCCGCAGAGGUUCCGUGUUGUUUAUAUGAGCAUCACCCGUCUUUCGGAUAACGGGU 540
301 -C.........................C..C................. CC.U...C.......
302 .C.........................C..C................. CC.U...C.......
303 ..................................................................
YM-1 .C......................... C..C................. CC.U...C.......
EdM AUUACACCGUUCCUAGAAGAAUGCUGGAAUUCAGAUCGGUCAAUGCAGUGGCCUUCAACC 600
301 .C............C ..................... G ...........................
302 .C......... ..C...................... G ...........................
303 ..................................................................
YM-1 .C............ C ..................... G ...........................
EdM UGCUGGUGACCCUUAGGAUUGACAAGGCGAUAGGCCCUGGGAAGAUCAUCGACAAUACAG 660
301 .A ..............U .......................... G...
302 .A ..............U .......................... G...
303 ..................................................................
YM-1 .................A ............... U .......................... G...
Results
EdM AGCAACUUCCUGAGGCAACAUUUAUGGUCCACAUCGGGAACUUCAGGAGAAAGAAGAGUG 720
301 .G .....................
302 .G .....................
303 ..................................................................
YM-1 ......................................... G .......................
EdM AAGUCUACUCUGCCGAUUAUUGCAAAAUGAAAAUCGAAAAGAUGGGCCUGGUUUUUGCAC 780
301 ...........................G ...................................
302 ..................... C ___ G ...................................
303 ..................................................................
YM-1 .......................... G .....................................
EdM UUGGUGGGAUAGGGGGCACCAGUCUUCACAUUAGAAGCACAGGCAAAAUGAGCAAGACUC 84 0
301 .................A ..............C ................................
302 ................................ C ................... G .........
303 ..................................................................
YM-1 ................................ C ................................
EdM UCCAUGCACAACUCGGGUUCAAGAAGACCUUAUGUUACCCGCUGAUGGAUAUCAAUGAAG 900
301  C .A.CA..........
302  C .A.CA..........
303 ..................................................................
YM-1 ................................ C ......... A.CA.................
EdM ACCUUAAUCGAUUACUCUGGAGGAGC 926
301 ...CC......................
302 ...CC......................
303 ............................
YM-1 ...CC......................
EdM correspond to the published M gene sequence (Bellini et at., 1986). 301, 302 and 303 are the 3 clones 
sequences of the M gene of YM-V passaged in MRC-5 cells followed by 5 passaged in IMR-32, and YM-1 
is the M gene of Yamagata-1 virus passaged in Vero cells only observed by Wong et at., 1989. The 
sequence was determined using both automated and manual sequencing methods. Clone 302 appears to be 
a chimera containing both EdM and YM-1 sequence. AUG is the translation initiation codon. The open 
reading frame extends past the 960 bases sequence, therefore, it is presumed that a full length M protein is 
translated.
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Results
Table 26. Comparison of sequence of clones 301 and 302 of the M gene of 
YM-V propagated in MRC-5 cell followed by 5 passages in IMR-32 cells with the 
M gene of Yamagata-1 virus described by Wong el al. (1989)
Clone 301 Clone 302
Position Base Change Position Base Change
26 C-U 26 C-U
34 c-u 34 C-U
45 C-U 45 C-U
- - 51 c-u
- - 77 A-G
- - 99 G-C
- - 108 C-U
- - 119 G-C
173 c-u 173 C-U
180 c-u 180 C-U
182 c-u 182 C-U
- - 220 A-G
- - 222 C-U
- - 290 A-G
- - 297 G-A
- - 321 G-C
345 G-A 324 A-G
- - 418 C-U
- - *457 -
- - 741 u-c
797 C-A 831 A-G
The M gene of YM-V propagated in MRC-5 cells, follow ed by 5 passage in IMR-32 cells was amplified by 
nested PCR and cloned into the pGEMT vector. Three clones were sequenced using manual and automated 
sequencing methods. The sequence of the 3 clones was compared with the M gene of Yamagata-1 virus 
propagated in Vero cells only (Wong et al.. 1989) and the base changes observed are tabulated above. * 
indicates the position at which the sequence for clone 302 reverts from EdM to the Yamagata-1 sequence 
determined by Wong el al (1989).
III.3.7.7 M Gene Sequence of YM-V in MRC-5 Cells Followed by 5 Passages 
in SK-N-SH Cells
The M gene of YM-V passaged 3 times in MRC-5 cells followed by 5 passages in SK-N- 
SH cells was amplified by nested PCR, cloned into pGEMT and sequenced. Three clones
(401, 402 & 403) of this passaged virus were sequenced in full (900 bases). Clone 401
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contained sequence resembling EdM. Clones 402 and 403 contained sequence 
resembling the M gene of Yamagata-1 (Wong el al., 1989), except that the translation 
initiation codon of these clones is not mutated (position 34). These two clones (402 and 
403) are also lacking 4 U-C base transitions at positions 26, 173, 180 and 182, which 
were described by Wong el al. (1989). A transversion at position 354 (A-U) is also 
present in these clones. Clone 402 contained one other base change at position 45. The 
U-C transition observed by Wong el al. (1989) at this position is not present in this clone. 
Clone 403 contains one other transition when compared to the M gene o f Yamagata-1 
virus, at position 73 (U-C). Tables 27 and 28 summarises the differences in the sequences 
of these three clones when compared to either EdM (III.2.2) or the M gene of Yamagata-1 
virus determined by Wong el al. (1989).
Results
Table 27. Comparison of the M gene sequence of clones 402 and 403 o f  YM-V 
propagated in MRC-5 cells followed by 5 passages in SK-N-SH cells with the M 
gene of Yamagata-1 virus described by Wong el al. (1989)
Clone 402 Clone 403
Position Base Change Position Base Change
26 C-U 26 C-U
34 C-U 34 C-U
45 C-U - -
- - 73 U-C
173 C-U 173 C-U
180 C-U 180 C-U
182 C-U 182 C-U
354 A-U 354 A-U
The M gene of YM-V propagated in MRC-5 cells followed by 5 passages in SK-N-SH cells was amplified 
by nested PCR and cloned into the pGEMT vector. Three clones were sequenced using manual and 
automated sequencing methods. The sequence of clones 402 and 403 was compared with the M gene of 
Yamagata-1 virus propagated in Vero cells only (Wong el al., 1989) and the base changes observed are 
tabulated above.
209
Results
Table 28. Comparison of the sequence of the M gene clone (401) of YM-V 
propagated in MRC-5 cells followed by 5 passages in SK-N-SH cells with EdM
Clone 401
Position Base Change
48 G-U
61 C-U
2 22 C-U
457 G-A
The M gene of YM-V propagated in MRC-5 cells, followed by 5 passaged in SK-N-SH cells was amplified 
by nested PCR and cloned into the pGEMT vector. Three clones were sequenced using manual and 
automated sequencing methods. The sequence clone 401 was compared with the published M gene 
sequence of the Edmonston strain of measles virus (Bellini el a!., 1986) and the base changes observed are 
tabulated above.
111.3.8 Conclusions and Discussion
III.3.8.1 Summary of Results
The following tables summarise the results of the M gene cloning reactions from the YM- 
V passage experiment. Table 29 presents the M l3 cloning results, and Table 30 those M 
gene fragments cloned into pGEMT.
Cloning of the M gene o f YM-V has revealed that the initial virus stock provided by 
Professor Homma contains a heterogeneous virus population consisting of both acute 
measles virus M gene (EdM) and Yamagata-1 virus M gene sequences. One of the aims 
of this project was to determine whether passage in neuroblastoma cells alone was 
enough to induce hypermutational events. In the present work, comparing the M gene 
sequence determined from YM-V passaged once in the neuroblastoma cell lines with that 
from YM-V passaged five times did not reveal any additional hypermutation events. In 
the study carried out by Wong el al. (1989) the sequence of the M gene of Yamagata-1
210
Table 29. Sum man of the YM-V M gene clones which were amplified by PCR and 
cloned into the bacteriophage M l3
Results
Passage 1 Passage 3 Passa ItS
Cell type MRC-5
SK-N-SH
IMR-32 MRC-5
IMR-32
SK-N-SH SK-N-SH MRC-5
SK-N-SH
IMR-32 MRC-5
IMR-32
No. Clones 10 25 4 II 19 29 18 21
Measles Vims 5 - 4 11 4 - - -
Unknown 5* 25 - - 15 29 18 19
Homo Sapiens 
cDNA clone
- - - - - - - 1
H influenzae 
recF.dnaF etc.
- - - - - - - 1
The M gene of Yamagata-1 vims, passaged as indicated above, was amplified using the YMP/YM2 primer 
pair. The resulting 1 kb fragment was cloned into the bacteriophage M13 using Sal I and Hind III 
restriction site. Clones were sequenced initially using the -40 primer provided with the Sequenase v2.0 
sequencing kit (USB) to determine whether they resembled measles vims M gene sequence, the unknown 
sequence (Appendix A) or artefacts produced from the cloning reaction. *1/5 unknown sequence 
(Appendix A); 4/5 artefacts produced during amplification and cloning reactions.
virus propagated in Vero cells differed by 41 bases within the first 926 bases of the M 
gene when compared with EdM. The M gene cloned from Yamagata-1 virus passaged 5 
times in IMR-32 cells contained an additional 38 U-C transitions between bases 90 and 
510. A biased hypermutational event was hypothesised to have occurred as a 
consequence of passage of the virus in the neuroblastoma cell line. The sequence data 
obtained from the passage of YM-V in the experiments described here did not contain 
these additional mutations. Thus, it was not possible to repeat the observation reported by 
Wong el al. (1989) (Figure 49). The only type of sequence which was novel to YM-V 
passaged 5 times was the chimeric M gene sequence observed in YM-V passaged 5 times 
in IMR-32 cells and in YM-V propagated in MRC-5 cells, followed by 5 passages in 
IMR-32 cells.
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Table 30. Summary of the YM-V M gene sequences which were amplified by both nested 
and traditional PCR methods
Results
Virus Passage Clone ID EdM-like YM-V-like Chimera Sequence length
YM-V 4 ✓ 1001 bases
5 ✓ 1001 bases
7 ✓ 1001 bases
SP3 8 ✓ 743 bases
10 ✓ 743 bases
18 ✓ 743 bases
S P5 2 ✓ 726 bases
5 ✓ 726 bases
18 ✓ 960 bases
MS PI 1 ✓ 960 bases
11 ✓ 960 bases
14 ✓ 960 bases
•MSP5 401 ✓ 900 bases
402 ✓ 900 bases
403 ✓ 900 bases
*1 PI 101 ✓ 900 bases
102 ✓ 900 bases
103 ✓ 900 bases
*1 P5 202 ✓ 900 bases
203 ✓ 900 bases
204 ✓ 900 bases
Ml PI 1 ✓ 960 bases
2 ✓ 960 bases
6 960 bases
•MI P5 301 s 900 bases
302 ✓ 900 bases
303 ✓ 900 bases
YM-V: virus passaged 102 times in Vero cells; I PI: virus passaged once in IMR-32 cells; I P5: virus 
passaged 5 times in IMR-32 cells; MI PI: virus grown in MRC-5 cells followed by once passage in IMR- 
32 cells; Ml P5: virus grown in MRC-5 cells, followed by 5 passages in IMR-32 cells; S P3: virus passaged 
3 times in SK-N-SH cells; S P5: virus passaged 5 times in SK-N-SH cells: MS PI: virus grown in MRC-5 
cells, followed by one passaged in SK-N-SH cells: MS P5: virus grown in MRC-5 cells, followed by 5 
passages in SK-N-SH cells. M gene of YM-V was amplified using the YMP/YM2 primer pair and cloned 
into the bacteriophage M l3. The sequence was determined using the Sequenase sequencing kit (USB). * 
indicates M gene products that were amplified using nested PCR (YM5/YM2 and MM02/YM6 primer 
pairs). The resulting fragment was cloned into the pGEMT vector (Promega) and sequenced using both 
manual and automated methods.
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Results
Figure 49. Summary of the M gene sequence determined by Wong et al. (1989)
Y a m a g a ta -1  v iru s  p a s s a g e d  in  V e r o  c e l ls  o n ly  ____* c o -c u lt iv a te d  w ith  e m b ry o n ic  lu n g  c e l ls
1
in fe c tio n  o f  1 M R -3 2  c e l ls  (5  p a s s a g e s )
v iru s  h a r v e s te d  a n d  c D N A  c lo n e d .
O v e r  th e  e n t ir e  M  g e n e  a n  to ta l  9 6  b a s e  
d i f f e r e n c e s  c o m p a re d  w i th  E d M
( 1 )  in fe c t io n  o f  V e ro  c e l ls
v iru s  h a rv e s te d  a n d  c D N A  c lo n e d .
M  g e n e  s e q u e n c e  c o m p a re d  w i th  (1 )  
c o n ta in e d  3 8  a d d i t io n a l  U -C  b a s e  c h a n g e s  
o c c u r r in g  w ith in  a  4 0 9  n u c le o t id e  r e g io n  
9 4 -5 0 2  n t)
(2)
T h e  Y a m a g a ta -1  v iru s  p a s s a g e d  p r o to c o l  a n d  a  s u m m a ry  o f  th e  r e s u l ts  o b ta in e d  b y  W o n g  et al. ( 1 9 8 9 ) .  
p o ly  A * m R N A  w a s  r e v e r s e  t r a n s c r ib e d  to  c D N A  u s in g  o l ig o  T  p r im e r .  T h e  re s u l t in g  c D N A  w a s  c lo n e d  
a n d  s e q u e n c e d .  F o u r  f u r th e r  c lo n e s  o f  1 M R -3 2  p a s s a g e d  v iru s  w e re  e v a lu a te d  fo r  r e s t r ic t io n  e n z y m e  
p o ly m o r p h is m  w h ic h  s h o w e d  th e  p r e s e n c e  o f  a t  le a s t  tw o  d is t in c t  M  g e n e  p o p u la t io n s ,  a l th o u g h  n o  fu r th e r  
s e q u e n c in g  w a s  c a r r ie d  o u t  o n  th e s e  c lo n e s .
Furthermore, propagation of YM-V in human diploid cells prior to passage in the 
neuroblastoma cell lines did not have any effect on the propensity for hypermutational 
events. There was no difference between the sequences obtained from YM-V which had 
been grown in MRC-5 cells before passaged in IMR-32 cells or SK-N-SH cells when 
compared with YM-V which had only been passaged in the neuroblastoma cells.
Two clones from YM-V passaged 5 times in IMR-32 cells (I P5 clones 202 and 203) and 
one clone from YM-V propagated in MRC-5 prior to 5 passages in IMR-32 cells (MI P5 
clone 302) were chimeras containing both EdM-like sequence and the M gene sequence 
of Yamagata-1 virus (Wong el al., 1989). This suggests that recombination between
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acute measles virus M gene and the mutated M gene associated with SSPE viruses had 
occurred.
III.3.8.2 Sequence Anomalies
The sequence data derived from three clones from YM-V passaged 3 times in SK-N-SH 
was 743 bases, whereas both the amplified product (Figure 37) and the inserted fragment 
in the vector M13 (Figure 38) was shown to be 1000 bases as expected. The reason for 
this discrepancy is unclear. A possible explanation is that the oligo dT primer used to 
synthesize the cDNA primed at the position 743/ AAAATGAAAATCGAAAA /760. The 
mRNAxDNA hybrid formed after cDNA synthesis would be 760 bases long. The YMP 
sequence would anneal to the negative sense cDNA, and amplify a fragment of 
approximately 760 bases which would contain Hind III ER site at both the 3' and 5’ end 
because the oligo dT primer contained the Hind III ER site which was one o f the enzymes 
used to clone the PCR fragments. One problem with this interpretation is that both the 
amplified product and the insert were shown to be 1000 bases (Figures 38 & 40) not 760 
bp w hich w ould be expected. If oligo dT mis-priming had occurred, the vector stock may 
not be contaminated with M13mpl9. The PCR fragment would contain Hind III sites at 
both ends, therefore, the exact orientation of the insert could not be ascertained until the 
positive clone was sequenced. However, the vector was digested with both Hind III and 
Sal I so an insert containing Hind 111 ER sites at both ends would not ligate into this 
vector.
Results
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Sequencing errors occurring at position 743/ AAAATGAAAATCGAAAA /760 might 
explain this anomaly. Errors during the sequencing reaction could reduce this sequence 
to a poly A tail, however, the 11 bases preceding the poly A tail (Figure 42) do not 
correspond with either the YM2 primer nor the M gene sequence directly after base 760.
The YM2 primer sequence was not observ ed in any of the 3 clones for this virus passage. 
It was possible, therefore, that contamination of the Ml 3 vector stock with the ADD-MV 
has occurred. The observation that the sequence of these 3 clones is exactly the same 
length as that determined for the M gene of ADD-MV passaged once in each of the four 
cell lines favours this, but does not account for the size of the insert being 1000 bases as 
expected (Figure 38).
It is also possible that the -40 primer has mis-primed. At position 957 to 941 of the M 
gene there is 53% homology with the -40 primer. This is not a high identity overall, 
however, the 3'-end o f the primer, which requires strong homology in order for the entire 
primer to anneal, has 100% identity over 5 bases. As such the -40 could have annealed at 
this position. This still does not explain why bases 744 to 941 were not determine, 
however, this could have been resolved by electrophoresis of the -40 sequencing reaction 
for <2 hrs in order to try to determine sequence nearer the primer. Also the deaza- 
reactants in the sequencing kit could have been used in order to sequence nearer the 
primer.
Two clones from YM-V passaged 5 times in SK-N-SH produced sequence that was 726 
bases instead of the expected 1000 bases. The most likely explanation for this is the
Results
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1introduction of a Sal I restriction site due to a U-G base change at position 726. As this 
ER site was used in the cloning procedure the amplified fragment to be cloned would be 
digested at this position, so the inserted sequence would be of a reduced size.
III.3.8.3 Discussion
The observation that the original virus stock was a heterogeneous population was made 
after YM-V passage in the neuroblastoma cells had been initiated and the cloning of 
passage one had been completed. Had the passage and cloning of YM-V not been so 
advanced, a more controlled experiment would have been carried out in which the YM-V 
stock was plaque-purified and then passaged. The M gene sequence of the biologically 
cloned virus would have to have been determined to ensure that the material for passage 
was the same genotype as that described by Wong el al. (1989).
It is possible that the passage protocol may have selected for virus with a lytic phenotype, 
but no assays were done to confirm this, such as titres of the virus after each passage. If a 
lytic phenotype was being positively selected one would expect to see an increase in virus 
titre during the passage experiments. However, for each passage two 25 cm2 flasks were 
infected, one of which was freeze/thawed and aliquoted into 1 ml portions as an RNA 
source, the remaining flask was treated with EDTA/Trypsin and the dispersed cells used 
as the inoculum for subsequent passage. Thus, reinfection was mediated by cell- 
associated rather than released virus and selection for lytic virus seems unlikely.
Results
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A low titre. less than 1000 pfu/ml, was determined from YM-V passage 96. Homma et 
al. (1982) also reported a titre o f  less that 1000 pfu/ml from the newly isolated Yamagata- 
1 virus, and in the study carried out by Wong et al. (1989) a titre of 2xl02 pfu/ml was 
determined from virus passaged in the IMR-32 cell. Thus, it is probable that the 
Yamagata-1 virus isolated from autopsy material contained acute measles virus and that 
the EdM M gene sequence isolated in the experiments described here was not a 
consequence of contamination during the passaged o f YM-V.
An independent study carried out by Baczko et al. (1993) detected both wild-type-like 
measles virus M gene sequence and hypermutated sequence in brain tissue from an SSPE 
patient. This information and the finding of this project, that EdM sequence can be 
detected in SSPE vims isolates, suggests that the acute measles vims M gene does not 
represents a contaminating virus. It is likely that the acute measles vims M gene detected 
represent the vims which initially infected the CNS of the patient from which Yamagata- 
1 vims was isolated. Vims populations with defective M genes are most likely selected 
for once the acute vims has entered neural tissue. Non-defective measles vims genomes 
are probably present in the brain during the progression of the disease, but at such low 
levels that they are not easily identified when extracting RNA directly from brain tissue.
In the study carried out by Bazcko et al. (1993), cDNA synthesised from RNA extracted 
from different regions of the brain was cloned directly. Fifteen percent o f the clones 
sequenced were ‘wild-type-like’, the remainder contained the U-C transitions associated 
with SSPE vims. Of the 27 clones sequenced in this project, 41 % contained EdM-like M 
gene sequence; 48% contained the mutated M gene sequence associated with Yamagata-1
Results
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virus M gene (Wong et al.. 1989) and 11% were chimeras i.e., contained both EdM-like 
sequence and the mutated M gene sequence determined by Wong et al. (1989). The 
higher frequency of the EdM-like sequence may not be a true representation of the 
concentration of plaque-forming virus as the M gene sequence used for cloning was 
produced by PCR amplification. When the proportion of EdM clones and hypermutated 
M gene clones are compared using the regular PCR method (one set of primers) and 
nested PCR (two sets of primers), the more specific nested PCR method produced 58.3 % 
of clones containing the hypermutated gene; 16.6 % containing the EdM-like gene and 
25% were chimeric clones. Whereas the cloning reaction where the M gene was 
amplified using the regular PCR method resulted in 40% of the clones containing 
hypermutated M gene sequence and 60% of the clones containing EdM-like sequence 
(Table 31). As such the nested PCR results correlate more closely with that of Baczko el 
al.. (1993).
Mutated sequences obtained from M genes cloned into both M l3 and pGEMT did not 
contain the U-C base changes at nucleotide positions 173, 180 and 182 observed by 
Wong et al. (1989). The clones isolated in this experiment were prepared by amplifying 
the M gene of the passaged vims after cDNA synthesis, therefore, the most abundant M 
gene variant present in vims population was cloned. Although some small variation was 
seen within the clones isolated and sequenced they all resembled the M gene sequence of 
Yamagata-1 vims propagated in Vero cells (Wong et al.. 1989) or the EdM (III.2.2) 
sequence. The sequence of vims passaged in the IMR-32 cells, as determined by Wong 
el al. (1989) contained 38 additional base changes when compared to vims passaged only 
in Vero cells. However, the clones sequenced in that study were from cDNA, so a more
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precise picture of the pre-existing variants would be observed. The M gene sequences 
determined in virus passaged 5 times in the neuroblastoma cell lines in the experiment 
described in this thesis were also detected in the YM-V starting material, except the 
chimeric species. It is likely, therefore, that the hypermutated clone sequenced after 5 
passages in IMR-32 determined by Wong el al. (1989) represents a pre-existing variant 
which is not the predominant variant of M gene within the virus population, explaining 
why it was not detected during the experiments detailed in this thesis.
Recovery of the unknown sequence (Appendix A) from various virus passages was not 
fully examined. The attempts at identification of this material are discussed in more 
detail in appendix A. The use of nested PCR to amplify the M gene of YM-V was 
successful. The nested PCR M gene fragments cloned into the pGEMT vector were more 
heterogeneous than those cloned into M l3. The translation initiation codons of these 
clones were not destroyed by a U-C mutation at position 34, unlike the M l3 clones and 
the Yamagata-1 M gene sequence described by Wong el al. (1989). This suggests that 
intact M protein could be translated from the mutated M gene. The open reading frame 
(ORF) of such clones was maintained throughout the 950 base pair fragment sequenced. 
Baczko el al. (1993) also detected mutated M gene sequence both with and without the 
translation initiation codon. It is likely that a minimal population of YM-V-type virus is 
present which retains the ORF allowing the expression of the M gene. It is possible that 
the small number of base changes observed between the different clones probably 
represents polymerase errors during the amplification of the M gene, rather than pre­
existing variants of the M gene within the virus population.
Results
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Two chimeric clones were detected; one contained M gene sequence that resembles the 
ADD-MV at the 5' end. and the Yamagata-1 virus M gene at the 3' region. Another clone 
contained ADD-MV M gene sequence at the 3' region, and Yamagata-1 M gene sequence 
at the 5' region (Figure 50). A common feature is that the base change at position 457 (G- 
A) was where the distinction between Yamagata-1 virus-like sequence and ADD-MV-like 
sequence occurred. This base change is one of the two observed in the M gene which 
differentiated the ADD-MV sequence from that described by Bellini et al. (1986). This 
may be the first evidence of intragenic recombination in measles virus.
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• General Discussion
This part of the thesis should complement and round-off the discussions at the end of the 
three results chapter. The mechanism of biased hypermutation and exposure of measles 
virus RNA to the DRADA enzyme will be discussed first. The role o f truncated M 
protein in measles virus infections is discussed further, along with examples of RNA 
editing resulting in potential truncation of proteins in other viruses. The possible 
mechanisms which would result in the insertion o f the mitochondrial tRNA are discussed 
in detail, along with mechanisms which could account for the chimeric YM-V clones 
isolated. The YM-V cloning results using the general and nested PCR method are 
discussed and suggestions why the more highly mutated M gene sequence from YM-V 
passaged in neuroblastoma cell lines was not observed. Finally, further experimentation 
which could clarify some of the results observed during this project is suggested.
IV.1.1 Biased Hypermutation
The mechanism suggested to account for the biased hypermutation seen within the M 
gene of SSPE virus material isolated from autopsy brain material involves the action of 
double-stranded RNA adenosine deaminase - DRADA- previously referred to as double- 
stranded RNA unwindase/modifying enzyme. The production of U-C transitions 
observed within the M gene of measles virus is hypothesised to occur by the deamination 
of adenosine to inosine in both negative and positive sense measles virus RNA (1.2.2.2). 
This activity was originally localised exclusively in the nucleus of mammalian somatic 
cells (Wagner el al., 1990), consequently, it is unlikely that under normal conditions 
measles virus RNA would be a substrate since measles virus replication takes place in the 
cytoplasm of the cell. However, it has been shown that the production of infectious 
measles virus particles in enucleated cells does not occur (Follett et al., 1976), thus, it is
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possible that under some circumstances the replicative cycle of measles virus may have 
some dependence on the host cell nucleus since nucleocapsid structures have been 
observed in the nucleus of infected cells (Dubois-Dalaq et al., 1974b). It is possible that 
in persistently infected cells the virus genome may be exposed to this enzyme activity at 
some stage of the cell cycle i.e., mitosis, however, the neuronal cells of the CNS are fully 
differentiation and, therefore, do not undergo cell division.
It has been shown that there are two forms o f the DRADA enzyme; pi 10, which appears 
to be located exclusively in the nucleus and is constitutively expressed, and a p i50 form 
which is interferon-inducible and located in both the cytoplasm and the nucleus (Patterson 
& Samuel, 1995). Type I interferon (a and p) has been shown to be induced in brain cells 
during persistent measles virus infection, leading to the induction of the MxA protein 
which actively interferes with measles virus replication (Schneider-Schaulies et al., 
1994a). If DRADA is also induced then the cytoplasmic location of this enzyme would 
allow the measles virus genome to become exposed to this enzyme.
Whether biased hypermutation occurs as a result of the activity of DRADA in-vivo 
remains undetermined. As this enzyme is ubiquitous it seems unlikely that measles virus 
associated with the CNS is its only target. A-G hypermutation has been described in the 
provirus of an avian retrovirus (Hajjar & Linial, 1995), vesicular stomatitis virus (O’Hara 
et al., 1984) and in two escape mutants o f huRS virus (Rueda et al., 1994). More 
recently, RNA editing of hepatitis delta virus (HDV) negative sense RNA (anti-genomic) 
by DRADA has been observed, resulting in the production of the larger hepatitis delta 
antigen (HDAg-p27) (Poison et al., 1996). The fact that other RNA viruses have been
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shown to exhibit hypermutations, and that DRADA activity does have a functional role in 
HDV, suggests that this phenomenon may be a naturally occurring event in virus 
replication.
In measles virus pre-existing hypermutated variants might be positively selected during 
the development of a persistent infection within the CNS. It has been hypothesised that 
the DRADA enzyme directs the deamination of adenosine residues in both strands of 
duplex RNA, suggesting that the U-C transition observed in positive sense mRNA 
correlates with an A-G transition in the negative sense genome (Bass el a i,  1989). 
However, it should be noted that double-stranded RNA is not an intermediate in measles 
virus replication, thus double-stranded RNA is only likely to occur as a result of local 
collapse of mRNA onto the negative strand template during synthesis.
All sequence data from the M gene of SSPE virus has been carried out by cloning cDNA 
derived from poly A RNA i.e. plus sense mRNA. Confirmation of the A-G transition in 
the negative sense RNA genome needs to be undertaken to confirm whether 
hypermutations can occur in both strands of duplex RNA. Alternatively, error prone 
RNA polymerase complexes could possibly be responsible for biased hypermutation by 
incorporating U or C residues when copying A residues. Imbalances in the nucleotide 
pools may also be responsible for hypermutational events. G-A hypermutation in the 
HIV type I genome has been shown to be related to fluctuations in the intracellular dCTP 
pool which force the viral reverse transcriptase into making errors (Vartanian et ai,
1994).
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Biased hypermutated M gene species were not observed in the experiments described in 
this thesis. This would not be an unexpected result in virus passaged in Vero cells, as the 
activity of DRADA in this cell line is low (Rataul et al., 1992). However, in the 
neuroblastoma cell line, IMR-32, the activity of this enzyme was found to be substantially 
higher. In-vitro synthesised 5 sense and anti-sense oligos corresponding to the M RNA 
from the Edmonston strain o f measles virus was found to be a substrate for DRADA from 
the nuclear (Rataul et al., 1992) and cytoplasmic (Ecker et al., 1995) extracts of IMR-32 
cells, also double-stranded M gene fragments and double-stranded RNA covering the 
entire M gene were found to be substrates for DRADA (Ecker et al., 1995). Therefore, it 
is surprising that hypermutated M gene was not observed in these experiments. It is 
possible that a sub-population of M gene species was hypermutated, but due to the 
procedures used a true representation of the M gene population present was not 
determined (III.2.4.4). In the experiments reported here the M gene clones isolated from 
passaged Yamagata-1 virus did not exhibit additional hypermutational events as a 
consequence of propagation in the neuroblastoma cell lines, which is contrary to the 
findings of Wong et al. (1989). The cloning procedures described (III.3.2 & III.3.7.2) 
may not have been adequate to reveal a minority component. Ecker et al. (1995) found 
that measles virus sequences already exhibiting hypermutation were less efficiently 
modified by DRADA in-vitro, when compared to the Edmonston strain sequence. 
Therefore, the presence of more highly mutated M gene sequence in the Yamagata-1 virus 
population would, theoretically, be more difficult to detect.
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The clones of ADD-MV M gene showed that the 3’ region of the gene was deleted. As 
already stated (III.2.4.4) there are several possible explanations as to how this may have 
occurred. The recovery of a 800 base fragment when using primers designed to amplify 
the entire M gene (1.4 kb), suggests that mis-priming may have occurred. However, the 
sequencing data confirmed the presence o f the 3’-end primer (MMOl) binding sequence. 
This sequenced defined the end of the clone. If the MMOl primer had been mis-priming 
one would expect to detect ADD-MV sequence following the primer binding sequence. 
This was not observed which suggests that these deleted M genes are present in the 
original ADD-MV stock. Some sequence heterogeneity was observed in the 24 clones 
sequenced in full. This may reflect polymerase malfunction during amplification of the 
M gene. Upto 5 base changes, when compared to EdM, were observed in any one clone. 
Therefore, the error rate of the polymerase when amplifying a 750 base pair fragment 
would have to be at least 0.66%, a rather high figure. Another possibility is that these 
different clones may represent pre-existing variants of the measles virus M gene, 
suggesting that this virus may exist as a quasispecies.
The translation initiation codon of the M gene ORF was intact in all 24 clones, however 
the stop codon was deleted. Potential stop codons are present down stream from the 
deletion in all but two of the clones, thus, it is possible that aberrant proteins could be 
translated. The expression of the aberrant M proteins has not been confirmed. An N gene 
deletion mutant, Alb4, has been isolated from the coronavirus, mouse hepatitis virus. 
This mutant contained an 87 nucleotide deletion at the 3’-end of the N gene, however, a
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translatable ORF remained intact (Koetzner et al., 1992). Initially, the full length M gene 
could be amplified, suggesting that an intact M gene is present, albeit at a lower 
concentration, so that this species of M gene was not readily amplified in these 
experiments. If the proteins expressed from the deleted clones are functional, it implies 
that the 3' region of the gene is not essential for the replication of measles virus in 
cultured cells. Other examples of truncated genes have been reported. A T-A mutation in 
the H gene of 4 out o f 5 measles virus isolates from the Coventry area creates an early 
termination signal. The predicted H protein would be truncated by 35 amino acids at the 
C-terminus, which could result in the loss of a neutralising epitope (Outlaw & Pringle,
1995). mRNA editing can result in production of truncated gene products. For example, 
at the 3’-end of the G protein mRNA of huRS virus there is a run of A residues. 
Occasionally an A base is deleted or inserted within this region of the gene, producing 
frame-shifts in the ORF which result in the translation of truncated proteins (Garcia- 
Barreno et al., 1990; Cane et al., 1993; Dr. J. Evans, University of Warwick, personal 
communication). As such, mRNA editing resulting in the production of aberrant proteins 
appears to be a relatively common phenomenon.
The size of the deleted region in the M gene clones varied, and there was some 
heterogeneity in the M gene sequence. The heterogeneity of the clones of the M gene of 
ADD-MV indicates that measles virus may exist as a quasispecies. Baczko el al. (1993) 
carried out a study which involved the cloning of measles virus M gene from several 
regions of the brain o f an SSPE patient. The cloning strategy should have resulted in full 
length M gene clones, however, approximately 80% of the clones sequenced contained 
deletions of various lengths within the 3’ region of the gene. Both wild-type-like
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sequence and hypermutated M gene sequence were observed, and in-situ hybridisation 
using probes to both negative and positive sense RNA produced signals, which suggests 
that both acute virus and ‘SSPE virus’ are replicating within the brain tissue of SSPE 
patients. Approximately 15% of the sequences determined were of wild-type-like genes. 
Positive sense cDNA clones of the M gene of measles virus from two SSPE patients (A 
and B) were sequenced by Cattaneo et al. (1988), patient B being the same patient used in 
the study carried out by Baczko et al. (1993). Some of the M gene clones were found to 
be incomplete at the 3’ end. Deletions ranging from 90 to 632 nucleotides were observed. 
One of the clones sequenced contained a deletion at nucleotide position 756, which 
introduced a frame-shift resulting in the production of a stop codon at position 793-795. 
It was hypothesised that an altered M protein would be translated. Using the rabbit 
reticulocyte lysate system this deleted clone was translated, and a protein with a apparent 
molecular weight of 25 kD was detected.
As deleted M gene clones have been detected in both ADD-MV and from viral RNA 
extracted from brain tissue of an SSPE patient, it seems likely that hypermutation events 
may not be restricted to full length M gene RNA, but can also occur to the defective M 
gene population already present. The presence of the deleted M gene species cannot be 
related to passage history, as the smaller PCR fragment could be generated from both 
early and late passaged virus. It seems likely that viruses with these defective genes are 
present in the original virus stock. However, the concentration of the defective genomes 
may have increased during in-vitro passage of the virus. The virus titre o f ADD-MV 
passaged in Vero cells, a cell line highly permissive for measles virus propagation, did 
diminish during passage. This may reflect an increase in the relative concentration of
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defective interfering particles. Alternatively, Lecouturier et al. (1996) have suggested 
that multiple virus passage in Vero cells selects for measles virus isolates with affinity for 
CD46, the putative measles virus receptor. Measles virus infection via the CD46 receptor 
molecule leads to down-regulation of the receptor, which may result in attachment and 
entry of fewer virus particles and a fall in virus titre.
It is possible that the deleted M gene was amplified from measles virus particles with 
defective genomes within the virus population. The high proportion of deleted M genes 
is not consistent with the moderated level of infectivity observed. DI particles have been 
suggested to play an important role in development of persistent infections. However, 
there was no obvious reduction in virus titre over the 10 passages of ADD-MV in each of 
the four cell lines which suggests that the phenotype of the virus was not changed. If the 
concentration of DI particles was high one might have expected that the infection would 
develop to a persistent phenotype. To determine whether DI particles were present in 
high concentration the virus preparations should be examined by limiting dilution 
infections. If DI particles are present, diluting the inoculum will reduce the 
concentration, and at a dilution where there is minimal interference from DI particles the 
titre of that virus would be expected to increase.
To investigate the deleted M gene products further, they could be sub-cloned into 
expression systems, and the resulting protein purified and detected via western blot using 
either polyclonal measles virus antisera or monoclonal antisera that was raised to an 
epitope within the amino terminal region of the M protein. The ability of the protein 
expressed from the deleted M gene clones to interact with the nucleocapsid and, possibly
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the membrane associated proteins could also be explored. However, as the 3’-end of the 
mRNA is deleted is unlikely that the translated protein would interact with the F and H 
proteins as it is the carboxy terminus that is thought to be responsible for this interaction.
IV.1.3 Evidence of Recombination in Measles Virus
A 54 base insertion has been reported in the HA gene of influenza virus, a segmented, 
negative-sense RNA (Khatchikian et al., 1989). The inserted nucleotide sequence 
resembled a region of the 28S ribosomal RNA. The suggested mechanism for this type of 
recombination was that the rRNA was used as a template during the synthesis of positive- 
stranded viral RNA from the negative-sense template by polymerase jumping. 
Recombination has been reported for most positive strand RNA viruses and non- 
homologous recombination is thought to be responsible for the presence of a modified 
cellular tRNAAsp at the 5’ terminus of naturally-occurring DI RNA’s of Sindbis virus 
(Monroe & Schlefinger, 1983). The cellular gene sequence ubiquitin has been shown to 
be integrated into the positive sense RNA genome of bovine viral diarrhoea vims 
(BVDV) (Meyers et al, 1991). The absence of recombination in non-segmented negative 
sense RNA viruses is thought to be a consequence of the encapsidation of replicative 
RNA.
In 13 of the 24 ADD-MV clones sequenced in this project, a 50 base insertion was 
observed. This sequence has high percentage identity with human mitochondrial Leu 
transfer RNA (tRNALeu). Whether non-homologous recombination could occur between 
viral RNA and mitochondrial tRNA is unknown. Mitochondria are capable of DNA
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replication, mRNA synthesis and protein synthesis. However, mitochondrial RNA is not 
usually present in the cell cytoplasm which is the site of measles virus replication. Two 
5'- and 3'-endonucleases (mitochondrial RNase P and nuclear RNase P) and an ATP(CTP) 
nucleotidyltransferase are required to process human mitochondrial tRNA precursors 
(Rossmanith et al, 1995). Both mitochondrial and nuclear RNase P recognise (mt)pre- 
tRNALeu as a substrate. However, (mt)pre-tRNATy  is cleaved by mitochondrial RNase 
P, but is not a substrate for nuclear RNase P. (mt)pre-tRNALeu is the most conventional 
mitochondrial tRNA in that it retains many of the nucleotides that are conserved in non­
organelle tRNAs (Anderson et al, 1981; Kim et al, 1974). Its tertiary structure may, 
therefore, be more similar to cytoplasmic tRNAs than that of other mitochondrial tRNAs. 
The 50 base insertion may, therefore, be a cytoplasmic tRNA that has been processed by 
the nuclear RNase P. This would be located in the cytoplasm although why it should 
recombine with measles virus RNA during viral replication is unclear.
Recombination by a cross-over event requires two areas o f homology between the 
sequence that is integrated and the target sequence. Once recombination has taken place 
there is no obvious homology at the site of integration. No homology is observed at the 
site of integration of the tRNALeu and the M gene o f measles virus, suggesting that non- 
homologous recombination may have taken place. If transpositional recombination had 
occurred short repeats of target sequence i.e., measles vims M gene sequence, would be 
observed surrounding the integrated sequence. This method of recombination is 
mediated by an integrase enzyme, which would have to be encoded by the mitochondrial 
DNA as the material to be integrated is of mitochondrial origin. Mitochondria are 
thought to have evolved from endocytosed bacteria, and many of the genes encoding
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mitochondrial proteins are located in the cell nucleus, which suggests that extensive gene 
transfers from organelle to the cell nucleus had occurred. However, the sequence of the 
genome of human mitochondria has been determined and sequence encoding an integrase 
enzyme has not been found. Integrases are present within cells, although they do tend to 
be specific for a particular transposon, therefore, it is unlikely that this method of 
recombination was responsible for the generation of the clones containing the 50 base 
insertion. The fact that the inserted sequence was found in the same region of the M gene 
in each clone is probably a consequence of the experimental protocol, namely, the clones 
were generated from PCR products, so each clone may have been generated from the 
same cDNA species. The slight variation in the sequence of the clones may represent 
polymerase errors during the amplification procedure.
The possibility that the 50 base insertion observed in the M gene clones of ADD-MV was 
a PCR artefact can not be entirely dismissed. If regions of homology between ADD-MV 
M gene and mitochondrial genome flanked the mitochondrial tRNALeu sequence and the 
mitochondrial genome was positioned close to the M gene of ADD-MV at these regions, 
it is possible that the polymerase could slip from the M gene o f ADD-MV to the 
mitochondrial genome (Figure 51). At another region of homology downstream the 
polymerase could then slip back onto the M gene which would result in the insertion of 
the tRNA.
This explanation could also account for the observation of deleted M gene clones. Rather 
than the polymerase slipping onto the mitochondrial genome, the region of the M gene 
not homologous to the mitochondrial sequence could loop-out, and the polymerase could
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slip across the junction, resulting in an apparent deletion in the M gene (Figure 52). 
Homology between the M gene of measles virus and the mitochondrial genome may not 
be necessary for such a loop to occur. Regions of homology within the M gene of 
measles virus itself may base pair, resulting in the formation of a loop, which the 
polymerase could jump across, producing a deletion within the gene.
Figure 51. Possible mechanism for the 50 base insertion by PCR artefact
nt. 600-700 nt. 1300-1400
Key: * route taken by polymerase
c— 3 polymerase 
*j^_P| mitochondrial genome
---------M gene cDNA
The entire length of mt-tRNA1 eu is only 75 nucleotides and the inserted sequence is 50 
nucleotides, therefore, if homology was occurring between the M gene and mitochondrial 
sequence, it would have to be somewhere else within the mitochondrial genome. To 
determine if this was indeed occurring regions of identity between the M gene of ADD- 
MV (accession number: U01981) and the human mitochondrial genome (accession 
number: J01415) were searched for using the Genetics Computer Group (GCG) program.
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Figure 52. Possible mechanism for M gene deletions by PCR artefact
Key: ► route taken by polymerase
c——3 polymerase
mitochondrial genome
---------M gene cDNA
Only one region of identity was found, this corresponded with the M gene at nucleotide 
position 246-277, and the mitochondrial genome at 1266-1297. Within this region there 
was a 71.9% identity. The position of the tRNAUu within the mitochondrial genome is at 
nucleotides 3231-3305, and the insertion in the M gene of ADD-MV occurred at 
nucleotide position 671-1348. If the insertion had occurred as consequence of PCR error, 
there would have to be homology at or around nucleotide positions 670 and 1340 on the 
M gene of ADD-MV, and, 3200 and 3300 on the mitochondrial genome. This was not 
found. In order to full investigate the possibility of PCR error, identity between the M 
gene of measles virus and the mitochondrial genome surrounding the tRNAlcu were 
determined. A 40 nucleotide base sequence 5’ to the tRNAl cu was found to have some 
identity with the M gene at nucleotide position 384-401. Within this 18 base region 14 
(77.8%) bases were identical. However, the position within the M gene were the identity 
was found does not correlate with the position of the inserted sequence. A 30 nucleotide
236
General Discussion
sequence 3’ to the tRNALeu was also used to search for identity with the M gene of 
measles virus. An 11 base region of the 30 base query sequence contained 90.9% identity 
with the M gene, however, the position within the M gene where this occurred was 383- 
393, not were the inserted sequence occurred. It, therefore seems unlikely that the 
insertion occurred as a consequence of PCR error.
The sequence of two chimeric clones derived from YM-V also suggests that 
recombination may occur rarely, possibly as a consequence of a delay or failure in 
encapsidation of replicative RNA. One M gene clone (III.3.7.4) from Yamagata-1 virus 
passaged 5 times in IMR-32 cells contained sequence corresponding to the M gene of 
Yamagata-1 virus (Wong et al., 1989) up to position 457 (G-A) after this base change the 
sequence reverted to that of EdM (Bellini et al., 1986). An M gene clone of YM-V 
propagated in MRC-5 cells followed by 5 passages in IMR-32 cells (III.3.7.6) contained 
EdM-like sequence up to position 457, after this base change the sequence reverted to that 
of the M gene of Yamagata-1 virus (Wong et al., 1989). This could be an example of 
homologous recombination between the lytic measles virus genome and the cell- 
associated Yamagata-1 virus. Homologous recombination involves the exchange of two 
comparable RNA regions at precise locations. The site of the recombination between 
these two virus populations appears to be position 457. The G-A base change at position 
457 is the only nucleotide substitution which is common to both the M gene sequence of 
ADD-MV passaged once and 10 times in all four cell lines used in these experiments and 
the Yamagata-1 virus M gene sequence determined by Wong et al., 1989. These data 
suggest that homologous recombination between negative-sense RNA viruses is possible. 
Template switching by the polymerase is a possible explanation for the generation of
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these clones. However, it should also be considered that these recombinant M gene 
sequences may have been amplified from DI genomes.
IV.1.4 Yamagata-1 Virus - a Heterogeneous Population
The initial conclusion made from the sequencing data of the YM-V clones was that the 
virus population was heterogeneous. The EdM sequence was observed along with the M 
gene sequence of Yamagata-1 virus determined by Wong el al. (1989). These findings 
are similar to those of Baczko el al. (1993) who determined, using autopsy material from 
an SSPE patient (B), that hypermutated measles virus expanded clonally from several 
sites throughout the brain, but differs from the results of Wong el al. (1989), who found 
that passage of the Yamagata-1 virus in the neuroblastoma cell line resulted in the 
production of additional mutation within the M gene when compared to virus passaged in 
Vero cells only. In that study wild-type M gene sequence was not detected, however, the 
number of clones analysed was much fewer than that done in the experiments detailed in 
this thesis, or the study carried out by Baczko el al. (1993).
The wild-type-like sequence (group B l) described by Baczko el al. (1993) contained 5 
base changes when compared to the most closely related acute disease measles virus M 
gene sequence. Group B2 contained sequence similar to that of B l, except that 13 U 
residues were replaced by Cs. This virus group contained mutated M genes but the 
translation initiation codon was intact and so the M protein could be translated. The M 
gene fragments of YM-V cloned into the vector pGEMT (III.3.7) in this project were 
similar to that of group B2, determined by Baczko el al. (1993). These clones did contain
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a mutated M gene sequence when compared to EdM, but the translation initiation codon 
was intact, so a full length protein could be produced. Hypermutated M gene clones from 
groups B3, B4 and B5, determined by Baczko et al. (1993) contained a mutation which 
destroyed the translation initiation codon. The M gene fragments of YM-V, which 
resembled the M gene of Yamagata-1 virus (Wong et al., 1989), cloned in the 
bacteriophage M l3 also contained a mutation which destroyed the translation initiation 
codon. Although their was no evidence of expansion of the degree of hypermutation 
within the clones isolated from passaged YM-V in this project, M gene clones were 
isolated which contain both intact and non-functional translation initiation codons, so in- 
vitro isolated clones, to some extent, did follow a similar pattern to those isolated from in- 
vivo i.e., isolated from autopsy material.
As the study of Baczko et al. (1993) has isolated both wild-type-like M gene clones and 
hypermutated M gene clones, it seems unlikely that the EdM clones isolated in this 
project, from the YM-V passaged material, represent a contaminating virus. The majority 
of the clones (80%) isolated by Baczko et al. (1993) contained deletions within the 3’-end 
of the gene. Although such deleted M gene fragments were detected from passaged 
ADD-MV, none were isolated from the passaged YM-V. This is an unusual result in that 
one might expect to detect more defective genes from virus with a persistent phenotype as 
DI particles are predicted to have a role in the development of persistence (Huang & 
Baltimore, 1970). As acute virus (or wild-type-like) M gene clones were detected from 
the brain material of patient B (Baczko, et al., 1989) resembled that of the measles virus 
strain JB, it is possible that this strain of measles virus was the initial infective agent and 
that deleted M genes were present within the virus population. These deletion mutants
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appear to have also undergone hypermutation. The progenitor strain of Yamagata-1 virus 
is not known. It is possible, therefore, that the acute disease progenitor of Yamagata-1 
virus does not produce deleted M gene species during an acute infection. If this was the 
case one would not expect to isolate such species from the mutated virus. However, the 
primer (YM2) used to amplify the Yamagata-1 virus M gene is positioned within the 
region of the M gene which was deleted from the ADD-MV population. It is unlikely, 
therefore, that deleted M gene would be amplified using this primer. To determine 
whether a sub-population of deleted M gene is present, the amplification procedures 
would need to be repeated using a primer which would anneal at the 3’ end of the gene.
The percentage of EdM sequence and YM-V sequence was compared between the two 
methods of M gene amplification i.e., traditional PCR and nested PCR. The nested PCR 
results correlated with the results from the study of Baczko et at. (1993). Approximately 
16% of the clones obtained using nested PCR were of the EdM sequence compared with 
the 15% reported by Baczko el al. (1993). However, for the traditional PCR method i.e., 
using only one set of PCR primers, 60% of the clones produced sequence corresponding 
to the EdM sequence. This could reflect the specificity of the PCR reaction. The nested 
PCR method is more specific and sensitive, so may reflect more accurately the proportion 
of wild-type : mutated M gene species present within the SSPE virus population.
As both acute virus and ‘SSPE virus’ M gene could be detected, the experiment could be 
repeated using plaque purified YM-V. The resulting vims clone would need to be 
sequenced to determine whether the M gene sequence was that of YM-V or the acute 
vims. The purified YM-V could then be passaged and the cDNA cloned in a library
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rather than the amplified M gene being isolated by PCR. This would give a better 
representation of the population of M gene sequences within the virus population.
IV .1 .5  Future Research Priorities
IV.1.5.1 D ele ted  M  G e n e  P o p u la tio n
The presence of the deleted M gene population in the original virus stock needs to be 
confirmed as it is possible that the clones isolated from the experiments detailed here 
were produced due to the formation of unique ER sites by base substitutions. This could 
be done by making a cDNA library and isolating M gene clones using oligonucleotide 
probes relating to the 5'-end of the M gene cDNA. If deleted M gene clones are isolated 
this would suggest that the clones isolated in this project were not artefacts of the 
amplification and/or cloning procedures.
To determine whether functional protein could be translated from the deleted M gene 
population, the clones would have to be subcloned into an expression vector and the 
resulting protein purified. This protein could be analysed by western blot using 
polyclonal sera and/or monoclonal sera raised to epitopes at the amino terminus of the 
protein to determine the apparent molecular weight of the protein. The ability of the 
protein to interact with the nucleocapsid could be determined. The carboxy terminus is 
thought to be involved in the interaction of M protein with the surface glycoproteins (F 
and H), therefore it is unlikely that the deleted clones would still maintain this function. 
Reverse genetics of measles virus has been reported (Radecke el ai, 1995). This system 
could be employed using the deleted M gene in the mini-genome, rather than the full
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length, to determine what effects, if any, the deleted M gene may have on the phenotype 
of the infection. As the interaction between the M protein and the F and H proteins would 
not be expected to occur, one could hypothesise that assembly of the virus would be 
destroyed and a persistent infection would ensue.
IV .1 .5 .2  Y a m a g a ta -1  V iru s  H y p e r m u ta tio n  a n d  R e c o m b in a t io n
The first priority would be to make a cDNA library and to isolate M gene clones using 
oligonucleotide probes to the M gene of Yamagata-1 virus (Wong et al, 1989). A large 
number of clones would have to be isolated and sequenced from virus passaged in IMR- 
32 and SK-N-SH cells to determine whether the M gene population does contain a small 
population which is more extensively mutated than virus passaged only in Vero cells. If  a 
range of more or less mutated M gene clones was isolated, this would suggest that the 
clone from Yamagata-1 virus passaged in IMR-32 cells (Wong et al., 1989), which 
contained 38 additional U-C transitions, was a pre-existing variant rather than a response 
to propagation in the neuroblastoma cell line.
The sequence of the genomic (- sense) RNA of the Yamagata-1 virus also needs to be 
determined. As the predicted method of biased hypermutation relies on the deamination 
of adenosine residues in both strands of duplex RNA it is important that the base changes 
observed in the mRNA are also present in the genomic material. If this is not confirmed 
another hypothesis for the development of biased hypermutation would have to be 
suggested, for example, alkylating damage. RNA polymerase will incorporate cytosine 
quite readily if adenosine is methylated (1-MeA) (Saffhill et a l, 1985).242
General Discussion
Investigations to determine whether the chimeric clones of YM-V were the product of 
homologous recombination involving breaking and rejoining strands at regions of 
homology, or a copy choice mechanism in which the viral RNA polymerase switches 
templates during replication should be carried out. Using the reverse genetics, M gene 
sequence that does not contain the A-G base change at position 457 could be cloned into 
the mini-genome and the resulting virus progeny co-infected with plaque-purified 
Yamagata-1 virus. The Yamagata-1 virus stock has been shown to contain a 
heterogeneous population of both acute and mutated M genes. The purified stock would 
have to contain only the mutated M gene. The resulting virus progeny would be plaque- 
purified and individual virus plaques propagated to produce a virus stock. The M genes 
from these stocks would need to be sequenced to determine whether any chimeric clones 
had been produced. The experiment would also need to be repeated using M gene 
sequence which does contain the A-G mutation at position 457. An alternative method 
for determining whether recombination had taken place would be to carry out RNAses A 
protection assays. A radioactive probe complementary to the EdM sequence around 
nucleotide position 457 would protect acute M gene, but at the recombination site mis­
matches would occur where the sequence corresponds with the Yamagata-1 virus and 
RNAses A would degrade this region producing a different banding pattern.
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APPENDIX A
Attempted Identification of the Unknown Sequence
Appendix
The unidentified sequence (Figure 53) was isolated from YM-V passaged once and five 
times in IMR-32 cells, passaged in MRC-5 prior to five passages in SK-N-SH cells and 
passaged in MRC-5 cells followed by 5 passages in IMR-32 cells.
Figure 53. Comparison of the 5 -end sequence o f the unknown PCR fragment and 
the M gene sequence of measles virus
EdM UACAGCUCAACUUACCUGCCAACCCCAUGCCAGUCGACCAACUAGUACAA 50 
Unk UACAGCUCAACUUACCUGCCCAAAGUGCCCCUCACUUCCCUCCGGCAGAU 
* * * * * * * * * * * * * * * * * * * *  * ** * ** * * * *
EdM CCUAAAUCCAUUAUAAAAAACUUAGGAGCAAAGUGAUUGCCUCCCAAGUU 100 
Unk UGUGCUUCUGGAAAGUUGUGUUUAGUAAUAUCUUAAACACUCAUUAUUCA 
* ★* * **** * * * * * *
EdM CCACAALTGACAGAGAUCUACGACUUCGACAAGUCGGCAUGGGACAUCAAA 150 
Unk AGGAACCCUGCGGUGGUUCCUUCUGUAAAAGCAAGGCUCUGUUGGUGAAG 
* * ★* ★ ★ * * **
EdM GGGUCGAUCGCUCCGAUACAACCCACCACCUACAGUGAUGGCAGGCUGGU 200 
Unk GAAAUAACAAGCUCUAAAUGACUCGUAAUAAAUUAGAGCUUUGAUAUAAA 
* * * * * * * * * *  *
EdM GCCCCAGGUCAGAGUCAUAGAUCCUGGUCUAGGCGACAGGAAGGAUGAAU 2 50
Unk AAGCUCUGUCCUACAUGUAGGACUUACACGUUAGACGAAUUCUCUUCACC 
* *** * *** * * * * * *
The sequence identity between the 5’-end of the M gene of the Edmonston strain of measles virus (EdM) 
(Bellini el a!., 1986) and the unidentified sequence (unk) produced from Yamagata-I virus passaged once 
in IMR-32 cells. The fragment was amplified using the YMP/YM2 primer pair and subsequently cloned 
into the bacteriophage M l3. Sequencing reaction was carried out using the -40 primer, following the 
manufacturer’s protocol for Sequenase sequencing kit (USB). * indicated homologous bases. Bases in 
bold-type represent the YMP primer sequence. AUG', translation initiation codon for the M gene of 
EdM
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Identification of the unknown sequence cloned from Yamagata-1 viral passage material 
was attempted using two approaches. The first method was to carry out a homology 
search using the Blast Database. Searches carried out upto January 1995 did not reveal 
any homology with the 666, 201 nucleotide sequences stored on the database. The second 
approach was to look for measles virus-specific sequence linked to the unknown sequence 
using PCR primers located in the measles virus genes adjacent to the M gene i.e., the P 
and F genes.
Only the 5’-end 250 bases of the unknown sequence had been determined. In order to 
determine whether this M primer amplified product was located between the P and F 
genes, it was necessary to determine the 3 end of this sequence. The unknown sequence 
was excised from M13mpl8 vector and re-cloned into M13mpl9. This reverses the 
orientation of the insert, so sequence reactions using the -40 primer will produce the 3’- 
end sequence of the unknown material (Figure 54).
The position of annealing of the 3' primer (YM2) sequence, which was used to amplify 
the unknown material, could be determined from the sequencing gels, therefore, the 
sequence obtained was confirmed as the 3' region of the fragment that was originally 
amplified by PCR and cloned into M13 m pl8. A 5’ primer (YM4) for further 
amplification experiments could now be designed.
Apendix
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Figure 54. The 3'-end sequence of the unknown PCR fragment
ATACGTATAATGTAAATTGTTCCCTAAGCAAGGCTGCCTATATAATCTAC 812 
AAGATAAAAACTGGAAGTGGTTTTCTCTAGCGAGGGTGGCGGGGCTGTCC 862 
CTGCCCCACAGGAATCAGGATAACTGCCCTGCCGTGTGTTCAGCACTTTA 912 
GAATTTTCACATTCTTCAGAATCCCCTAGCACGGTAGGTAGGCAGTGCTG 962
Apendix
GGACCATTGTCCGCATTTACGACGACGTGTCGACT 1007
I___________________________ I
YM2 primer
A total of 6 primers (Table 32 and Figure 55) were used in order to determine if the 
unknown material, amplified using the primer pair YMP and YM2, was flanked by 
measles virus P and F genes
Table 32. Primers used for the identification of the unknown fragment
Gene Name Position Sequence Restriction
sites
Tm
°C
P P03 1174- 1192 5' CGC CAT TCC TGG ACT TGG G 3’ Sal I 62
F F01 289-273 3' GGC CAG GGT GGT CTG GG 5' Pst I 60
Unknown YM3 120- 102 3' GGA ACC CTG CGG AGG TTC C 5' Pstl 64
Unknown YM4 949-967 5’ GGT AGG CAG TGC TGG GAC C 3’ Bam HI 64
M YMP -73 to -54 5' TAC AGC TCA ACT TAC CTG CC 3' Hind III 60
poly A tail Oligo dT - 5’ TTT TTT TTT TTT TTT 3' Hind III 60
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Figure 55. Position of primers for identification of unknown sequence 
Unknown Fragment
Apendix
P gene
YM3 oligo T YM4
/ 1653 1 < - <-------- >
- » 1 1000
P03 YMP
F gene
F01
The following primer pairs were used for amplification experiments, Oligo T and YMP, 
P03 and YM3, F01 and YM4, YMP and F01 and P03 and F01. For all reactions the same 
cycle parameters were used, 94°C for 45 secs, 60°C for 45 secs and 74°C for 2 mins for a 
total of 30 cycles. Table 33 shows the fragment size which should be amplified for the 
oligo T/YMP and P03/YM3 primer pairs. For the remaining primer pairs used to identify 
the unknown sequence, namely, F01/YM4, YMP/FOl and P03/F03, the expected size of 
the amplified fragment can not be determined as the full length of the unknown sequence 
has not been determined.
Table 33. Fragment sizes expected to be amplified if the unknown sequence is 
linked to measles virus specific gene
Primer Pair Expected Fragment Size (bases)
Oligo T and YMP 750
P03 and YM3 584
Each primer pair was used in 8 reactions, with a negative control which did not contain 
any cDNA. Mock infected IMR-32 cDNA was used to verify that the primers did not 
bind to cellular material. ADD-MV cDNA, synthesised from total RNA extracted from 
infected Vero cells, was also used as a control. P03, YMP, F04 and oligo T would be
247
expected to anneal to ADD-MV material. However, primers designed from the unknown 
sequence i.e., YM3 and YM4, will not be expected to bind, therefore, for these reactions 
the ADD-MV cDNA should be acting as a negative control. Yamagata-1 virus passaged 
in MRC-5 cells and once in IMR-32 cells cDNA was also used as the clones obtained 
from this passaged virus (III.3.5.4) resembled the M gene of YM-V (III.3.4), again, the 
YM3 and YM4 primers would not be expected to bind to this material. And finally the 
four cDNA's that correspond to the virus passage that produced only this unknown 
sequence were examined; i.e., Yamagata-1 virus passaged once and 5 times in IMR-32 
cells; Yamagata-1 virus passaged in MRC-5 cells followed by 5 passages in IMR-32 
cells; Yamagata-1 virus passaged in MRC-5 cells and 5 times in SK-N-SH cells. Figure 
56 shows the results of these PCR reactions.
Amplifications using cDNA synthesised from ADD-MV resulted in the amplification of 
fragments even when primers designed from the unknown material were used, i.e., 
P03/YM3 primer pair (Figure 56). The fact that these primers did anneal to ADD-MV 
material made it impossible to confirm whether the unknown material was linked to the P 
and F genes of measles virus. It is possible that bicistronic transcripts were not 
synthesised at a detectable frequency in the material used in this experiment. Re­
designing the experiment so that genomic material would be amplified may be required to 
determine whether measles virus genes are associated with the unknown material. 
Another approach would be to use this unknown material as a probe and carry out 
northern blots on RNA isolated from Yamagata-1 virus infected cells, ADD-MV infected 
cells and uninfected cells to determine whether this material does bind to measles virus 
RNA species. As the 3" and 5'-ends of this unknown material are known, the full length
Apendix
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Figure 56. PCR reactions with the primers designed to identify the 
unknown fragment
Apendix
1: negative control; 2: mock infected IMR-32 cells; 3: ADD-MV; 4: virus grown in MRC-5 cells and one 
passaged in IMR-32 cells; 5: virus grown in MRC-5 cells and 5 passages in IMR-32 cells; 6: virus passaged 
once in IMR-32 cells; 7: virus passaged 5 times in IMR-32 cells; 8: virus grown in MRC-5 cells and 5 
passages in IMR-32 cells. Total RNA was isolated from these virus passages, cDNA was amplified using 
Oligo T, as such, bicistronic mRNA would be the material amplified in these experiments. SSPE brain 
material has been shown to contain a high proportion of bicistronic message (Cattaneo et al., 1986; 
Hummel et al., 1994). The cycle used was 94°C for 45 secs, 60°C for 45 secs and 74°C for 2 mins (30 
cycles). 10 pi of the reaction was run on a 1% agarose TBE gel.
of this unknown material could be sequenced and then used to search the database again, 
to determine if any homology exists between this material and any of the nucleotide 
sequences stored on the database.
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